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ABSTRACT
Collagen-glycosaminoglycan (CG) scaffolds for the regeneration of skin and nerve have
previously been fabricated by freeze-drying a slurry containing a co-precipitate of
collagen and glycosaminoglycan. Recently, mineralized collagen-glycosaminoglycan
(MCG) scaffolds for bone regeneration have been developed by freeze-drying a slurry
containing a co-precipitate of calcium phosphate, collagen and glycosaminoglycan. Bi-
layer scaffolds with CG and MCG layers have been developed for cartilage-bone joint
regeneration. The mechanical properties (Young's modulus and strength) of scaffolds are
critical for handling during surgery as well as for cell differentiation. The mechanical
properties of the MCG scaffolds are low in the dry state (e.g. they can be crushed under
hard thumb pressure) as well as in the hydrated state (e.g. they do not have the optimal
modulus for mesenchymal stem cells (MSC) to differentiate into bone cells). In addition,
there is interest in extending the application of CG scaffolds to tendon and ligament,
which carry significant mechanical loads. This thesis aims to improve the mechanical
properties of the both CG and MCG scaffolds and to characterize their microstructure and
mechanical properties.
Models for cellular solids suggest that the overall mechanical properties of the scaffold
can be increased by either increasing the mechanical properties of the solid from which
the scaffold is made or by increasing the relative density of the scaffold. In an attempt to
increase the solid properties, the MCG scaffolds with increasing mineral content were
fabricated. The mechanical properties were lower for the more highly mineralized
scaffolds as a result of an increase in the number of defects such as cracked and
disconnected walls. Next, we attempted to increase the mechanical properties by
increasing the relative density of the MCG scaffolds. The volume fraction of solids in the
slurry was increased by a vacuum-filtration technique. The slurry was then freeze-dried
in the conventional manner to produce scaffolds with increased relative densities.
Increasing the relative density by a factor of 3 increased the dry Young's modulus and
crushing strength roughly by 9 and 7 times, respectively, allowing the dry scaffolds to
withstand hard thumb pressure. The Young's modulus for the densest scaffold in the
hydrated state was in the optimum range for MSC to differentiate into bone cells. Further,
we attempted to improve the mechanical properties of the CG scaffold using the same
technique. We were able to achieve an increase in its tensile Young's modulus in the dry
state by a factor of aboutl0 times. Finally, the fraction of MC3T3 cells attaching to the
CG scaffolds was found to increase linearly with the specific surface area of the scaffold,
or with the number of binding sites available for cell attachment.
Thesis Supervisor: Lorna J. Gibson
Title: Matoula S. Salapatas Professor of Materials Science and Engineering
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CHAPTER 1. Introduction and Background: Collagen-
Based Scaffolds
1.1 Tissue engineering and regenerative medicine
Every year, millions of patients suffer tissue loss or end-stage organ failure as a result of
accidents or disease (Table 1.1). Over 8 million surgical procedures are performed to
treat these patients in the U.S. each year, and the overall health care cost for these
patients exceeds $400 billion per year [1-3]. Treatment options for organ injury depend
on the scale of the defect. Microscopic defects can be treated using a wide variety of
soluble factors (i.e., pharmaceuticals, vitamins, hormones, and antibiotics). Organ-scale
defects, presenting significantly larger sites, and requiring considerably different
treatment practices, are the focus of this thesis. Five approaches have been used to treat
organ or tissue loss: (1) autografting (the donor and the recipient are the same individual;
a fraction of the tissue or organ is harvested from an uninjured site and grafted at the
nonfunctional site), (2) allografting (transplantation between different individuals of the
same species), (3) xenografting (transplantation between individuals of different species),
(4) implantation of a permanent prosthetic device (devices are typically fabricated from
biologically inert materials such as metals, ceramics, and synthetic materials that do not
provoke immune response problems), and (5) tissue engineering. Table 1.2 lists the
-21-
advantages and disadvantages of all the above approaches. Tissue engineering uses three
general strategies for the creation of new tissues: (1) stem cells, (2) in-vitro synthesis of
organs, and (3) induced in-vivo organ regeneration [1, 4]. Porous, three-dimensional
scaffolds have been used extensively as biomaterials in the field of tissue engineering for
in-vitro study of cell-scaffold interactions and tissue synthesis and in-vivo study of
induced tissue and organ regeneration [4, 5].
Skin
Bone
Cartilage
Tendon and Ligament repair
Blood vessels
Pancreas
Urological
Dental
4, 750, 000
1, 340, 000
1, 150, 000
123, 000
1, 360, 000
728, 000
82, 000
10, 000, 000
Table 1.1. Number of cases of end stage organ
America per year [1].
or tissue failure in United States of
In addition to the above approaches; cell sheet engineering is a new technique for
culturing cells as intact sheets in-vitro without the use of bio-degradable scaffolds [6].
Using temperature-responsive culture dishes, cells can be harvested as intact sheets by
simple temperature changes, thereby avoiding the use of proteolytic enzymes. Cell sheet
engineering allows for tissue regeneration by either direct transplantation of cell sheets to
host tissues or the creation of three-dimensional structures via the layering of individual
-22-
cell sheets. By avoiding the use of any additional materials such as carrier substrate or
scaffolds, the complications associated with traditional tissue engineering approaches
such as host inflammatory responses to implanted polymer materials, can be avoided.
However, this method is in the initial phase and extensive research needs to be done
before it becomes viable.
Induced in-vivo organ regeneration is potentially the most advantageous approach with
the fewest limitations. It is the only method to modify the mammalian wound healing
response to induce regeneration (unlike the usual repair process). The host inflammatory
response in in-vivo organ generation can be overcome by using natural polymers such as
collagen, which is the focus of this thesis. Although the therapeutic promise for
regenerative medicine is immensely exciting, the cost of product development, and
particularly of clinical trials, for the more demanding applications will be high. However,
it has been shown (by comparing the cost per quality-adjusted life year, QALY, the
product of life expectancy and a measure of the quality of the remaining life years) that
the regenerative industry can yield an appropriate return on investment [3].
No Immunorejection
No diseases transmission
Better bonding of the graft
to the host tissue and long-
term graft stability [7]
Donor site morbidity
Shortage of donor sites
(especially for large wounds)
Tendency towards resorption [8]
Allografting o Avoids donor site morbidity o Donor shortage
in case of grafts taken from o Delayed remodeling of the host
cadavers tissue
o Economic compared to o Immunorejection leading to
autografts [9] lifetime use of
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o No size limitation on the immunosuppressants
grafts [10] o Concern of viral contamination [8]
o Ethical and religious concerns
Xenografting o Adequate supply o Immunorejection leading to
o Resist infection by human lifetime use of
viruses or recurrence of the immunosuppressants
diseases that caused organ o Concern of viral contamination
failure [11-13] o Inefficient performance compared
o Genetic manipulation of the to human tissues or organs
animal to customize the
transplantation [13]
Permanent o No Immunorejection o Lower quality performance. For
prosthetic o Prevents sudden failure and example: lack the ability to self-
devices death [14] repair and modify the structure
o Acts as a bridge to and properties based on the
transplantation [15] environment [8]
o Adequate mechanical o Unfavorable interaction between
stability for specific uses the implant and the surrounding
biological environment. For
example: formation of thick,
fibrous, scar tissue capsule around
the implants, accumulating wear
particles, and stress-shield of
surrounding tissue [4]
o Host tissue resorption
o Revision surgery [8]
Stem cells o Pluripotent behavior of stem o Difficulty in getting the cells to
cells to differentiate into mature and contribute
various phenotypes physiological functions [17]
o Through cloning, the genetic o Immunorejection, especially in use
capability of the donor's of embryonic stem cells [17]
nucleus is combined with o Not fully understood at this point
functional properties of the and further research is needed
recipient cytoplasm [16] o Ethical and religious concerns [4]
In-vitro o Total control over the culture o Construct size limit (< 1 cm) due
synthesis environment such as soluble to diffusion constraints as there is
regulator content (i.e., growth no angiogenesis [17]
factors, cytokines), insoluble o Complexity of biological systems,
regulator content (i.e., ECM specifically cytokine, growth
proteins), and a variety of factor, and inter-cellular signaling
cell culture medium and needs throughout the volume of
loading conditions [4] the developing tissue have
precluded the formation of
complex tissue in-vivo [4]
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In-vivo o Angiogenesis possible that o Host inflammatory responses,
synthesis relaxes the limit on construct especially in synthetic polymeric
size [17] scaffolds [6]
o Availability of nutrients from o Difficult to regenerate complex
the surrounding tissue organs as a whole
Table 1.2. Limitations of current treatment methods to repair the organ or tissue
failure.
1.2 Design parameters for scaffolds in tissue engineering
Scaffolds for tissue regeneration are three dimensional porous matrixes which mimic
body's own extracellular matrix, onto which cells attach, multiply, migrate, and begin
synthesizing new tissue [18]. Scaffolds can also potentially serve several additional
functions, such as (1) structurally reinforcing the defect, (2) preventing ingress of
surrounding tissue, and (3) acting as a delivery vehicle for cells, growth factors, or genes
[19]. Although unproven, a widely believed design paradigm for scaffolds is that the
scaffold should mimic the composition of the natural extracellular matrix as closely as
possible in order to have better regenerating capability [20]. Biologically active scaffolds
used for tissue regeneration must meet a number of biophysical and biochemical
constraints. The required parameters can be explained in terms of the properties of the
polymer of which the scaffold is made (i.e. biocompatibility, biodegradability, cell-
polymer interaction, and release of bioactive molecules) and the properties of the overall
scaffold (i.e. pore size, porosity or pore volume fraction, and mechanical properties of the
scaffold).
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Biocompatibility
One critical parameter for polymers for tissue engineering applications is
biocompatibility. Biocompatibility relates to a material's ability to exist within the body
with no inflammatory response and no toxicity to cells. The products of degradation must
also be biocompatible. Naturally derived polymers often demonstrate adequate
biocompatibility, while synthetic polymers may elicit significant negative responses from
the body [21]. Adhesive interactions of cells with polymers may significantly affect the
proliferation, migration, and differentiation of cells to be engineered. The adhesion of
cells to polymer scaffolds may be cell-type specific, depending on the interaction of
specific cell receptors that recognize adhesion molecules (i.e. ligands) at the surface of
the material. The ligand molecules can either be inherent components of the materials (in
case of natural polymers) or be artificially introduced into the materials (in case of
synthetic polymers).
Biodegradability
Controlled degradation of the polymer scaffold is critical to tissue engineering. The
degradation rate of the polymer has to be almost equal to the regeneration rate of the
extracellular matrix by the cells. The degradation rate must allow the scaffold to remain
insoluble for the duration of the critical cellular processes, a time period particular to
each biological system [5, 22, 23]. Some synthetic polymers are non-degradable while
others have cytotoxic degradation byproducts, limiting their use in-vivo.
Pore microstructure
The pore size of the scaffold must be large enough to allow cell migration into the
scaffold. However, the pores have to be small enough that the specific surface area
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provides a sufficiently large number of binding sites for cell attachment. And to allow for
transport of cells and metabolites, the scaffold must have a large pore volume fraction
(generally greater than 90%) as well as an interconnected pore network [24].
Mechanical properties
Controlling the mechanical properties of the scaffold is also an important design
parameter, as the adhesion and gene expression of interacting cells may be related to the
mechanical properties of the scaffold [21, 25]. Recently, Engler et al.. [26] showed that
human mesenchymal stem cells (MSC) differentiate into specific lineages and commit to
phenotypes (neurogenic, myogenic, and osteogenic) depending on the substrate elasticity.
They used an inert polyacralymide gel with varying concentrations of bis-acrylamide
crosslinker that controls the matrix stiffness to mimic various tissue microenvironments.
Cell adhesion was provided by coating the gel with type I collagen that is known to
support myogenic and osteogenic differentiation. On soft collagen coated gel that mimics
brain elasticity (Ebrain - 0.1 - 1 kPa) [27], MSCs cultured for several weeks differentiated
into neurogenic cells. MSCs on 10-fold stiffer matrices that mimic muscle elasticity
(Emuscle - 8 - 17 kPa) [28] lead to myoblast-like cells. Stiffer matrices (25 - 40 kPa) that
mimic the crosslinked collagen of osteoids [29] yielded osteoblast-like cells. The
mechanical properties of the scaffold depend on the inherent physical characteristics of
the solid polymer (which, in turn, depend on the type and density of cross-links), as well
as on the relative density of the scaffold (the density of the cellular solid, divided by that
of the solid from which it is made).
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Release of bioactive molecules and ease ofprocessing
Release of bioactive molecules (e.g. growth factors) is another critical element in
engineering large tissues as it helps in development of new vascular network structures,
which enable the delivery of sufficient oxygen and other nutrients to the engineered
tissues. Also the scaffold material should be such that it is easily processed into three-
dimensional shapes of irregular geometry.
1.3 Biomaterials for scaffolds in tissue engineering
Natural polymers
Figure 1.1 is a schematic showing the different categories of biomaterials used to
fabricate scaffolds for tissue engineering [30, 31]. Natural-organic polymers are isolated
directly from the natural extracellular-matrix (ECM) and therefore contain a host of
surface ligands appropriate for the formation of cell-scaffold complexes. Additionally,
the degradation rate of natural-organic polymers can be controlled through the degree and
type of crosslinking techniques and the degradation products are non-toxic. However,
they typically do not exhibit the required mechanical properties for regenerating hard
tissues like bone. Among all the natural-organic polymers collagen is the most versatile
substrate for supporting cell proliferation and differentiation. Type I collagen is the
predominant form found in the ECM of various tissues. Its low antigenicity and
immunogenicity make it attractive for scaffolds [31]. Collagen has been approved by the
United States Food and Drug Administration (FDA) for many types of medical
applications including wound dressing and artificial skin. Glycosaminoglycans (GAG)
are a significant part of proteoglycans (another class of organic polymers found in the
ECM) and have been used extensively for tissue engineering scaffolds. Copolymers of
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collagen and GAG (CG) have been used to regenerate skin, conjunctiva, and peripheral
nerves [31]. Copolymerization of collagen and GAG has been observed to increase the
stiffness and toughness and decrease the degradation rate of collagen. CG scaffolds are
primarily manufactured using a freeze-drying process from a suspension consisting of co-
precipitated collagen and GAG from acetic acid solution. The details of this method will
be described later in this text. Alginate, a polysaccharide isolated from seaweed, is
biocompatible and has been approved by the FDA for human use as a wound-dressing
material. It has also been used as an injectable cell-delivery vehicle [32].
Synthetic polymers
Figure 1.1 lists the major synthetic polymers used in tissue engineering [20, 30, 31]. Due
to the fact that they are chemically synthesized, it is possible to control (with varying
degrees of accuracy depending on, among other factors, the type of polymerization
reaction) their stiffness and degradation rate. Another benefit to using synthetic polymers
is that a range of processing techniques, some involving high temperature and pressure
(which is not possible in case of natural polymers), can be used to produce scaffolds with
complex microstructure. Cells do not necessarily recognize synthetic polymer surfaces.
Integrin or receptor binding, critical for the necessary cell-ECM communication, is
lacking in synthetic polymeric scaffolds [33]. Another area of concern is scaffold
degradation; some synthetic polymers are non-degradable while others have cytotoxic
degradation products.
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Figure 1.1. Various biomaterials used as tissue engineering scaffolds [30, 31].
Porosity can be introduced into synthetic polymeric scaffolds using a variety of
techniques such as particulate-leaching, emulsion freeze-drying, phase separation, 3-D
printing and gas foaming. Particulate-leaching involves dispersing water soluble
particles, such as salt, sugar, or polymer spheres in a matrix consisting of the scaffold
material and an organic solvent. The solvent is evaporated and a composite of scaffold
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Scaffold I
material and the water soluble particles remains. The composite is immersed in water in
order to dissolve the water soluble particles resulting in a porous scaffold. Emulsion-
freeze drying involves creating an emulsion by homogenizing a polymer solvent solution
and water. The mixture is quenched in liquid nitrogen and later freeze-dried to obtain the
porous scaffold. Phase separation involves thermodynamic demixing (either by cooling
the mixture below a bi-modal solubility curve or exposing it to another immiscible
solvent) of a homogeneous polymer/solvent mixture into polymer rich and solvent rich
phases. 3-D printing is a solid free form technique, in which the sliced two dimensional
profile of a computer model is printed on a fresh layer of powder via deposition of a
suitable binder. Successive 2D profiles are then printed on freshly laid layers of powder
until the whole model is completed. The printed binder joins the respective profiles of
each layer together. The part is completed upon removal of the unbound powder and
suitable post-processing (e.g. by sintering). 3D printing in combination with salt leaching
has been used in the past for fabricating scaffolds for tissue engineering [34, 35] that
involves directing a solvent onto polymer packed with salt particles to build a complex 3-
D structure from a series of thin 2-D slices. The salt particles are dissolved by immersing
the composite structure in water. Scaffolds with macro-pores (via 3D printing) on the
order of 800 [m and micro-pores (via salt leaching) on the order of 45-150 [im were
fabricated. The structure is computer controlled to obtain custom designs. Gas foaming
involves exposing the polymer to high pressure carbon dioxide (-800 psi) for around 48
hours to saturate the polymer with gas [20]. When the pressure is slowly reduced to
atmospheric pressure, carbon dioxide nucleates within the polymer, forming pores.
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Polymeric microspheres are used in order to deliver growth factors (which stimulate and
increase the production of connective tissue, promote remodeling and help supply blood
vessels to nourish the site to be regenerated) to the regenerating site. Growth factors can
be encapsulated in microspheres which are then subsequently introduced into the
scaffolds. Growth factor delivery is regulated by the degradation of the polymer of which
the microspheres are made: e.g. synthetic polymers such as PLA/PGA copolymer, or
natural polymers (e.g. gelatin). Microspheres are made by techniques such as
water/oil/water emulsion, oil/water emulsion, and spray-drying [20].
Decellularized matrices
Decellularized matrices are derived by decellularizing the native tissue by enzymatic or
detergent methods instead of fabricating a three dimensional scaffold from synthetic or
natural polymers. Decellularized matrices are either allogenic or xenogenic. Examples of
decellularized allogenic matrices include the small intestinal submucosa (SIS) construct
and naturally derived collagen matrix (NDCM) [31]. Xenogenic (pig) decellularized
matrices are mostly used in case of heart valves. However the challenge is to
decellularize without disrupting the complex structure of extracellular matrix. Therefore
these matrices will not work for all applications, especially not for more complex systems
such as liver or the heart [36].
Bioceramics
Bioceramics are widely used as inorganic biomaterials in bone tissue engineering, with
tricalcium phosphate (TCP) (Ca 3(PO 4)2), octacalcium phosphate (OCP)
(Ca 8(HPO 4)2 (PO 4)4 .5H 20) and hydroxyapatite (HAP) (Cal0 (PO4)6(OH) 2), and their
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combinations, being the most frequently used. Hydroxyapatite is the major constituent of
bone, constituting - 75% by dry weight and responsible for much of its mechanical
stiffness and strength. CaP-based scaffolds are biocompatible and have the unique
capacity to bond directly to bone. They are osteoconductive and bioactive despite their
low degradation rate. However, their usage by themselves is limited because of their
brittle nature and the difficulty in processing them into highly porous structures with
controlled porosity. The simplest way to generate porous scaffolds from ceramics such as
HAP is to sinter particles, preferably spheres of equal size [37]. Briefly, ceramic particles
in a wetting solution such as poly (vinyl alcohol) are compacted through cold isostatic
pressing followed by sintering. A more advanced way of making ceramic scaffolds with
higher porosities is by adding porogens such as polymer foams and polymer gels
followed by sintering. During sintering the porogen is burnt out leaving a highly porous
ceramic scaffold [37]. Another process for making porous ceramic scaffolds is gel-
casting where the polymer foam is formed in situ by a catalyst. The polymer is burnt out
during sintering of the ceramic-polymer construct [37].
Bioactive glasses
Bioactive glasses composed of 45 to 52% SiO 2, 20 to 24% CaO, 20 to 24% Na20, and
6% P2 0 5 have been successfully used to regenerate both bone as well as soft connective
tissues [30]. However, like CaP-based biomaterials, these bioactive glasses are relatively
stiff and brittle and difficult to form into complex shapes, particularly as porous
scaffolds, making their application limited in vivo [31]. The basic way to make porous
bioactive glasses is by sol-gel foaming. Briefly, hydrolysis of alcoxide precursors, such
as tetraethyle orthosilicate, forms a colloidal solution (sol). Polycondensation of-Si-OH
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groups continues after hydrolysis is complete, beginning the formation of the silicate (-
Si- O-Si-) network. As the network connectivity increases, viscosity increases and
eventually a gel forms. The gel is then subjected to controlled thermal treatment of
ageing to strengthen the gel followed by sintering to eliminate the organic species [37].
Rapid prototyping techniques, such as 3D printing, stereo lithography, laser sintering, are
also used to fabricate bioactive glass scaffolds.
Composites ofpolymers and ceramics
Composite scaffolds with synthetic or natural polymers and calcium phosphate have been
developed for high strength applications, mainly for bone. Most of the fabrication
techniques for synthetic polymer based composite scaffolds use particulate-leaching in
combination with other techniques. Laurencin and his co-workers have developed
composite PLGA/HA scaffolds via a combination of emulsion freeze drying and salt-
leaching techniques [38]. Solvent casting followed by salt-leaching is a common
technique wherein the polymer/ceramic/porogen/slovent mixer is cast into a mold and the
solvent is evaporated at room temperature followed by dissolving the composite in a
suitable solvent to remove the porogen [39-41]. Pal et al. have used hot isostatic pressing
along with salt leaching to fabricate high strength composite scaffolds [42]. Jung et al.
have used a sintering technique along with salt leaching in order to overcome the problem
of residual solvent in the scaffold [43]. Gas foaming followed by salt leaching is another
technique to fabricate composite scaffolds. Freeze drying is also used to produce
composite scaffolds wherein the polymer/ceramic/solvent mixture is frozen to obtain
interconnected ice crystals of the required size and shape. Sublimation of the frozen
slurry leaves behind the foam-like network of struts with interconnected pores [44, 45].
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3-D printing followed by freeze drying is also used to make composite scaffolds [46, 47].
In brief, the polymer/ceramic/solvent is 3-D printed onto a liquid nitrogen cooled base
plate followed by sublimating the frozen composite template. This technique produces a
bimodal pore distribution with macro- and micro pores (macro-pores resulting from the
3-D printing template and micro-pores resulting from the freeze drying of the struts of the
3-D template).
Composite scaffolds of collagen with a calcium phosphate mineral (eg HA and TCP)
have also been developed to regenerate bone. Freeze drying is widely used to make
collagen based composite scaffolds. Collagen/ceramic composite scaffolds have been
developed by mechanical mixing of the collagen fibers and ceramic powders in a solvent
followed by freeze drying [48, 49]. Rucker et al. have developed collagen/HA/chitosan
scaffolds via 3-D printing wherein the composite slurry (formed by mechanical mixing)
is 3-D printed onto a liquid nitrogen cooled base plate followed by solvent removal using
ethanol [50]. Gelatin/chitosan/ceramic (HA or TCP) scaffolds have been developed by
freeze drying the slurry [51, 52]. Most of these processes include mechanical mixing of
the desired amount of the ceramic particles with the natural polymer. The major problem
with these methods is that the mineral phase does not form in situ and simply adheres to
the outside of the collagen or gelatin fibers forming agglomerates [53]. A more advanced
method is the biomimetic approach, the precipitation of mineral phase within the polymer
solution (which is known as direct mineralization) [49, 54-57]. Using this method, the
collagen-HA composites have been synthesized to maintain the nanoscale HA
precipitates along the collagen fiber. In brief, precursors of calcium and phosphorous (eg.
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Ca(OH)2 and H3P0 4 for Ca and P respectively) are added to the collagen solution where
the mineral phase directly precipitates on the collagen fibers. Researchers have also
added osteonectin to the collagen-HA composite (accounts for - 20-25% of non-
collagenous proteins in demineralized bone) in order to facilitate the formation of a
hierarchal matrix with c-axis of the nano-HA oriented parallel to the longitudinal axis of
the collagen fibril [58]. The mineralized collagen solution is freeze dried to obtain the
porous scaffold. Inspired by the collagen-HA composites, Chang et al. and Kim et al.
have synthesized gelatin-HA composites by the direct mineralization method [53, 59].
Composite scaffolds of collagen/HA/PLA have been developed by direct mineralization
processes [60]. However, most of these processes use a titrant to control the pH of the
solution (in order to control the mineral phase precipitated). Therefore, they have the
inherent problem of residual contaminant titrant phase. In these processes the pH of the
solution is usually maintained in the range of 7-10. However, collagen fibers only
become highly swollen and disaggregated and lose their banding (keeping the triple
helical structure intact) below a pH of 4.25±0.30 [5]. For direct mineralization, it is
desirable to precipitate calcium phosphate particles within and between the collagen
fibrils in order to mimic the nanoscale structure of bone. This is achieved when the
collagen fibrils are disaggregated without losing their triple helical structure. Therefore,
the above processes do not mimic the nanoscale structure of bone even though they
increase the mechanical properties (Young's modulus and strength) of the scaffold by
many fold.
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This thesis focuses on porous, mineralized as well as unmineralized, type I collagen-
glycosaminoglycan (CG) scaffolds for soft and hard tissue regeneration. Collagen is a
significant constituent of natural extracellular matrices (ECM) and possesses the right
biochemical properties such as low level of antigenicity and optimal biodegradation rate
without release of toxic products [61]. Collagen is amenable to very high degree of
purification and, in the form of reconstituted crosslinked fiber, tape, or membrane, is
sufficiently tough to be useful in many surgical applications. The physical properties of
solid collagen are also relatively well understood. Even though the biodegradation rate of
collagen can be adjusted over a wide range by controlling the crosslink density, heavily
crosslinked collagen is a stiff, brittle material [61]. Coprecipitation of collagen with
glycosaminoglycan (GAG) yields membranes which are significantly more resistant to
degradation than is pure collagen and can be used as an alternative to crosslinking for
control of biodegradation. In addition, CG copolymer possesses significantly higher
modulus of elasticity and higher energy to fracture than pure collagen. Another reason for
using GAG is that CG scaffolds exhibit a significantly more open pore structure than the
GAG-free collagen scaffolds [61]. CG scaffolds made from collagen have been used in a
variety of applications [24].
1.4 Collagen-GAG (CG) scaffolds for soft tissue regeneration
Dermal and nerve regeneration templates
CG scaffolds were originally developed by the research group of Prof. I. V. Yannas at the
Massachusetts Institute of Technology and were first used for the dermal-regeneration-
template (DRT) in 1975. This was followed by DRT's early clinical use (1979), as a cell-
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seeded scaffold to regenerate skin (1981), and its eventual approval by the US Food and
Drug Administration (FDA) for the treatment of massively burned patients and patients
undergoing plastic and reconstructive surgery of the skin. This was the first tissue-
engineered device approved by the FDA (1996) [62]. Recently, the cell-free DRT
scaffold (Integra LifeSciences) was found to be a very effective treatment, by induction
of skin regeneration, for deep skin ulcers in patients [63]. Another scaffold developed by
Yannas' group, the nerve regeneration template (NRT), has induced regeneration of
peripheral nerves across unprecedented distances (> 25 mm); an early version has been
approved by the FDA for treatment of patients suffering from paralysis resulting from
severe injury in the peripheral nerves of the arms, legs or the face [24, 62]. Figure 1.2
shows scanning electron micrographs of the DRT scaffold and the nerve regeneration
template developed by Prof. Yannas at MIT. CG scaffolds have also been used for a wide
variety of in vitro studies of cell migration, contraction, and tissue growth [4, 24, 64-66].
(a) (b)
Figure 1.2. (a) The dermal regeneration template (DRT) and (b) the nerve
regeneration template (NRT) developed by Yannas et al. at the Massachussetts
Institute of Technology [67].
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Fabrication of the CG suspension
To fabricate CG scaffolds, a collagen-glycosaminoglycan suspension is first produced.
Microfibrillar type I collagen is mixed with acetic acid (0.05M, pH - 3.2). The low pH
acetic acid solution acts to swell the collagen fibers, destroying the native banding
structure of collagen but keeping the triple-helical structure intact [61]. These structural
modifications reduce host immunological response and significantly prolong the whole-
blood clotting time of the scaffold that is critical for bonding of the scaffold to the defect
site [61]. A glycosaminoglycan (GAG), typically chondroitin 6-sulfate, is then added to
the collagen-acetic acid mixture. Spontaneous crosslinks are formed between the collagen
fibrils and the GAG, resulting in the formation of a collagen-GAG suspension in the
aqueous acetic acid phase.
Freeze drying of the CG scaffolds
The CG scaffold is manufactured by freeze-drying the CG suspension. Freeze drying is a
two step process in which a temporary space holding network is infiltrated with the
material to be shaped and then removed during the sublimation step. The temporary
network is formed in situ by freezing the solvent in the CG suspension (i.e., acetic acid
solution) below its melting point. In the second step the network is then removed by
sublimation of ice crystals formed during freezing, avoiding any liquid contact of the
biomaterial which might otherwise dissolve. Freeze drying is best described using an
illustration (Figure 1.3) of the phase diagram of the CG suspension during the process. At
first the CG suspension is frozen from the initial room temperature and pressure to a
freezing temperature at a constant cooling rate (A to B in Figure 1.3). Previously,
quenching was used to freeze the CG suspension; however, due to variable heat transfer
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through suspension, the pore microstructure was heterogeneous. A constant cooling rate
during freezing ensures a more controlled heat transfer and hence a homogeneous pore
microstructure. The suspension is then kept at Tf and Pat,,, for time, tf, where tf is long
enough (usually - 1 hr) to completely solidify all the solvent. During this step the CG co-
precipitate is localized between the growing ice crystals, forming a continuous,
interpenetrating network of ice and the CG co-precipitate. Finally upon application of
vacuum (Psub) and heating (Ta,,) for time tsub, direct sublimation removes the ice crystals
(B to C in Figure 1.3), leaving a highly porous scaffold structure where the scaffold
microstructure is defined by the ice crystals formed during solidification. Ultimately the
scaffold is brought back to room temperature and pressure (C to A in Figure 1.3).
Pore size can be controlled by controlling the size of the ice crystals that nucleate during
freezing of the CG suspension [68]. Final pore size depends on both the nucleation rate
and the growth rate of the ice crystals. The number density of the pores will depend
mostly on nucleation (highest at largest undercooling). Nucleation of ice crystals can be
increased by increasing the chemical free energy (and so the under-cooling - Tm - T),
where Tm is the melting temperature of the solvent (- 0.01oC). Hence by decreasing Tf
much below Tm the final pore size can be decreased [68]. Slower cooling rate during
freeze drying has the effect of decreasing the nucleation rate and increasing the growth
rate of the ice crystals that do form, making them larger than the ones formed at higher
cooling rates (where nucleation is delayed to lower temperatures where more ice crystals
nucleate but they can not grow as much).
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Figure 1.3. Phase diagram of the CG suspension during freeze drying [4].
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Crosslinking of the CG scaffolds
Crosslinking is carried out after freeze drying. The extent of crosslinking depends on the
required mechanical properties and degradation rate of the scaffold. Highly crosslinked
scaffolds impart high strength and stiffness but they take longer to degrade. Therefore we
have to optimize the degree of cross-linking for the required mechanical properties and
degradation rate. Crosslinking can be chemical (e.g., glutaraldehyde or carbodimide) or
physical (e.g., dehydrothermal treatment or ultraviolet irradiation) [4, 31, 68]. However,
in case of the chemical crosslinking, there is a risk of post-implantation toxicity due to
residual crosslinking agent. Here we will describe only two methods that are important
for collagen-GAG scaffolds: dehydrothermal treatment (DHT) and carbodimide
crosslinking. DHT involves exposure of collagenous biomaterial to heating at 105 0C
under vacuum (-30 mTorr) for 24 hours. This results in crosslinking between the
polypeptide chains of the collagen fibers. 1-ethyle-3-(3-dimethylaminopropyl)
carbodimide (EDAC) is used to create chemical crosslinking between the carboxyl group
(COOH) of GAG and the amino group of collagen. The degree of cross-linking is varied
by the addition of N-hydroxysuccinimide (NHS). Optimization of the ratio of EDAC to
NHS to COOH- groups can also further affect the extent of cross-linking [69]. EDAC
crosslinking is carried out in the hydrated state where the scaffolds are hydrated in
deionized water for -15 min followed by mixing the required amount of EDAC/NHS
solution into the deionized water and maintaining the scaffold in this solution for -1 hr.
The scaffolds are subsequently freeze dried to obtain dry scaffolds.
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Figure 1.4. (a) Contours ofpH and (b) mass yield of the mineral for the titrant free
triple co-precipitation method [69, 70].
1.5 Mineralized collagen-GAG (MCG) scaffolds: titrant free triple co-precipitation
method
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As described above (section 1.3), current methods used to fabricate mineralized
composite scaffolds do not mimic the nanoscale structure of bone even though they
increase the mechanical properties by many times. The most recent fabrication technique,
developed by Lynn et al. [70-73], improves upon this by forming a triple co-precipitate of
mineral, collagen and glycosaminoglycan, without using a titrant, by controlling the
molarity of the reactant acid and molar ratios of the different calcium sources. Three
reactants in this case are used: (1) solvent-phosphoric acid (H3PO 4) solution, (2) dry
calcium nitrate (Ca(N0 3)2.4H20) powder, and (3) dry calcium hydroxide (Ca(OH)2)
powder; Ca:P ratio is always kept at 1:1.
Control ofpH and mineral content
Different concentrations of H3PO4 and ratios of calcium-nitrite:calcium-hydroxide are
responsible for different pH and different mass yield of the mineral. Contours of pH and
mass yield are drawn versus concentrations of H3PO 4 and ratios of calcium-
nitrite:calcium-hydroxide (Figure 1.4). Therefore for a particular pH there will be a locus
of points on the H3PO4 concentration and nitrite:hydroxide ratio. For the same locus of
points, there will be different mass yields and hence we can obtain a particular
combination of "H3PO 4 concentration and nitrite:hydroxide ratio" for which the mass
yield will be maximum. Hence this is useful in fabricating scaffolds with control over the
amount of mineral content. In addition, the pH is maintained below 4.25 + 0.30, assisting
in the in situ co-precipitation of the mineral phase within the collagen fibers, increasing
the mechanical properties of the scaffold while mimicking the natural bone structure. The
pH of the triple co-precipitate slurry for mineralized CG scaffolds with different mineral
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contents is shown in Figure 1.5. As described above, co-precipitation of CG copolymer
takes place at an acidic pH of 3.2 [61]. At this lowpH the stable calcium phosphate phase
obtained in the triple-co-precipitation method is brushite (CaHPO 4.2H 20). Freeze drying
is then used to fabricate porous dry scaffolds from the triple co-precipitated slurry [74].
Mineralized collagen-GAG scaffolds are cross-linked through any of the two methods
described above (section 1.4), preferably EDAC.
4.0
3.5
pH 3.0
2.5
2.0
20% 40% 60% 80%
Mass fraction, CaP
Figure 1.5. pH of the triple co-precipitate for different mineral content
mineralzied CG suspension [69, 70].
Control of biodegradability via hydrolysis
In addition to the extent of crosslinking, the other factor that affects bio-degradability is
the ratio of different mineral phases in the scaffold [69]. Bone has collagen microfibrils
which are surrounded by very small crystals of hydroxyapatite, whose unit cell contains
Cao(PO4)6(OH)2. However the bone mineral is impure and has many structural
substitutes (e.g., carbonate, fluoride, citrate). As described above, the stable mineral
phase obtained under an acidic pH is brushite. However, brushite can be converted to
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octacalcium phosphate (Ca 8(HPO4)2(PO 4)4 .5H 20) and octacalcium phosphate in return
can be converted to hydroxyapatite through hydrolytic conversions. Therefore different
compositions of these three forms can be maintained in the final scaffold by carrying out
partial hydrolytic conversions. However, brushite is very soluble where as hydroxyapatite
is less soluble with octacalcium phosphate some where intermediate between them.
Hence by varying the relative composition of these three mineral phases, we can vary the
bio-degradability of the scaffold. Mineralized CG scaffolds with 50% by weight mineral
has been developed via titrant free triple co-precipitation method by Lynn et al. [69, 70,
75]; the relative density of which is 0.15.
1.6 Chondral and osteochondral defects
Current repair strategies and limitations
Bi-layer scaffolds have also been designed for regenerative repair of chondral (defective
cartilage) and osteochondral (defective cartilage as well as subchondral bone) defects of
articular cartilage [76]. The current strategies for clinical treatment of these defects
include microfracturing (Figure 1.6a), mosaicplasty (Figure 1.6b), and autologous
chondrocyte implantation (ACI) (Figure 1.6c) [19]. Microfracturing involves removing
the defective cartilage followed with making perforations, or "microfractures", in the
subchondral bone plate, introducing blood and marrow into the cartilage defect. This in
turn stimulates formation of fibrin clot that acts as a provisional scaffold into which cells
can migrate and begin synthesizing reparative tissue [77]. It has been reported that the
reparative tissue formed post microfracture in human is primarily fibrocartilage that is not
as efficient as healthy cartilage for long term load-bearing situations [78]. Mosaicplasty
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involves transplanting single or multiple cylindrical healthy osteochondral grafts taken
from low load-bearing regions of the joint into holes created at the defect site. Several
inherent difficulties with this procedure include: donor site morbidity [79], chondrocyte
death due to the harvest procedure [80] and impact loading during the placement of the
graft [81], mismatch of stiffness between transplanted and recipient tissue [82], increase
in subchondral bone density at the recipient tissue [82], and incomplete integration with
the host cartilage [83]. Autologous chondrocyte implantation involves implanting
autologous chondrocytes which have been proliferated in vitro. Cartilage biopsies from
low load-bearing regions of the same or other joints are enzymatically digested to isolate
the chondrocytes. The cells are expanded in vitro to obtain a sufficient number to
populate the defect site when re-implanted. The defect site along with the condrocytes is
then sealed using a periosteal flap that is sutured in place and glued via fibrin glue.
However, it has been shown that the reparative tissue formed post ACI is primarily
fibrocartilage that is not as efficient as healthy cartilage for long term load-bearing
situations [8].
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Figure 1.6. Current repair strategies for cartilage chondral and osteochondral
defects: (a) microfractures, (b) mosaicplasty, and (c) autologous chondrocyte
implantation.
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Proposed method using a bi-layer scaffold
The proposed new procedure involves removing the defective cartilage as well as the
subchondral bone below the defective cartilage and replacing it with two layers of
scaffold, one for the cartilage and the other for the bone. The top layer is unmineralized
collagen-GAG scaffold for cartilage repair while the bottom layer is mineralized
collagen-GAG scaffold for bone regeneration (Figure 1.7). This procedure using a bi-
layer scaffold has been shown to regenerate cartilage and bone in an osteochondral defect
in a goat knee joint by Vickers et al. [19]. As said earlier, the closer the scaffold
composition and structure are to the real tissues, the better the regeneration. In an
articular joint, the interface between the bone and cartilage is diffused that decreases any
sharp gradients in mechanical properties (mostly shear properties) at the interface.
Therefore it is desirable to have a diffuse interface between the two layers of scaffold.
This is accomplished by pouring one slurry on top of the other: collagen-GAG slurry is
kept on the bottom and mineralized collagen-GAG slurry is kept on top of it. They are
allowed to inter-diffuse at the interface for -5 min. The combined layers of slurries then
undergo normal freeze drying. The advantage of this procedure is to obtain an inter-
diffused bi-layer without any sharp gradients in mechanical properties. As described
earlier EDAC crosslinking is compatible for both the layers (collagen-GAG and
mineralized collagen-GAG) and therefore the bi-layer scaffold is crosslinked via EDAC
after freeze drying.
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Figure 1.7. Proposed method to repair chondral and osteochondral defects using a
bi-layer CG scaffold.
1.7 Mechanical properties of the collagen-based scaffolds
CG scaffolds
Quantitative mechanical analysis of CG scaffolds, previously found to have equiaxed
pores and a uniform pore microstructure (P*/ps: 0.0058; mean pore size: 96-121 gtm) [66,
68], has been performed by Harley et al. [17]. The effect of mean pore size, crosslink
density, and relative density on scaffold mechanical properties (Young's modulus, E*,
and collapse strength, a*) for the unmineralized CG scaffold has been listed in Table 1.3
[17]. Mechanical properties were found to be independent of the pore size (or mean pore
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diameter). Hydration decreased the mechanical properties further by a factor of 150 for
the Young's modulus and 250 for the collapse strength. Post-fabrication crosslinking
increased the mechanical properties by a factor of 7 for Young's modulus, and by a factor
of 3.6 for the collapse strength. With an increase in relative density by a factor of 3, the
mechanical properties roughly increased by 3 times. However, the elastic strain, e*,
remained independent of pore size, crosslink density, and relative density. The Young's
modulus (Es) of the individual scaffold struts (dry and DHT crosslinked) that define the
scaffold microstructure was measured via AFM to be 762 MPa [17].
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Test Scaffold f E 4 7g Awo e
I Variant
Effect of mean pore size (dry) kP I t, Pa 4 JaM, kPa
96 m_ 31.7 3.9 i 53501630 1 0.184-0.017 7.0 0,9
11 m 28.5 3.4 4810 *520 0.196* 0.024 9.2 1.5
121 gm 29.8 * 3.9 5290 280 0.202 + 0.021 10.6 ± 1.9
151 pm 39.4 4.5 6250 280 -0.182 0.027 13.9 * 3.8
Effect of mean pore size 9 , Pa of, Pa dd A e, Pa
96 m 206: 36 18*4 0.079*0.017 98* 15
110 176*41 14+8 0.076±0.031 83 ± 11
121 pm 221 *47T 31 5 0.151 + 0.055 93 a 11
151 pm 229 2222 4 0.107* 0.022 94 18
Effect of crossik density E, , A
(hdted) normaaed normalized normalized normalized
_S_____ 0 Z* 4I Pi * a& 4 9a*14Pa
NX 0.74 0.13 0.73 0.096 094 0.073 0.85 a 0.23
________ 4 D.0+ OSI 1 .L A*7 1.0* &*P093 .
DHT120/48 1.08 ± 0.063 1.03 a 0.076 1.02 0.091 1.03 ± 0.11
EDACI:1:5 2.04: 0.11 1.06 0.65 0.72+0.42 125 04 i
DACs:2:1 7(0 + 0.14 3.59 0.87 0.83 ± 0.35 3.06 t 0.18
Scaffold isotropy (dry) ' e ', A s,
normalized normalized normalized normalized
x-xis 081 027 0.64 ±0.21 1.00* 0.18 0.58 * 0.071
y-axis 1.01 0.15 .94 0.1 1.00+0.11 0.66 0.25
Effect of reladve denmty (dry) E cirosrk det ive, d a A ,
normaze, d normalized normalized normay lied
0.009 (1 128 0.11 1 1.05 0.042 2.16 0.05
0.012 (2.0x) 2.24 : 0.058 - 206 k 0.025 1.00 + 0.061 3.32 - 0.049
0.018 (3.04 2.76 ± 0.10 2.77 0.62 1.25 + 0.064 8.66 ± 0.062
Table 1.3. Effect of mean pore size, crosslink density, and relative density on the
mechanical properties (measured through unconfined comrepssion tests) of the
unmineralized CG scaffold. *, *, and *** denote distinct, statistically signficant
results [17].
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ScaffP (80:20 by wt.)old
PCL/TCP (80:20 by wt.) 9,300-15,600 3,100- 43 [47]4,400
Synthetic
polymer
+
ceramic
Natural
polymer
ceramic
Unmineralized
Pure Ceramic
PLGA/HA (50:50 by wt.)
PLA/CaP glass (60:40 by
wt.)
PLLA/TCP (50:50 by wt.)
PLLA/HA
PLLA/HA (50:50 by wt.)
PLGA/HA fibers
PLA/HA
Polyethylene/HA (33:77
by wt)
Polyethylene/HA (50:50
by wt)
Polyurethane/CaP glass
Collagen/HA (varying
mineral content)
Collagen/HA (20:80 by
wt.)
MCG (50 wt% mineral)
Collagen/alginate/HA
Gelatin/HA (10-30% HA)
Chitosan/Gelatin/TCP
Chitosan/TCP
Collagen/PGA fibers
(80/20 by wt)
PLGA
PLA
Unmineralized CG
CaP cement
Macro-porous HA
20
4,710
400
390
1,000-
3,000
300-400
5
9
1,500
30-60
85
5,000-
25,000
91
97
89
90-95
90
50-60
86-92
70
60
87-95
95
85
65-80
85
4,500
120
60,110
10,000
10,870
40,000-
75,000
5,000-11,000
5,000
30,000
[54]
[89]
[51]
[90]
[84, 85]
[40]
[46]
[45]
[44]
[39]
[86]
[42]
[42]
[87]
[88]
[55]
[69]
37-82
50-300
762
50,000-
350,000
2,280-4,010
830-10,880
1,000-3,000
18
30,000
75
30
150,000
1,240,000
90-880
100-300
750
18
5
500
34,400
[91]
[39]
[40]
[17]
[92]
[93]
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Micro- & Macro-porou
HA " 1,110,000 27,400 70 [93]
10,000- 1,000-Cancellous bone 10,000 30,000 75-95 [94-96]Bones 1,000,000 30,000
Cortical bone 10,000,000- 110,000- 5-10 [94-96]20,000,000 180,000
Table 1.4. Elastic moduli and collapse strrengths of various bone regeneration
scaffolds in the dry state.
MCG scaffolds
The mechanical properties of the dry mineralized scaffolds fabricated by Lynn et al. are
compared to other synthetic and natural polymer based scaffolds for bone regeneration in
Table 1.4 [69, 74, 75]. Among the mineralized natural polymer/ceramic scaffolds,
scaffolds with higher mechanical properties than the mineralized CG (50% mineral by
weight) scaffolds have either gelatin or a third component (chitosan or alginate) in them.
Their chemical compositions vary from natural bone, and hence, are not biomimetic in a
true sense. The effect of mineralization of CG scaffolds is apparent by comparing the
properties of the mineralized scaffolds to the unmineralized CG scaffolds.
Tissue E (MPa) a (MPa) Reference
Tendon 870 72 [97]
Ligament 515 54 [98]
Cancellous 90-1000 1-30 [94-96]bone
Cortical bone 10,000-20,000 110-254 [94-96]
Table 1.5. Young's modulus, E*, and strength, o*, of tissues facing relatively
higher mechanical loads.
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1.8 Goal of this thesis: increasing the mechanical properties of collagen-based
scaffolds
The mechanical properties of the mineralized and unmineralized CG scaffolds are much
lower than some of the tissues facing higher mechanical stresses in-vivo such as tendon,
ligament, and bone (Table 1.5). However, the mechanical properties for the tissues listed
in Table 1.5 are the properties of fully developed tissues. As described above, the
scaffold should mimic the natural extracellular matrix of the tissue to have better
regenerative capability [5, 20, 22, 61, 63, 99]. The mechanical properties of the natural
extracellular matrix are lower than the fully developed tissues; e.g., osteoid (ground
collagenous precursor which later mineralizes to form bone along with the bone cells) has
lower Young's modulus (-25-40 kPa) than that of cencellous and cortical bones (Table
1.5) [26]. The properties of the CG scaffolds (both mineralized and unmineralized) are
lower than the natural extracellular matrix; e.g., hydrated mineralized CG scaffold has
Young's modulus of about 4 kPa [74] that is lower than the 25-40 kPa for the osteoid
[26]. The goal of this thesis is to improve the mechanical properties of the collagen-based
scaffolds to match upto the mechanical properties of the natural extracellular matrix.
Apart from mimicking the natural extracellular matrix, mechanical properties of the
scaffolds are critical for many other reasons. First, as described above, mesenchymal
stem cells differentiate into specific lineage and commit to phenotypes (neurogenic,
myogenic, and osteogenic) depending on the matrix elasticity [26]. Second, it is critical
that the scaffold should have sufficient stiffness and strength to maintain its shape and
size during surgical procedures such as implantation and to enhance tissue in-growth
while preventing encroachment of competing cell types after implantation [100].
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Therefore, the mechanical properties of the mineralized and unmineralized CG scaffolds
have to be improved significantly for tissues such as ligament, tendon, and bone. For the
mineralized CG scaffold, we set our target Young's modulus in the hydrated state to be
the modulus at which MSC stem cells differentiate into osteoblast-like cells: 25-40 kPa
[26]. For the unmineralized CG scaffolds our target was to increase the Young's modulus
as much as possible. In addition, another target for both mineralized and unmineralized
CG scaffolds was that the strength of the dry scaffolds should be enough to withstand
hard thumb pressure (- 100-200 kPa) that the scaffold frequently faces during
implantation at the defect site. In order to improve the mechanical properties, we need to
understand the deformation mechanism in porous solids (or foams). The following
section explains the deformation mechanism of porous foams and shows similarity
between the mechanical behaviors of CG scaffolds and porous foams.
1.9 Cellular solids model
The compressive stress-strain curves for unmineralized and mineralized CG scaffolds
with elastomeric and elastic-plastic foams are shown in Figure 1.8. The mineralized and
unmineralized CG scaffolds exhibited stress-strain behavior characteristic of low-
density, open-cell foams with distinct linear elastic, collapse plateau and densification
regimes. Therefore mineralized and unmineralized CG scaffolds with an interconnected
network of pores defined by struts can be mechanically as well as microstructurally
modeled as a low-density foam structure. The characteristics of open cell foams are
discussed in detail in section below. Modeling them as cellular solids provides a powerful
tool to investigate and describe the salient features of a scaffold. In nature, materials with
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a cellular (porous) structure are widespread, and extensive study and modeling of the
microstructural and mechanical properties of these materials has been performed [95].
The microstructural features of cellular solids affect their mechanical performance.
Foams, with their polyhedral cells, are three dimensional cellular solids and can be either
open cell (with solid only at the edges of the polyhedra exhibiting pore interconnectivity)
or closed cell (with solid membranes over the faces of the polyhedra without exhibiting
pore interconnectivity). Pore interconnectivity is critical for scaffold bioactivity because
cells need to be able to migrate through the construct and to interact with other cells in a
manner similar to that observed in vivo. An active ECM analog must possess an open-cell
pore structure with a relative density below a critical value that is characteristic of each
application, but is typically significantly < 10% (or porosity typically > 90%) [24]. These
structural criteria, determined from the results of a number of experiments studying cell-
scaffold interactions, suggest that a critical number of cells are required within a
bioactive scaffold [24]. The relative density, also termed the solid volume fraction (SVF),
is the most important parameter that determines the mechanical properties of the foam.
The relative density is the density of the cellular solid divided by that of the solid it is
made from. Porosity, also termed the pore volume fraction (PVF) of a scaffold, is another
variable often used interchangeably in the tissue engineering literature to describe
scaffold microstructure; PVF = 1 - SVF.
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Figure 1.8. Compressive stress-strain curves for (a) unmineralized-, (b)
mineralzied-CG scaffolds, (c) elastomeric foam, and (d) elastic-plastic foam [17,
95, 101, 102].
The stress-strain curve for a foam in compression is characterized by three distinct
regimes (Figure 1.8): (1) a linear elastic regime (controlled by strut bending), (2) a
collapse plateau regime (controlled by struts elastically buckling, or plastically yielding ,
or brittle crushing, depending on the nature of solid from which the foam is made) and
(3) a densification regime (complete pore collapse throughout the material). The
mechanical response of cellular solids has been modeled by using dimensional analysis of
the deformation and the failure mechanisms of the foam depending on the nature of the
solid it is made from [95]. Dimensional analysis assumes that the polyhedral cells in
foams of different relative densities are geometrically similar. This method gives the
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dependence of mechanical properties on the relative density and the mechanical
properties of the solid it is made from. However, the constants associated with the pore
geometry are determined empirically. The specific equations with the respective
constants used to model mineralized and unmineralized CG scaffolds are described in the
respective chapters.
1.1OThesis organization
As described above: the mechanical properties of the foam (or scaffolds) depend on the
relative density of the foam and the mechanical properties of the solid the foam is made
from. Therefore, the two obvious ways to increase the mechanical properties of the
scaffold are to: (1) increase the relative density of the scaffold, and (2) increase the
mechanical property of the solid the scaffold is made from. In this work, we have
explored these two methods in the case of mineralized and unmineralized CG scaffolds.
The thesis is organized in the following manner:
o Chapter 2: We attempted to increase the mechanical properties of the mineralized
CG scaffold by increasing the solid mechanical properties using a higher mineral
content scaffold. The microstructure and mechanical properties of mineralized CG
scaffolds with different mineral content is described in chapter 2 (which is based
on my published work in Acta Biomaterialia [103]). The measured mechanical
properties of the mineralized CG scaffolds were compared with models for
cellular solids. It was found, somewhat unexpectedly, that increasing the mineral
content introduced defects such as cracked and disconnected pore walls into the
scaffold, which resulted in a net decrease in the scaffold mechanical properties.
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o Chapter 3: Next, we attempted to increase the relative density of the mineralized
CG scaffold by using slurries of higher solids content. The higher viscosity of the
slurry made it difficult to mix and obtain a homogeneous scaffold. We found we
could produce a higher density mineralized scaffold by starting out with the low
density slurry and suctioning off solvent using a vacuum pump. The process that
was developed and the microstructure and mechanical properties of the resulting
scaffolds are described in chapter 3 (which is based on my published work in Acta
Biomaterialia [103]). The resulting scaffolds were up to 4 times as dense as the
initial ones, with mechanical properties about 10 times that of the original
scaffold. The measured mechanical properties of the mineralized CG scaffolds
were also compared with models for cellular solids.
o Chapter 4: We next applied the same modified vacuum process to unmineralized
CG scaffolds to increase the relative density. The measured mechanical properties
of the unmineralized CG scaffolds were compared with models for cellular solids.
Models for cellular solids also suggest that the surface area per unit volume (and
hence the number of binding sites per unit volume) increase with square root of
the relative density. Therefore we completed our study by measuring the cell
attachment on CG scaffolds of increasing relative density in chapter 4 (which is
based on my submitted work in Acta Biomaterialia [104])
o Chapter 5: The conclusion of the study and recommendations for future research
are described in chapter 5.
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CHAPTER 2. Microstructure and Mechanical Properties
of Mineralized Collagen-Glycosaminoglycan Scaffolds
with Increased Mineral Contents
2.1 Introduction
Scaffolds for tissue regeneration are structural mimics of the extracellular matrix of the
tissue and can be made of bio-degradable synthetic polymers (e.g., polylactic and
polyglycolic acid) or natural polymers (e.g., collagen, collagen-glycosaminoglycan
copolymer). It has been demonstrated that scaffold pore size and shape, porosity, specific
surface area, biodegradability and stiffness significantly influence cell functions [4]. A
variety of fabrication techniques have been developed for different biomaterials. For
instance, synthetic polymer scaffolds can be made by negative mold infiltration, ceramic
scaffolds can be made by a casting and sintering operation, and collagen scaffolds are
formed by freeze-drying (described in more detail below). Recently, attempts have been
made to regenerate bone using synthetic [41, 46, 95, 105-107] as well as natural polymer
scaffolds [69-72, 74-76, 108-110].
Bone is comprised principally of the fibrous protein collagen (type I), impregnated with a
mineral closely resembling hydroxyapatite, Calo(PO4)6(OH)2; it also contains non-
collagenous proteins and water [94, 96]. The bone mineral is impure and has many
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structural substitutes (e.g., carbonate, fluoride and citrate); crystals are initially
precipitated between and within the layers of collagen molecules [94, 96]. Living cells
(osteocytes, osteoblasts and osteoclasts) populate the vascularized extracellular matrix.
The Young's modulus of wet cancellous bone ranges from 0.09-1.0 GPa, while that of
wet cortical bone ranges from 10-20 GPa, depending on the direction of loading. The
relative density (the density of the porous solid, p, divided by that of the solid from
which it is made, ps) of cancellous bone ranges from 0.05-0.6 [94, 96].
To optimize the regenerative capability of a scaffold, it is generally believed that the
composition and physical/mechanical properties of the scaffold should be similar to that
of the physiological extracellular matrix [5, 20, 22, 61, 63, 99]. To this end, collagen-
glycosaminoglycan (CG) scaffolds have been developed and used clinically for skin
regeneration and experimentally for nerve regeneration over the past decade [5, 17, 22,
61, 63, 66, 68, 99, 101, 102, 111]. CG scaffolds are primarily manufactured through a
freeze-drying process. Briefly, an aqueous CG slurry suspension is frozen to obtain
interconnected ice crystals of the required size and shape. Sublimation of the frozen
slurry leaves behind the foam-like network of struts with interconnected pores.
Subsequently, the scaffolds are cross-linked to obtain the required mechanical properties
and biodegradability. Extensive mechanical characterization of CG scaffolds has been
reported by Harley et al.. [17]. To mimic natural bone tissue, a mineral phase similar to
hydroxyapatite must be added to the CG scaffold. A major area of recent progress has
been the fabrication of mineralized bio-organic composites [60, 89, 112-115]. Most of
these processes include mechanical mixing of the desired amount of monolithic calcium
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phosphate with the bio-organics. The major problem with these methods is that the
mineral phase does not form in situ and simply adheres to the outside of the collagen
fibers. Other techniques yield in situ formation of calcium phosphate on the bio-organic
component by adjusting the pH via a titrant phase. However, these techniques have
difficulty in controlling the mass yield of mineral phase as well as in removing the
residual titrant phase. The most recent fabrication technique, developed by Lynn et al..
[69, 70, 72, 74-76, 110], improves upon this mineralization process by forming a triple
co-precipitate of mineral, collagen and glycosaminoglycan, without using a titrant, by
controlling the molarity of the reactant acid and molar ratios of the different calcium
sources. Due to the in situ co-precipitation of the mineral phase, calcium phosphate
crystals form within the collagen fibers, resulting in a more uniformly mineralized
scaffold. Freeze drying is then used to fabricate porous scaffolds from the triple co-
precipitated slurry.
Scaffolds with well-characterized and controllable chemical, mechanical and micro-
structural properties are also suitable for basic in vitro studies of cell interactions. The
mineralized CG scaffold developed by Lynn et al. [74-76] had 50% mineral content by
weight. However, extensive mechanical characterization of these newly developed
mineralized collagen-glycosaminoglycan (MCG) scaffolds has not yet been done. The
Young's modulus and collapse strength of the scaffolds in the hydrated state were -4 kPa
and -0.3 kPa, respectively. These properties are much lower than that of mature cortical
and trabecular bone (Table 1.5). As described in chapter 1, our proposed new procedure
for chondral and osteochondral defects involves a bi-layer scaffold with a mineralized
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CG scaffold as the bottom layer that would support the mesenchymal stem cells from the
bone marrow space. It has been shown that mesenchymal stem cells differentiate to
osteoblast-like cells on substrates with a matrix stiffness of 25-40 kPa. In addition, the
current mineralized CG scaffold can be compressed between the thumb and forefinger (in
specimens of about 6-8 mm diameters, typical of that used surgically). Therefore it would
be beneficial to improve the mechanical properties of the current mineralized CG
scaffold.
As described by cellular solids models, the mechanical properties of the foam (or
scaffolds) depend on the relative density of the foam and the mechanical properties of the
solid the foam is made from. In this study we attempt to increase the mechanical
properties of the mineralized CG scaffold by increasing the solid mechanical properties
using a higher mineral content scaffold. We fabricate mineralized CG scaffolds with
varying mineral contents via the triple co-precipitation method and characterize the
microstructure as well as the mechanical properties. The mechanical properties of these
mineralized scaffolds are discussed in light of the cellular solids model for porous open
cell foams. The mechanical properties were found to be less than those of scaffolds made
by previous techniques, as well as those predicted by theoretical models, suggesting that
their properties could be improved. In the future, we plan to modify further the process
used to make our scaffolds in order to improve their mechanical properties [95].
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2.2 Materials and methods
Fabrication of the MCG scaffolds
MCG scaffolds were fabricated using microfibrillar, type I collagen isolated from bovine
tendon (Integra LifeSciences, Plainsboro, NJ), chondroitin-6-sulfate isolated from shark
cartilage (Sigma-Aldrich Chemical Co., St. Louis, MO), phosphoric acid (H3PO 4) (EMD
Chemicals Inc., Gibbstown, NJ), calcium nitrate (Ca(NO 3)2.4H20) and calcium
hydroxide (Ca(OH)2) (Sigma-Aldrich Chemical Co., St. Louis, MO). MCG slurries with
varying mineral content (50% and 75% by weight) and same overall density (0.042 g mL-
1) were prepared using the triple co-precipitation method described elsewhere [69, 70, 72,
74-76, 110]. Briefly, the collagen was mixed with H3PO4 solution at 15,000 rpm at room
temperature in an overhead blender (IKA works Inc., Wilmington, NC) for 60 minutes.
Glycosaminoglycan was added to the collagen-H 3PO4 mix using a peristaltic pump
(Manostat, New York, NY) and mixed for another 60 minutes at 15,000 rpm. Dry-mixed
Ca(NO 3)2.4H20 and Ca(OH) 2 were added to the collagen-glycosaminoglycan-H 3PO4
solution and mixed for additional 15 minutes at 15,000 rpm. The slurry was poured into
polysulfone molds (McMaster Carr Supplies, Dayton NJ) with dimensions of 12cm x
3cm x lcm (x, y and z-axis respectively), placed in a freeze-drier at room temperature,
and then freeze-dried as described elsewhere [23, 66, 68, 102, 111]. Briefly, the slurry
was cooled down to -200 C at a cooling rate of 0.33°C min 1 and kept at that temperature
for 4 hr for the slurry to completely freeze. Heat transfer was primarily in the through-
thickness or z direction. The frozen slurry was then sublimated at 250C under vacuum for
36 hr to obtain the dry scaffold. A schematic of the scaffold fabrication process is shown
in Figure 2.1.
-65-
H3PO4 solution Collagen
GAG
8FS~
Refrigerant-cooled
flask (40C) 1 Collagen-
- H3PO4
solution
Mix for 60 min
Collagen-GAG-
CaP-H3P0 4
suspension
Mix for 60 min
Dry-mixed
Ca(OH)2 + I
Ca(N0 3)2.4H20
Polysulfone mold
Collagen-GAG-
H3P0 4 solution
XIlaC Ua L UI
Freeze-dried Mix for 15 min
Figure 2.1. Schematic of scaffold fabrication via triple co-precipitation method
followed by freeze drying [103].
Crosslinking of the MCG scaffold
Two techniques were used to cross-link the scaffolds: (1) dehydrothermal treatment
(DHT) and (2) l-ethyl-3-(3-dimethylaminopropyl) carbodimide treatment (EDAC). The
parameters for the DHT treatment were guided by previous work on CG scaffolds [17,
22, 69, 76, 110]. Briefly, the freeze-dried scaffold was placed under vacuum (50 mTorr)
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at a temperature of 1050C for 24 hr. The EDAC process was carried out on the scaffolds
according to previously described methods [69, 74, 76, 110]. A 5:2:1 ratio of
EDAC:NHS:COOH was used for the current study. Briefly, the scaffolds were hydrated
in deionized water for -15 min followed by mixing the required amount of EDAC/NHS
solution into the deionized water and maintaining the scaffold in this solution for -1 hr.
Samples were prepared and tested in the dry state as well as hydrated state (soaked in
10% PBS solution for at least 12 hr before testing). Six types of samples were prepared:
(1) NX-DRY: Non-cross-linked, dry scaffold, (2) DHT-DRY: Dehydrothermal treatment,
dry scaffold, (3) EDAC-DRY: EDAC cross-linked followed by drying via freeze-drying,
(4) NX-HYD: Non-cross-linked, hydrated, (5) DHT-HYD: Dehydrothermal, hydrated,
and (6) EDAC-HYD: EDAC cross-linked, hydrated.
Microstructural characterization of the MCG scaffolds
Relative density was calculated from the dry densities of collagen, brushite
(CaHPO4.2H 20) and monetite (CaHPO 4) according to equation (2.1):
Relative density = p* Xcoll Xbrushte + Xmonetite (2.1)
coll brushrte Pmonetite )
where xcol, Xbrushite and Xmonetite are the weight fractions of collagen, brushite and monetite
in the scaffold material (note that xcoil + Xbrushite + Xmonetite = 1), Pcoll (-1.3 g cm-3) [22, 116],
Pbrushite (-2.33 g cm-3) [117] and Pmonette (-2.93 g cm-3 ) [118] are the densities of dry
collagen, dry brushite and dry monetite and p* is the density of the dry scaffolds. The
weight fractions of brushite, monetite and collagen were determined using X-ray
diffraction as described below. The contribution of glycosaminoglycan was not
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considered, as the amount of glycosaminoglycan was much less than that of the other
constituents.
The mean pore diameter, D, on different planes (yz, xz and xy) was measured using the
mean intercept method (D for a particular plane is the average of the major and minor
axes of the best-fit ellipse on that plane) [66]; the ratio of the minor to the major axes of
the best-fit ellipse gives the pore anisotropy ratio, R, on that plane [66]. Briefly,
rectangular specimens taken from five different locations were cut perpendicular to the
three axes (corresponding to the three different planes as described above) and were
embedded in glycolmythacrylate (Polysciences Inc., Warrington, PA). The embedded
specimens were cut into 5 [tm-thick sections at various depths using a Leica RM2165
microtome (Mannheim, Germany). The sectioned films were stained with Aniline-Blue
(Polysciences Inc., Warrington, PA) and observed under an inverted optical microscope
(Nikon Optiphot, Japan) at 40x magnification. Images were obtained using a CCD color
video camera (Optronics Engineering, Inc., Goleta, GA), and image analysis was
conducted using Scion Image analysis software (Scion Corporation, Frederick, MD).
Semi-quantitative and qualitative analyses of the constituent mineral phases in the slurry
as well as the dry scaffolds were done using X-ray diffraction (XRD). Semi-quantitative
analysis of the weight fractions of brushite and monetite was conducted using the
reference-intensity-ratio method (with -10% accuracy). Direct comparison between the
highest peak intensity of the mix phase and the highest peak intensity produced by the
pure phases was used to predict the weight fraction of different phases [119, 120]. The
slurries were mounted inside a silicate glass tube of 0.5 mm diameter and 0.001 mm
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thickness and the dry scaffolds were mounted on an aluminum holder by manually
compressing the scaffold materials. For the slurry analysis, a D8 Discover XRD machine
(Bruker AXS, Madison, WI) was used. The X-ray intersected the slurry-filled tube in the
horizontal plane and the tube was oscillated in the vertical direction in order to scan a
large amount of the slurry. The dry scaffold specimens were analyzed using the X'Pert
PRO MPD XRD machine (PANalytical, Natick, MA). An incidence angle range of 5°-
750 was used, with a step size of 0.01670 and a dwell time of 36.83 s/step. For all scans,
Cu Ka radiation was used, and XRD peak analysis was conducted using MDI Jade 7
software (Materials Data, Inc, Livermore, CA).
Scanning electron microscopy (Leo VP438 SEM Leo Electron Microscopy Inc.,
Thornwood, NY) was used to study the pore structure of the scaffolds. Cylindrical
specimens of 5 mm diameter were cut at random locations in the scaffolds using biopsy
punches (Miltex Inc., York, PA). Specimens were mounted on an aluminum holder; the
specimens were not gold coated. To study the mineral distribution through the wall
thickness, specimens were embedded in resin (similar to the specimen preparation for the
pore size measurement as described above) and 5 tm-thick sections were sliced out. The
backscattered electron detector was used under variable pressure mode to obtain the
images. Elemental analysis was done using energy dispersive X-ray analysis (EDAX) in
order to identify the calcium and phosphorous distributions.
Microtomography (Scanco USA, Inc., Southeastern, PA) was used to analyze the three-
dimensional calcium phase distribution in the scaffolds. Rectangular specimens of 1 cm x
1 cm x 1 cm were cut from the scaffolds perpendicular to the three axes and placed inside
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a glass tube. Cross-sectional images (with resolution 1024 x 1024 pixel) were acquired at
different depths (seven images at an interval of 125 ptm along the axis) for each of the
specimens.
Mechanical characterization of the MCG scaffolds
Compressive stress-strain curves for the scaffolds were measured using a Zwick/Roell
Z2.5 static materials tester (Zwick GmbH & Co., Ulm, Germany). Cylindrical specimens,
5 mm in diameter and 3-6 mm thick, were cut at random locations in the scaffold along
the three axes using biopsy punches (Miltex Inc., York, PA). All of the specimens were
compressed at a uniform strain rate of 0.001 sec' up to a maximum strain of 0.75.
Poisson's ratio, v, of the dry scaffolds was measured by capturing images of the
compressed specimen within the linear elastic regime of the stress-strain response.
Images were acquired at a time interval of 0.2 s using a high-speed CCD camera (Retiga
1300, QImaging corp., Canada) with a 200 mm lens (Nikon, Japan). Poisson's ratio (the
negative ratio of lateral/applied strain) was measured from the images using the software
analysis package-Vic 2D (Correlated solutions, West Columbia, SC).
The Young's modulus of the solid comprising the scaffold, Es, was measured via bending
of individual scaffold struts using an atomic force microscope (3DMFP, Asylum
Research, Santa Barbara, CA). This is an established method to measure the Young's
modulus of microscale and nanoscale fibers [121-123]. Es was measured for both the
50% and 75% by weight NX MCG scaffolds. Rectangular beams were cut from the pore
walls of the scaffold using microsurgical forceps and a scalpel under an inverted optical
microscope. The length of the beams, Lmax, varied from 40-120 tm, the width, b, varied
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from 25-90 jim and depth, h, varied from 3-12[tm as measured via optical microscopy
(Nikon Optiphot, Japan). One end of each beam was bonded to a rigid support with
cyanoacrylate, with creating a cantilevered beam of length L from the support point
(Figure 2.2). The bending test was carried out using an AC160TS cantilever (Olympus,
Tokyo, Japan) of stiffness = 48.42 N m 1', as measured via thermal power spectral density
[121]. The force-deflection relation (F-A) of the beam is given by:
F 3EI (2.2)
A L
where I = bh 3/12.
A B CD
Beam _L
cross-section
Figure 2.2. Schematic of the experimental set up for the AFM bending test to
determine modulus of the pore walls, Es. Point A is the free end of the beam,
point B is the loading point on the beam, point C is the reference point on the
glass slide, and point D is the support point of the beam [103].
L could not be measured accurately from optical images of the beam setup because the
support point was not well-defined (Figure 2.3), but it was estimated by loading the
cantilever at various points along the length of each strut (five to seven points) and
measuring F vs. A for each loading point. The length between the loading point and the
support point, L, was represented as (L +2) where L is the measured distance between the
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loading point and a reference point on the support (the edge of the glass slide as shown in
Figure 2.2) and A is the distance between the support point and the reference point (note
that A is an unknown quantity). A typical F-A response is shown in Figure 2.4a. A
schematic diagram of the bending experiment is shown in the top-right of the figure. For
each plot, F/A was measured from the slope of the initial retraction curve (as shown in
Figure 2.4a) to isolate the elastic response [121, 122]. A graph of L' versus (A/F) 3 for
the tests with the loading point at different points along the length of the beam was
constructed (Figure 2.4b). A straight line was fit to these points with R2 > 0.95 indicated
that the beams were of uniform moment of inertia I (= bh3/12). The slope of this line is
(3EsI)/3 and the intercept is -A (see Eq. (2.2)). As I is known, Es can thus be calculated.
Five strut sections from each of the 50% and 75% by weight MCG scaffolds were tested
in this manner.
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(b)
Figure 2.3. Longitudinal and cross sectional views of individual beams cut out of
the MCG scaffolds, used in measuring Es. (a) 50% by weight MCG scaffold (b)
75% by weight MCG scaffold [103].
The rupture strength of the solid, af, was estimated via nanoindentation using a Hysitron
triboindenter (Hysitron, Inc., Minneapolis, MN) [124-126]. Samples were cut from the
walls of the scaffold using microsurgical forceps and a scalpel under a bottoms-up optical
microscope. The samples were bonded to a glass slide using cyanoacrylate and indented
using a Berkovich indenter (Hysitron, Inc., Minneapolis, MN).
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Slope= F/ L
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Deflection, A (pm)
(a)
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Figure 2.4. (a) A sample bending force-deflection plot for a single beam of the 50
wt.% MCG is scaffold is shown. Similar plots were obtained for loading at
different points along the length of the strut, Lmax. From the L' vs (A/F) 1/3 plot, the
modulus of the strut, E,, was calculated (Eq (2.2)). (b) Plot of L' vs (A/F)1/3 for 50
wt.% MCG beam is shown. Slope of this line it is equal to (3E1) 1/3. Knowing the
dimensions of the beam, (I = bh3/12), E, can be calculated [103].
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The load function consisted of three steps: (1) loading up to 75 gN at a rate of 7.5 iN/s,
(2) saturating at 75 gN for 5 s and (3) unloading to zero load at a rate of 7.5 gN/s.
Twenty-five indents were conducted per sample and at least four samples were tested for
each of the 50% and 75% by weight NX MCG scaffolds. A typical load-displacement
curve for a 50% by weight MCG scffold in the NX-DRY state is shown in Figure 2.5
(those for the 75% by weight MCG scaffold were similar).
50 -
- 30 -Pm=
10
0 50 100 150
Displacement, d(nm)
Figure 2.5. A sample load-displacement plot for the 50% wt.% MCG scaffold
wall is shown. Similar plots were obtained for the 75% wt.% MCG scaffold. Note
that these nanoindentation experiments were conducted in open-loop load control,
resulting in partial dissipation of the requested applied load via the transducer of
this indenter. Thus, the maximum load exerted on the scaffold pore wall solid
material was less than the requested magnitude of 75 gN. The dwell period at
maximum load exhibits a slight decrease in load due to this open-loop feedback,
as well as creep, but is not indicative of rupture or fracture of the mineralized pore
wall. For this indenter geometry, indentation depths of 100 nm sample a contact
area exceeding 0.2 gm2 and a subsurface volume exceeding 0.04 gim3, sufficient
for at least some indentations to sample both the mineral and the polymer phases
of the pore wall [103].
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Rupture strength, ufs, was approximated from the calculated hardness, H, or mean
pressure at maximum load as:
H PmX
a-~ 3 3Ax (2.3)
* 3 3A
where cys is yield strength, Pmax is the maximum indentation load and Ac is the projected
area of contact. Note that this assumption of equivalence between the compressive yield
strength and rupture strength of the mineralized pore wall material will tend to
underestimate the actual rupture strength of the material, as the rupture strength will
exceed the yield strength if the mineralized pore wall material effectively strain hardens
upon yielding. Thus, the approximation in Eq. (2.3) should be considered a lower limit of
the solid material rupture strength. Fused silica was used to calculate the machine
compliance and the projected area of contact as a function of the contact depth. From the
same load-displacement response, the elastic modulus of the sample, EsNX-D R Y was
estimated from Ac and the slope of the initial portion of the unloading curve, S (Figure
2.5), according to the method of Oliver and Pharr [124].
Cellular solids model of the MCG scaffold
The mechanical properties of cellular solids depend on relative density and the properties
of the solid of which the cellular solid is made (such as density, ps, Young's modulus, Es,
rupture strength, fs) and the cell geometry (e.g., open- or closed-cells) [17, 95, 101].
Simple relationships between overall foam properties (such as Young's modulus, E*, and
strength, a*), and the relative density and solid cell wall properties can be derived using
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dimensional analysis [95, 101]. Key relationships for open-cell foams that are relevant for
mechanical characterization of the scaffolds are given below:
E P (2.4)
3
* ( 2
S0.2 p (2.5)
Statistical analysis
One-way analysis of variance (ANOVA) and Fisher's protected least significant
difference (Fisher's PLSD) methods were used to determine statistical significance
between different sets of data and pair wise data sets, respectively. A probability value of
95% (p <0.05) was used to determine the significance. All the measurements are reported
as mean ± standard deviation. The symbols , , and indicates statistically
significantly different results.
2.3 Results
Microstructural characterization
The experimentally measured overall scaffold densities (p*) for the 50% and 75% by
weight MCG scaffolds were 0.063 ± 0.0015 g cm-3 and 0.06±0.0034 g cm-3 , respectively.
The densities are statistically significantly different (p = 0.039) even though the target
slurry densities were the same (0.042 g mL-1). The difference arises from the fact that
some of the calcium phosphate phase adhered to the surface of the beaker while mixing.
The relative densities can be calculated using Eq (2.1). For the 50% scaffold, xcot = 0.5,
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Xbrushite = 0.485 and Xmonette= 0.015 while for the 75% scaffold, x,,0co= 0.25, Xbrushte= 0.503
and xmone,ite = 0.248, these results are described in further detail below. Relative densities
for 50% and 75% by weight MCG scaffolds are calculated to be 0.038±0.001 and
0.030±0.002, respectively. The 75% scaffold was observed via SEM to have a bilayer
structure with small pores in the top layer, closer to the air side during freeze-drying, and
larger pores in the bottom layer, closer to the cooling plate on the base. The densities of
these layers were measured separately by sectioning the scaffold at the interface and
punching out specimens from both the layers. The relative densities were 0.032±0.003
and 0.024±0.002 for the top and bottom layers respectively. The characteristics of the
bilayer are described in more detail below.
Optical images of an embedded specimen perpendicular and parallel to the z-axis,
through the thickness of the scaffold sheet, are shown in Figure 2.6. The 50% by weight
MCG scaffold exhibited a uniform microstructure throughout the scaffold, with a roughly
uniform pore size and interconnected walls throughout. The 75% by weight MCG
scaffold exhibited a bimodal pore size distribution, with smaller pores and interconnected
walls in the top zone and larger pores and disconnected walls in the bottom zone. The
mean pore diameter, D, and anisotropy ratios, R, on the three different planes are listed in
Table 2.1; for the 75% scaffold, measurements for the top and bottom layers are reported
separately. R on different planes were greater than 0.92 and D on different planes were
similar; the pores are roughly equiaxed for both scaffolds. The average pore diameter was
calculated by averaging all the values (on different planes). The average pore diameter
for the 50% scaffold was 202±25 jtm. The average pore diameters of the 75% scaffold
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for the top and bottom parts of the scaffold were 227±31 gtm and 343±38 jim,
respectively. These values were statistically significantly different (p < 0.05).
(f)
Figure 2.6. Optical micrographs of embedded MCG scaffolds with planes
perpendicular to the z-axis. (a) and (c) 50% by weight scaffold and (b) and (d)
75% by weight scaffold, taken at different depths along the z-axis. (e) and (f)
entire cross-section of plane parallel to the z-axis for the 50% and 75% by weight
MCG scaffolds respectively, showing uniform pore size distribution for the 50%
scaffold and bimodal pore size distribution for the 75% scaffold [103].
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Figure 2.7a shows the XRD plots for the 50% and 75% by weight MCG slurries. The
straight lines represent brushite peaks. It is apparent that both slurries exhibited 100%
brushite as the only mineral phase. Figure 2.7b shows the XRD plots for the NX-DRY
MCG scaffolds. Based on the reference intensity ratio method as described above, the
50% scaffold comprised 97 wt% brushite and 3 wt% monetite as the crystalline phases,
while the 75% scaffold comprised 67 wt% brushite and 33 wt% monetite as the
crystalline phases.
yz 216 ± 26.0' 0.972 ± 0.023
50%-NX xz 194 ± 21.0 0.966 ± 0.039
xy 196 ± 23.1 0.957 + 0.035
75 %%-NX yz-top 214 ± 26.8 0.955 ± 0.040
xz-top 242 ± 17.6 0.939 ± 0.049
xy-top 224 ± 42.6 0.922 ± 0.075
yz-bottom 344 ± 42.0 0.929 ± 0.053
xz-bottom 342 ± 42.2 0.959 ± 0.049
xy-bottom 343 ± 31.9 0.963 ± 0.042
* Indicates statistically different value
Table 2.1. Pore size measurements for the 50% and 75% by weight NX-DRY
MCG scaffolds [103].
SEM micrographs of the 50% and 75% by weight MCG scaffolds (images taken of the
plane perpendicular to the z-axis) are shown in Figure 2.8. The scaffolds exhibit a
homogeneous distribution of mixed open and closed cell microstructure with
interconnected pores (Figure 2.8a and b). Unlike unmineralized CG scaffolds [17, 66,
68], MCG scaffolds exhibited pore walls as well as thin struts.
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Figure 2.7. (a) X-ray diffraction plots for for the 50% and 75% by weight MCG
slurries are compared in this figure. The vertical lines represent brushite peaks.
(b) X-ray diffraction plots for the dry 50% and 75% by weight MCG scaffolds are
compared in this figure. The 50% scaffold has mostly brushite while the 75%
scaffold has a significant amount of monetite along with brushite [103].
EDAX analysis showed that the white particles through the thickness of these walls
(Figure 2.8c and d) are calcium- and phosphorous- rich particles. As described above,
XRD results confirmed these particles to be either brushite or monetite. The more highly
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mineralized scaffold had a denser packing of calcium phosphate. The denser calcium
phosphate packing in the 75% by weight MCG scaffold causes a large variation in the
wall thickness (Figure 2.8c and d). Mineral phase particle size ranged from 100s nm to
Rm with a mode cross-sectional area of -1.3 Rm2 (calculated from Figure 2.8c and d).
Figure 2.8. (a, b) SEM images for the 50% and 75% by weight MCG scaffolds
measured on the 5 mm dia punched out of the scaffolds. (c, d) Mineral
distribution through the thickness of the pore walls measured on the 5 jtm thick
resin embedded samples [103].
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Microtomographic images for the 50% and the 75% by weight MCG scaffolds are shown
in Figure 2.9, indicating planes perpendicular to the z-axis at two specific depths. Due to
the higher density of the calcium-phosphate phases compared to collagen,
microtomographic images had different contrast than the SEM micrographs: calcium-
phosphate phases correspond to dark regions and collagen corresponds to lighter regions.
Because of the non-uniform contrast and beam hardening, these images are unsuitable for
quantitative analysis (such as pore diameter calculations) [127]. However, by
thresholding the images, we can qualitatively determine the calcium-phosphate
distribution in the scaffolds. Microtomographic images confirmed that the mineral phases
were distributed homogeneously throughout the walls and struts of the scaffolds. These
results also confirm that the 50% scaffold has a uniform pore size throughout the entire
scaffold while the 75% scaffold has a bilayer structure with two distinct pore sizes. Also,
it is clear that the mineral phases are distributed homogeneously throughout the walls and
struts of the scaffolds.
The 50% scaffold has a uniform pore size throughout the entire scaffold. However, both
SEM and microtomographic images of the 75% scaffold indicated a distinct boundary
between the top portion of the scaffold, which had smaller pores, and the bottom portion
of the scaffold, which had larger pores (Figure 2.10). The boundary between the two
zones varied from near the edge of the sample to the center of the sample. SEM and
optical micrographs indicated defects such as voids and cracks in the walls and struts of
the MCG scaffolds (Figure 2.1 la and b), as well as disconnected pore walls and struts
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(Figure 2.1 lc and d). The 75% by weight MCG scaffold exhibited more defect sites than
the 50% scaffold.
(a)
rbrm (b)
(d)
Figure 2.9. (a, b) Micro-CT images for the 50% by weight MCG scaffold taken at
two different depths along the z-axis. (c, d) Micro-CT images for the 75% by
weight MCG scaffold taken at two different depths along the z-axis [103].
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Figure 2.10. Bimodal pore size distribution in the 75% by weight MCG scaffold is
demonstrated in (a) the SEM and (b) the micro CT images. The arrows separate
the section with smaller pores (top) from that with larger pores (bottom) [103].
Mechanical characterization
A typical compressive stress-strain curve for a 50% by weight MCG scaffold in the dry
state is shown in Figure 2.12 (those for the 75% by weight MCG scaffold were similar).
Distinct linear elastic, collapse plateau and densification regimes were observed. Elastic
modulus (E*), collapse strength and strain (o* and e* respectively) and collapse modulus
(Au/Ac) are measured from the stress-strain curve. E* is the slope of the linear elastic
regime, Au/Ae is the slope of the collapse regime, a and c* are the point of transition
from linear to the collapse regime (determined from the intersection of the E* and Au/Ac
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regression lines). Curves of similar shape, but lower modulus and strength were obtained
for the hydrated states of the scaffolds.
Figure 2.11. (a, b) SEM images of the 50% and 75% by weight MCG scaffolds
showing voids on the pore walls. (c, d) Optical images of the 50% and 75% by
weight MCG scaffolds showing disconnected walls and struts [103].
The values of E*, a*, e* and An/Ac for loading along the three axes for the 50% and 75%
by weight MCG scaffolds in the NX-DRY state are listed in Table 2.2. The Young's
moduli of the 50% scaffold are typically about twice those of the 75% scaffold and the
strength of the 50% scaffold is typically about thrice those of the 75% scaffold. The 75%
scaffold has a lower E* and a* in the z direction due in part to the two layers of different
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densities through the height of the scaffold. For both scaffolds E* is on the order of 10-
15%. Collapse moduli of the 50% scaffold are higher than those of the 75% scaffold.
300
Densification
200
Elastic Collapse
Regime Regime
S100
E*
0 20 40 60 80
Strain,(%)
Figure 2.12. A typical compressive stress-strain curve for a 50% by weight NX-
DRY MCG scaffold. The slope in the linear elastic regime is the modulus of the
scaffold (E*), the slope in the collapse regime is the collapse modulus (Ao/Ae)
and the point of intersection of the regression lines for modulus and collapse
modulus are characterized by collapse strength (t*) and collapse strain (*). The
75% by weight MCG scaffold had a similar stress-strain curve [103].
The values of E*, *, e* and A/AE in the z-direction for scaffolds with the different cross-
linking treatments are listed in Table 2.2. The properties for the hydrated 75% by weight
MCG scaffold could not be determined, as the slope difference between the linear elastic
regime and the collapse plateau regime was negligible. The specific cross-linking
treatments had no statistically significant effect on any of the properties (p>0.05) for both
scaffolds in the dry state, with the exception of the DHT treatment on the 75%
mineralized scaffold. As expected, the hydrated state exhibits a much lower E*, a* and
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A/Ae than that of the dry state for the 50% scaffolds. In the hydrated state, DHT and
EDAC crosslinking increase the E*, a*, and Au/Ae over that of the non crosslinked
scaffold by 1.5 and 5 times, respectively. There was no statistically significant effect on
the collapse strain, e*, with the exception of the EDAC crosslinking.
Scalloid Axis EI (kPa) o' (kPa) * (C%) Aa/A (kPa)
ElfeCt of loading direction h dr
50% NX-DRY v 1000 1 267" 102 1 9.03* 10.4 1 2.29 103 ± 41.6
S615 ± 146 88 8.69 13.9 1 3.38 111 ± 35.9
720 1 215 83 - 11.2 12.4 1 3.82 123 1 37.4
75%' NX-DRY .x 403 152 33.8 1 5.79 9.01 12.78 77.2 120.3
V 495 1 119 43.1 1 9.99* 8.87 -_ 1.41 67.4 119.3
204 1 36.8* 28.4 ± 4.81 13.4 1.06* 112 ± 15.4*
Scaflfold Cross-link E* (kPa) * ( : (kPa)
Eflect of cross-linkin 'dr):. revred in the :-direction
50'l, NX-DR Y 720 1 215 83 1 11.2 12.4 1 3.82 123 1 37.4
DIIT-DRY 853199.0 97.51_t 11.6 11.41 0.72 1581--34.8
EDAC-DRY 759 1 230 88.0 ± 14.6 12.5 1 3.99 139 145.7
75",, NX-DRY 2041 36.8 28.4 1_4.81 13.4 1.06 112 ± 15.4
DIIT-DRY 274 1 51.6 48.3 1 18.0* 17.1 1 3.81* 160 148.6
EDAC-DRY 230 1 110 29.8 ± 12.0 13.6 1 2.84 87.5 1 73.5
Scaffold Cross-link E* (kPa) o* (kPa) ;* (% An/A; (kPa)
Efect of cro0s-linkina( hydrated).': ived in the :-direction
50",i, NX-IIYD 3.86 1 0.738* 0.341 1 0.060 9.78 1 1.90 1.95 ± 0.187*
DIHI'-IIYD 6.20 1 1.51** 0.547 1 0.089 9.60 - 3.02 3.05 ± 0.392**
EDAC-IIYD 15.20 1.68*** 2.0801 0.337* 13.301 3.26* 8.541L 1.25"***
75%' The properties of the scatolblds could not be determined as the slope difference
between the linear elastic regime and the collapse plateau regime was negligible.
The behavior could not be idealized as that of open-cell foams.
Note: results are reported as mean I_ standard deviation: ,. ** and **
denote distinct, statistically significant results 'via ANOVA.
Table 2.2. Mechanical properties of the 50% and 75% by weight MCG scaffolds
determined from the compression tests [103].
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For the 75% by weight NX-DRY MCG scaffold, the Young's modulus and collapse
strength in the z direction of the top and bottom zones, which are of different pore sizes
and densities, were measured separately. The scaffold was cross-sectioned perpendicular
to the z-axis at the boundary between the zones (determined by visual inspection) to
obtain two separate pieces with the two different pore sizes. Figure 2.13 shows E* and a*
for the top and the bottom zones of the 75% NX MCG scaffold along with the overall E*
and a*. As expected from a simple lower bound composites model, the overall E* lies
between that of the top and bottom layers.
The Poisson's ratio for the 50% and 75% by weight NX-DRY MCG scaffolds were
measured to be 0.02 ± 0.005 and 0.02 ± 0.007 respectively (samples were loaded in the z
direction). These are negligible compared to the expected value of v for open cell foam
(i.e., 0.3) [95].
Young's moduli of the solid, ENX-DRY, for the 50% and 75% by weight NX-DRY MCG
scaffolds were measured to be 9.15±0.983 GPa and 6.31±1.43 GPa, respectively (based
on the AFM bending test). ENX-DRY varied from -7.8 - 10.5 GPa and 4.5 - 7.7 GPa for the
50% and 75% by weight scaffolds, respectively. These results can be linearly
extrapolated to the crosslinked and hydrated states, based on the relative difference in E*
for different states (for example, EDHT-DR =Y EsNx -D R Y x [EDHT-DRY*/ENX-DRY*] and EsDHT-HmD
=EsD H T-D R Y x [EDHT-HYD*/EDHT-DRY*]) [17].
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Figure 2.13. Young's modulus (E*) and cocllapse strength (a*) of each of the
layers of the 75% by weight NX-DRY MCG scaffolds of differing density and
pore size, is compared with the over all modulus and strength of the scaffold. All
the modulus and strength values are measured along z-direction (E*Top = 329 ±
48.9 kPa, E*Boom = 98.2 + 28.5 kPa and E* Tota 204 ± 36.8 kPa, a Top = 36 +1.73
kPa, a Bottom = 10.7 + 3.21 kPa, a rotal = 28.4 + 4.81 kPa) [103].
Measurement of rupture strength of the solid, af, based on nanoindentation, is an
approximation to the actual strength of the composite, as the variation in af, was much
larger depending on the local composition of the point of indentation. As seen in Figure
2.8c and d, the pore walls consisted of CG matrix reinforced with mineral phases. Since
the area indented was nanoscale in volume (see Figure 2.5), the extreme values plausibly
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corresponded to the mechanical response of the CG matrix phase and the mineral phases.
of, varied from -0.5 to 300 MPa and from 30 to 350 MPa for the 50% and 75% by weight
NX-DRY MCG scaffolds, respectively. However, for calculations of scaffold mechanical
properties based on the cellular solids model, the values of cf, within this range were
chosen from the subset of nanoindentation experiments that predicted the same Es as that
obtained from AFM beam-bending tests. Both the beam-bending experiments and pore-
wall-indentation experiment probed the Young's modulus of the solid, Es; the former
approach captures the modulus over a larger volume than is represented by the
nanoindented volumes. Thus, we assume that the mineralized composite (volume-
averaged) mechanical response is best represented by nanoindented regions of the
mineralized pore wall that exhibited the same modulus as that measured via beam-
bending. This assumption is supported by the fact that the mode mineral phase cross-
sectional area of 1.3 Rm 2 exceeds the projected area of contact of these indentations
computed from probe geometry and maximum depth (0.24 jtm 2). Given the wide mineral
phase particle size distribution (Figure 2.8), an array of indentations of this size could
sample the stiff particles, the compliant CG pore wall and a composite mixture of these
two phases. The solid wall modulus, Es, measured from the nanoindentation tests, varied
from -13.4 GPa to 19 GPa and from 2 to 25 GPa for the 50% and 75% by weight NX-
DRY MCG scaffolds, respectively. As noted above, the range of Es obtained from the
AFM bending test was similar to that obtained from the nanoindentation tests. The
resulting strengths of the solid materials making up the scaffold struts, cq, were 201 ± 52
MPa and 149 ± 66 MPa for the 50% and 75% by weight MCG NX-DRY scaffolds,
respectively. These results can be linearly extrapolated to the cross-linked and hydrated
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states, based on the relative difference in a for different states (similar to Young's
modulus predictions for different states, as described above).
2.4 Discussion
The pore sizes for both scaffolds were in the range of 200-350 [tm, which is optimal for
bone growth [20, 37, 128, 129]. For both scaffolds, the mineral phase was distributed
throughout the walls, which is an improvement over existing mineralized scaffolds in
which the mineral simply coats the outside of the collagen struts [48, 90, 130-132].
There were substantial differences in the microstructure and mechanical properties of the
50% and 75% by weight MCG scaffolds. The 50% scaffold had a higher relative density,
as well as a more uniform density and pore size than the 75% scaffold. The walls of the
75% scaffold were more variable in thickness along their length and were less well
connected, with ruptures and cracked walls visible in the SEM images, compared with
the 50% scaffold.
Bone mineral closely resembles hydroxyapatite, a calcium phosphate. Scaffolds for bone
regeneration usually involve some form of calcium phosphate, typically hydroxyapatite
[54, 89] or tricalcium phosphate [51, 90]. In our scaffolds, most of the calcium phosphate
exists as brushite, which can be converted to octacalcium phosphate and then to apatite
by hydrolysis. Monetite, on the other hand, does not convert to octacalcium phosphate
[69, 74, 133, 134]. The 50% scaffold was comprised chiefly of brushite (97 wt.%), while
the 75% scaffold was comprised of 66 wt.% brushite and 33 wt.% monetite. In the 75%
MCG scaffold, some of the brushite in the slurry phase transformed to monetite during
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freeze-drying (note that monetite is a dehydrated form of brushite). During this phase
change, the by-product (i.e. water) was liberated to the immediate vicinity of the scaffold
walls and struts, making this scaffold partially hydrated even after extended sublimation.
This was evident from the adhesive nature of the scaffold upon handling. The phase
concentration is believed to be due to the higher concentration of H3PO4 used in the
synthesis of the 75% by weight scaffold. During sublimation, with a decrease in pressure,
water vaporizes faster than H3PO4 (the vapor pressure of H3PO4 is much lower than that of
water at 250C), increasing the pH of the residual solvent. Monetite is a more stable phase
than brushite at lower pH and therefore it is possible that the phase change is driven by
the high residual concentrations of H3P04 during sublimation. The 75% scaffold had a
denser packing of mineral, as expected from the increased weight fraction of mineral.
The compressive stress-strain curves for the scaffolds exhibited shapes characteristic of
cellular solids, with the three regimes corresponding to linear elasticity, cell collapse and,
at high strains, densification [95]. The Young's modulus and compressive strength of the
50% scaffold were higher than those of the 75% scaffold. This was expected from the
lower stiffness and strength of the 75% scaffold struts and the lower relative density of
the 75% scaffold. The inferior strut properties of the highly mineralized scaffold are
attributed to the water retention of the scaffold, as described above. The Young's
modulus and strength of these scaffolds are in the lower range, relative to mineralized
scaffolds made by other techniques (Table 2.3).
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Dry
MCG (50 wt.% mineral) 762 85 85 [69]
MCG (50 wt.% mineral) 720-1000 83-102 96 Current
scaffold
MCG (75 wt.% mineral) 204-495 28-43 97 Current
scaffold
Chitosan/TCP 1000-3000 100-300 90 [90]
Gelatin/HA (10-30 wt.% mineral) 2280-4010 - 85 [89]
Chitosan/Gelatin/TCP 830-10,880 90-880 - [51]
Collagen/alginate/HA 50,000- 5000- 65-80 [54]350,000 25,000
Hydrated
MCG (50 wt.% mineral) 4-15 0.34-2 96 Current
scaffold
Collagen/HA (70 wt.% mineral) 37-75 
- 87-95 [88]
Collagen/HA (80 wt.% mineral) 50-300 30-60 95 [55]
Table 2.3. Mechanical properties Elastic moduli, E*, collapse strengths, a*, and
porosities of various bone regenerating composite scaffolds based on natural
polymers and calcium phosphate ceramics [103]. Note: TCP = Tri-calcium
phosphate, and HA = Hydroxyapatite.
We can compare the measured properties of the scaffolds with values predicted from
engineering models. We first estimate the modulus of the solid strut material, using a
simple Voigt-Reuss composite model, and then estimate the modulus of the scaffold,
using a cellular solids model [95]. The upper and lower bounds on the Young's modulus
of the solid for the 50% by weight MCG scaffolds are estimated from the composites
model, based on the Young's modulus of collagen and brushite. The Young's modulus of
collagen struts in a DHT-DRY CG scaffold has been measured to be 762 + 35.4 MPa,
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from AFM-enabled strut bending tests [17]. The Young's modulus of brushite is assumed
to be similar to that of hydroxyapatite (- 110 GPa) [94, 135]. The volume fractions of
collagen and brushite in the 50% by weight MCG scaffold are 0.642 and 0.358,
respectively (based on the mass fractions obtained from the XRD results, as described
above). The composite Young's modulus of the solid for the 50% DHT-DRY scaffold is
predicted to range between I and 40 GPa. Our measured value of the solid strut modulus
EsNX-DRY for the 50% scaffold is 9.15 GPa, while that estimated for the DHT-DRY
scaffold, EsDHT-DR , is 10.84 GPa; both values are closer to the lower bound of this
composite model, as might be expected from the unaligned distribution of brushite within
the struts. The Young's modulus of the dry MCG scaffold strut material is comparable to
wet cortical bone (- 10-20 GPa).
Cellular solids models for open-cell foams predict values of Young's modulus, Es, and
compressive strength, us, of the 50% DHT-DRY scaffold of 15.7 and 0.35 MPa (Eq.
(2.4) and (2.5)), respectively, compared with our experimentally observed values of E* -
0.8 MPa and u, - 0.100 MPa. For the 75% scaffold, the model predicts E*= 5 MPa and
afs = 0.14 MPa, compared with our experimentally observed E* - 0.4 MPa and Ufs -0.04
MPa. The modulus and strength data are factors of - 10-15 and 3 times lower than the
values given by the cellular solids model, respectively. Possible reasons for the
discrepancy include the observed presence of defects, such as voids and cracks in the
walls and struts of the scaffold, as well as disconnected walls and struts [136-139]. This
was apparent from the SEM and optical images of the scaffolds (Figure 2.11). The above
reduction in properties correspond to 25-40% defects by volume in the scaffold [137]. In
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addition, our approximation of the scaffold pore wall rupture strength (as measured via
nanoindentation) tends to underestimate the actual strength of the scaffold solid, such that
one would reasonably expect the cellular solids model prediction to underestimate the
experimentally measured scaffold strength.
The mechanical properties of scaffolds in this study are lower than those of scaffolds
described in the literature (Table 2.3). They are also substantially lower than theoretically
predicted by engineering models, suggesting that they can be improved with appropriate
control of the microstructure. In our future work, we seek to improve the mechanical
properties of the scaffolds.
2.5 Conclusions
MCG scaffolds with 50% and 75% by weight mineral content were fabricated via a
titrant-free triple co-precipitation method followed by freeze-drying. The pore sizes for
both scaffolds were in the range of 200-350 jim, which is optimal for bone growth [20,
37, 128, 129]. For both scaffolds, the mineral phase was distributed throughout the walls,
which mimics bone and is an improvement over existing mineralized scaffolds in which
the mineral simply coats the outside of the collagen struts [48, 90, 130-132]. The 50%
NX-DRY scaffold had brushite as the major mineral phase with a negligible amount of
monetite (- 3 wt.%), while the 75% NX-DRY scaffold was comprised of -67 wt.% of
brushite and 33 wt.% of monetite. The elastic moduli and strength of the 50% scaffold
were typically about twice and three times those of the 75% scaffold, respectively. This
unexpected decrease in Young's modulus and strength with increasing mineral content
was attributed to lower solid properties, lower relative density and more defect sites in
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the highly mineralized scaffold. The mechanical properties of the scaffolds in this study
are lower than those of mineralized scaffolds made by other techniques, as well as
cortical and cancellous bone. The mechanical properties of the scaffolds in this study are
also less than the values predicted by engineering models, suggesting that there is
potential for improved performance with appropriate control of the microstructure, to
eliminate voids and unsupported walls and struts. Future research is directed towards
modifying the current fabrication techniques to obtain mechanically stiffer and stronger
scaffolds.
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CHAPTER 3. Microstructure and Mechanical Properties
of Mineralized Collagen-Glycosaminoglycan Scaffolds
with Increased Relative Density
3.1 Introduction
Scaffolds for tissue regeneration are three-dimensional porous matrices which mimic
body's own extracellular matrix, onto which cells attach, multiply, migrate, and begin
synthesizing new tissue [18]. Scaffolds also serve several other functions, such as (1)
structurally reinforcing the defect, (2) preventing ingress of surrounding tissue, and (3)
acting as a delivery vehicle for cells, growth factors, or genes [19]. Although unproven, a
widely believed design paradigm for scaffolds is that mimicking the composition of the
natural tissue as closely as possible improves the capacity for regeneration [20]. The
ability of a scaffold to regenerate tissue depends on its pore size, pore shape, porosity,
biodegradability and mechanical properties. The average pore diameter must be large
enough for cells to migrate through the pores yet small enough to retain an appropriate
specific surface area for sufficient cell binding. For example, pore sizes in excess of 100
jim are optimal for bone growth [20, 37, 128]. Equiaxed pore shape and homogeneity are
optimum for uniform cell adhesion and distribution of extracellular matrix proteins.
Scaffolds must have large enough porosity (generally greater than 90%) and
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interconnectivity for effective transfer of cells and metabolites [4]. The degradation rate
of the scaffold has to be roughly equal to the regeneration rate of the tissue. And cells
have been observed to be sensitive to the mechanical properties of the scaffold which in
turn affects the overall construct bioactivity [25].
Ideally, scaffolds should be similar to their natural counterparts in terms of chemical
composition and physical structure. For this reason, natural polymers such as collagen are
of major interest. To this end, collagen-glycosaminoglycan (CG) scaffolds have been
developed and used clinically for skin regeneration and experimentally for nerve
regeneration over the past three decades [5, 22, 61, 63, 67, 140-147]. Composite scaffolds
of collagen or gelatin with ceramics (e.g. hydroxyapatite and tri-calcium-phosphate); i.e.,
mineralized CG (MCG) scaffolds have been developed to regenerate hard tissues such as
bone [48, 49, 51, 52]. The most recent fabrication technique improves upon this
mineralization process by forming a triple co-precipitate of mineral, collagen and
glycosaminoglycan, without using a titrant, by controlling the molarity of the reactant
acid and molar ratios of the different calcium sources [69-73, 103, 110]. Due to the in situ
co-precipitation of the mineral phase, calcium phosphate crystals form within the
collagen fibers, resulting in a more uniformly mineralized scaffold. Freeze drying is then
used to fabricate porous scaffolds from the triple co-precipitated slurry. These MCG
scaffolds have regenerated subchondral bone at 16 weeks in a 4 mm diameter and 6 mm
depth defect site at the knee joint in a goat model [19].
Extensive microstructural and mechanical characterization of CG and of MCG scaffolds
of varying mineral content has been reported by Harley et al. [17] and by Kanungo et al.
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[103], respectively. Critical mechanical properties of scaffolds include elastic modulus,
E*, compressive crushing strength, a*, and compressive crushing strain, E*. Mechanical
properties of different MCG scaffolds (along with the triple co-precipitated scaffolds) are
compared in literature [103]. The triple co-precipitated mineralized scaffolds have
relative densities (the density of the cellular solid, p*, divided by that of the solid from
which it is made, s,) of roughly 0.03-0.04; that of trabecular bone varies from 0.05 - 0.60
[94, 96]. The mechanical properties of human compact and trabecular bone, along with
50 wt.% MCG scaffold (with a relative density, p*/p,, of 0.04), are listed in Table 3.1.
Wet 10,000 - 20,000 110-254
Compact bone --- - ~-
Dry 16,500 - 33,000 170-390
Wet 90 - 1,000 1 - 30 i
T r a b e c u la r b o n e ................... ........... ............. ........................................................
Dry 150-1,650 1.5-45
Wet 0.004 - 0.015 0.0003 - 0.002
50 wt.% M CG scaffold ................................. .....
Dry 0.2 - 1 0.03 - 0.1
Table 3.1. Mechanical properties of human compact bone, trabecular bone, and
50 wt.% MCG scaffold with p/p, = 0.04 [103, 148-150].
As described in chapter 1, stem cells differentiate to osteoblast-like cells on substrates
with a matrix stiffness of 25-40 kPa. Therefore, ideally, the mechanical properties of the
hydrated mineralized CG scaffold should be in a similar range for regenerating bone. In
addition, it is also critical that the scaffold should have sufficient stiffness and strength to
maintain its shape and size during surgical procedures such as implantation and to
enhance bone in-growth while preventing encroachment of non-osseous tissue and
competing cell types after implantation [100]. The optimal requirements for the above
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properties vary depending on the defect site and there are no established optimal
magnitudes of the mechanical properties from an implementation point of view [151].
The current triple co-precipitated MCG scaffold (with a p*/ps of 0.04) can be crushed by
hard thumb pressure. Hence, it is critical to improve the mechanical properties of the
MCG scaffold such that they can be functionally suitable for bone regeneration. The
mechanical properties (E* and a*) of the scaffold depend on those of the solid (Es and af,)
they are made from as well as the relative density of the scaffold, (p*/ps) [4, 17, 95, 103].
The overall properties of the scaffolds can be improved by either improving the
properties of the solid it is made from or by increasing the relative density of the scaffold.
Previous attempts to increase the mechanical properties of the scaffold by increasing the
mineral content led to scaffolds with lower mechanical properties due to the introduction
of defects [103]. Our previous attempts to increase the mechanical properties by
increasing the volume fraction of the components of the slurry have not been successful
due to the difficulty in mixing the viscous slurry at higher volume fractions of the
mineral, collagen and GAG [17]. In this chapter we describe a new technique to improve
the mechanical properties by increasing the relative density of the scaffold by a vacuum
filtration technique.
3.2 Materials and methods
Fabrication of the MCG scaffolds
A mineralized collagen-glycosaminoglycan suspension (50 wt.% mineral) was fabricated
using microfibrillar, type I collagen isolated from bovine achilles tendon (Sigma-Aldrich
Chemical Co, St. Louis, MO), chondroitin-6-sulfate (GAG) isolated from shark cartilage
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(Sigma-Aldrich Chemical Co., St. Louis, MO), phosphoric acid (H3PO4) (EMD
Chemicals Inc., Gibbstown, NJ), calcium nitrate (Ca(N0 3)2.4H 20) and calcium
hydroxide (Ca(OH)2) (Sigma-Aldrich Chemical Co., St. Louis, MO). The suspension was
prepared by combining collagen (0.019 wt.%), GAG (0.002 wt.%), calcium nitrate (0.004
wt.%), and calcium hydroxide (0.009 wt.%) in a solution of 0. 14M phosphoric acid (pH
1.47) through a triple co-precipitation method described elsewhere [4, 69-73, 103, 110].
The collagen was mixed with phosphoric acid solution at 15,000 rpm and 4oC in an
overhead blender (IKA works Inc., Wilmington, NC) for 60 minutes. Glycosaminoglycan
was added to the collagen-phosphoric acid mix using a peristaltic pump (Manostat, New
York, NY) and mixed for another 60 minutes at 15,000 rpm. Dry-mixed calcium nitrate
and calcium hydroxide were added to the collagen-GAG-phosphoric acid solution and
mixed for additional 15 minutes at 15,000 rpm. The suspension was mixed for an
additional 24 hours on a magnetic stirrer at room temperature and was stored at 40C. The
co-precipitate within the slurry had a mass of 0.042 g per 1 ml of slurry; we refer to the
density of the co-precipitate within the slurry as 0.042 g ml 1.
The above slurry (denoted as 1 x, where 1 x - 0.042 g ml') was densified using the set-up
shown in Figure 3.1. A cylindrical polysulfone mold (McMaster Carr Supplies, Dayton
NJ), with an inside diameter of 5.7 cm, was perforated at the base with holes of 1 mm
diameter for filtering the solvent to the aluminum base. Two filter papers with 5 .m pore
diameter (VWR, West Chester, PA) were placed at the base of the mold in order to filter
out desired amount of the solvent. The 1 x slurry was poured into the mold and subjected
to vacuum as shown in the schematic. The extracted solvent was collected in the bottom
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container; the slurry remaining in the top compartment became denser as the time the
suspension was subjected to vacuum increased.
Filter papers
Ah Vacuumn pump
It
Altuminum base
Densified slurry
t
X -
I tf
Figure 3.1. Schematic of the vacuum filtering process. The initial low density
slurry is densified via vacuum suctioning the solvent to the bottom container. The
final density of the slurry is controlled by the time the slurry is subjected to
vacuum [152].
The density of the co-precipitate in the remaining slurry in the top compartment was
calculated by dividing the initial solid weight by the remaining volume of the slurry (or in
other words x = ti/tf where ti and tf were the initial thickness of the 1 x slurry and the final
-104-
Slurry
5.7 cm
*
thickness of the densified slurry, respectively). The density was plotted against the time it
was subjected to vacuum, as shown in Figure 3.2. The densification saturates at a density
of 4.5 x which is equivalent to 0.189 g of the co-precipitate per 1 ml of slurry. To achieve
a particular density, the initial slurry can be filtered under vacuum for a specific time
according to this plot. For this study the MCG slurry was densified to three higher
densities of the co-precipitate within the slurry: 2x (0.084 g ml-'), 3x (0.126 g ml-'), and
4x (0.168 g ml-1).
4
3
2
2X IX (Slurry) = 0.042 gi/ml
IX (Dry scaffold) = 0.07
1X
6 g/cm
U 1 I I I I I 1
0 25 50 75 100 125 150
Time (min)
Figure 3.2. Densification vs. time for an input of 80 ml MCG slurry is shown. The
starting density was 0.042 g of co-precipitate per 1 ml of slurry which
corresponds to a dry scaffold density of 0.076 + 0.003 g/cm 3 [152].
Scaffolds with four nominal densities (lx, 2x, 3x, and 4x) were fabricated through
freeze-drying. The 1x suspension was freeze-dried in a rectangular polysulfone mold
with dimensions of 12 x 3 x lcm (x-, y-, z-axis respectively) (Figure 3.3). The denser
suspensions, 2x, 3x, and 4x, were freeze-dried in the cylindrical polysulfone molds (r-
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and z-axis are in the radial and through-thickness directions respectively) in which they
were subjected to vacuum because it was difficult to transfer the densified slurry to
another mold without disturbing the homogeneity of the slurry (Figure 3.3). The molds
were placed in a freeze-drier at room temperature, and then freeze-dried as described
elsewhere [17, 66, 68, 74, 111]. The MCG suspension was cooled to -100C at a cooling
rate of 0.10C min"' and kept at that temperature for 6 hours to allow the suspension to
freeze completely. Heat transfer was primarily in the through-thickness or z-direction.
The frozen suspension was then sublimated at 250 C under vacuum for 48 hours to obtain
the dry scaffold.
3 cm
A
Figure 3.3. Scaffold geometries for the lx (rectangular) and the 2x, 3x, 4x(cylindrical) scaffolds. Rectangular specimens were cut out of these scaffolds
from different planes (as shown above) for pore size analysis. Plane of the
scaffold sheet is normal to the z-axis [152].
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Crosslinking of the 3x MCG scaffold
Two techniques were used to cross-link the 3x scaffold: (1) dehydrothermal treatment
(DHT) and (2) 1-ethyl-3-(3-dimethylaminopropyl) carbodimide treatment (EDAC). The
parameters for the DHT treatment were guided by previous work on CG scaffolds [17,
22, 69, 76, 110]. The freeze-dried scaffold was placed under vacuum (30 mTorr) at a
temperature of 105'C for 24 hr. The EDAC process was carried out on the scaffold
according to previously described methods [69, 74, 76, 110]. A 5:2:1 molar ratio of
EDAC:NHS:COOH (based on the mass of the MCG scaffold samples) was used for the
current study (where the COOH groups are on the MCG scaffolds). Briefly, the scaffolds
were first hydrated in deionized water for -15 min. The required amount of EDAC/NHS
solution was then mixed into the deionized water and the scaffolds were maintained in
this solution for -1 hr. Samples were prepared and tested in the dry state as well as
hydrated state (soaked in 10% phosphate buffered saline (PBS) solution for at least 12 hr
before testing).
Microstructural characterization of the MCG Scaffolds
Relative density was calculated from the dry densities of collagen, brushite
(CaHPO 4.2H20) and monetite (CaHPO4) according to Eq (2.1); where xcon1 , Xbrushite and
Xmonetite are the weight fractions of collagen, brushite and monetite in the scaffold material
(note that xcoll + Xbrushite + Xmonetite = 1), Pcoll, Pbrushite and Pmonetite are the densities of dry
collagen, dry brushite and dry monetite and p* is the measured density of the dry
scaffolds. The weight fractions of brushite, monetite and collagen for a 50 wt.% MCG
scaffold were determined using X-ray diffraction in our previous work; Xcoll = 0.5, Xbrushite
= 0.485 and Xmonette = 0.015 [103]. The dry densities of collagen, brushite and monetite
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are 1.3 g cm 3, 2.33 g cm-3 and 2.93 g cm-3, respectively [22, 103, 116]. The contribution
of GAG was not considered, as the amount of GAG was much less than that of the other
constituents. The density of the solid wall material of the 50 wt.% MCG scaffold, ps, is
1.67 g cm-3 according to Eq (2.1).
The pore microstructure was measured using optical images of the scaffold at various
cross sections through the thickness of the scaffold. Six rectangular specimens with
dimensions 5 x 5 mm taken from different locations (for each plane: xy, yz, xz, Oz, rO; and
for each of the 4 densities) were cut using a laser cutter, model X660 (Universal Laser
System, Scottsdale, AZ) and were embedded in glycolmythacrylate (Polysciences Inc.,
Warrington, PA). The specimens were cut at high speed and low power setting (3 cm s ,
10 Watt) such that the cell structure of the specimens was not damaged by the cutting
technique (except a very thin layer at the periphery). The embedded specimens were cut
into 5 [tm-thick sections (5 to 6 sections from each rectangular specimen) at various
depths along the plane of analysis using a Leica RM2165 microtome (Mannheim,
Germany). The sectioned films were stained with Aniline-Blue (Polysciences Inc.,
Warrington, PA) and observed under an inverted optical microscope (Nikon Optiphot,
Japan) at 40x magnification. Images were obtained using a CCD color video camera
(Optronics Engineering, Inc., Goleta, GA), and image analysis was conducted using
Scion Image analysis software (Scion Corporation, Frederick, MD).
The mean pore diameter of the scaffold, D, on different planes (yz, xz and xy for the 1 x
scaffold; rO and Oz for the 2x, 3x, and 4x scaffolds as shown in Figure 3.3) was measured
using the mean intercept method. D for a particular plane is the average of the major and
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minor axes of the best-fit ellipse on that plane [66, 103]. The ratio of the minor to the
major axes of the best-fit ellipse gives the pore anisotropy ratio, R, on that plane [66,
103]. The average wall thickness in two-dimension, t2d, was calculated using Euclidean
distance mapping from the 2D images of the scaffolds on different planes [153]. The
average wall thickness in three-dimension, t, was calculated from t2d by assuming
spherical pores with mean pore diameter, D, as shown in Figure 3.4.
t(x)
To
D
Figure 3.4. Schematic of the pore assuming a speherical shape with average
diameter, D, and average pore wall thickness t.
The optical images were taken from the 2D cross sections of the scaffold at different
heights. Assuming the pores were cross sectioned equally through the diameter, the 2D
thickness observed at a height x from the center of the pore, t2d (x), (Figure 3.4) is given
by:
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2 2 2 2
r -X _X
t2d(X) = /2 2
r-X r,<x<r,
(3.1)
where ro and r, are the outer and inner radii of the pore (Figure 3.4). ro and ri can be given
in terms of D and t as:
D-t D+t
r, 2 , r  22 2
(3.2)
The average pore wall thickness in two-dimension, t2d, that we observe from the optical
images can be calculated by averaging t2d (x) over the diameter of the spherical pore as:
ro
t2d(xdx r, ro
t2d = 0- t2d (x)dx + t2d (x)dx
Jdx r° r,
0
Using Eq (3.1), (3.2), and (3.3), t2d can be represented in terms of D and t as:
;- Dt
t2d -=
2(D + t)
(3.3)
(3.4)
Therefore, from Eq (3.4), the average three-dimensional pore wall thickness, t, can be
calculated from the average two-dimensional pore wall thickness, t2d, and average pore
diameter, D, diameter as:
2Dt2d
t=- 2
t2d;TD - 2t2d
(3.5)
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Scanning electron microscopy (Leo VP438 SEM Leo Electron Microscopy Inc.,
Thornwood, NY) was used to study the pore structure of the scaffolds. Specimens were
mounted on an aluminum holder; the specimens were not gold coated. To study the
mineral distribution through the wall thickness, specimens were embedded in resin
(similar to the specimen preparation for the pore size measurement as described above)
and 5 tm-thick sections were sliced out. The backscattered electron detector was used
under variable pressure mode to obtain the images.
Mechanical characterization of the MCG Scaffolds
Compressive stress-strain curves for the dry scaffolds were measured for loading in the z-
direction using an Instron model 4201 universal testing instrument (Instron Corporation,
Norwood, MA). Compressive stress-strain curves for the hydrated scaffolds (soaked in
10% PBS for 72 hour prior to test) were measured using a Zwick/Roell Z2.5 static
materials tester (Zwick GmbH & Co., Ulm, Germany). For each density of scaffold, six
cylindrical specimens, 5 mm in diameter and 5-8 mm thick, were cut at different
locations in the scaffold along the through-thickness direction (z-axis) using a laser cutter
as described above. All of the specimens were compressed at a uniform strain rate of
0.002 sec-1 up to a maximum strain of 0.80.
The Young's modulus of the solid comprising the scaffold, Es, was measured via bending
of individual scaffold struts using an atomic force microscope (3DMFP, Asylum
Research, Santa Barbara, CA) as described in CHAPTER 2 [103, 121-123]. Six
rectangular beams were cut from the walls of the 1 x scaffold at different locations using
microsurgical forceps and a scalpel under an inverted optical microscope. One end of
-111-
each beam was bonded to a rigid support with cyanoacrylate, creating a cantilevered
beam of length L from the support point (Figure 2.2). The bending test was carried out
using an AC160TS cantilever (Olympus, Tokyo, Japan) of stiffness = 44.82 N/m, as
measured via thermal power spectral density [121]. The force-deflection relation (F-A) of
the beam is given by Eq (2.2); where I = bh3/12 (where b and h are the width and
thickness of the scaffold strut as shown in the figure). L could not be measured accurately
from the beam set-up (Figure 2.2) because the support point was not well-defined, but it
was estimated by loading the cantilever at various points along the length of each strut
(five to seven points) and measuring F vs. A for each loading point [103].
The rupture strength of the solid for the 50 wt.% MCG scaffold, oYf, was estimated via
nanoindentation using a Hysitron triboindenter (Hysitron, Inc., Minneapolis, MN) in our
previous work [103]. Samples were cut from the walls of the scaffold using microsurgical
forceps and a scalpel under a bottoms-up optical microscope. The samples were bonded
to a glass slide using cyanoacrylate and indented using a Berkovich indenter (Hysitron,
Inc., Minneapolis, MN). Rupture strength, ajq, was approximated from the calculated
hardness, H, or mean pressure at maximum load given by Eq (2.3); where cys is yield
strength, Pmax is the maximum indentation load and Ac is the projected area of contact.
Cellular solids model of the MCG scaffolds
The relative density of the scaffold can be related to the ratio of edge thickness, t, to the
edge length, 1, using a polyhedral unit cell model [95]. In the literature a
tetrakaidecahedral unit cell (a fourteen-sided polyhedron that packs to fill space) has been
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used to model the geometry of CG scaffolds (Figure 3.5) [66]. Here we have used the
same unit cell to model the MCG scaffolds.
t
-L
Figure 3.5. The tetrakaidecahedral unit cell that is used
unmineralized and mineralzeid CG scaffold microstructure [95].
to model the
The relative density of a low density open cell foam modeled with the tetrakaidecahedral
unit cell is given as:
p (t= I (3.6)
where t is the edge thickness and I is the edge length of the unit cell [95]. To calculate the
mean spacing (equivalent to the diameter, D) between opposite sides of this structure, we
assume that the internal volume is similar to that of a sphere of diameter D. Using this
assumption, the average pore diameter, D, can be calculated from the edge length by
[66]:
D = 2.781 (3.7)
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Therefore the relative density can be represented in terms of the diameter, D, and edge
thickness, t, as:
= 8.19 - (3.8)
From Eq (3.8) it is evident that the increase in relative density, p*/ps, of a scaffold results
in either increase in the strut thickness, t, or decrease in the pore diameter, D, or both.
The mechanical properties of cellular solids depend on their relative density, the
properties of the solid of which the cellular solid is made (such as Young's modulus, Es,
rupture strength, ays) and the cell geometry (e.g., open- or closed-cells) [17, 95, 101, 103].
Simple relationships between overall foam mechanical properties (such as Young's
modulus, E*, and crushing strength, o*), and the relative density and solid cell wall
properties can be derived using dimensional analysis [95, 101]. Eq (2.4) and (2.5) are the
key relationships for the Young's modulus, E*, and the crushing strength, o*, for open-
cell foams that are relevant for mechanical characterization of the mineralized scaffolds.
Statistical analysis
One-way analysis of variance (ANOVA) and Fisher's protected least significant
difference (Fisher's PLSD) methods were used to determine statistical significance
between different sets of data and pair wise data sets, respectively. A probability value of
95% (p < 0.05) was used to determine the significance. All the measurements are
reported as mean + standard deviation. The symbols *, and in Table 3.1-3.4
indicates statistically significantly different results.
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3.3 Results
Microstructural characterization
The measured overall scaffold dry densities (p*) for the MCG scaffolds are listed in Table
3.2. The starting densities of the co-precipitate in the slurry were less than the dry
scaffold densities (for example: for the lx scaffold, 0.042 g mlf' and 0.076 g cm-3 are the
slurry and dry densities respectively) partly because some of the solvent was soaked into
the collagen reducing the solidified solvent volume (and hence increasing the dry density)
[56, 154, 155]. The relative densities can be calculated using Eq (2.1) and are listed in
Table 3.2 as well. As expected, the relative densities of the 2x, 3x, and 4x scaffolds were
roughly two, three, and four times that of the 1 x scaffold, respectively.
1 x 0.076 + 0.003 0.045 0.002 311 85 23+2
2x 0.164+0.006 0.098+0.004 196 31 26+2*
3x 0.228 0.004 0.137 0.002 159 30 * 24±2
4x 0.312 0.045 0.187 0.027 136 29* 34-5**
Table 3.2. Dry densities (p*), relative densities (p*/ps), average pore diameters
(D), and average wall thicknesses (t) for the lx, 2x, 3x, and 4x MCG scaffolds
[152].
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Figure 3.6. Optical micrographs of thin sections of the embedded MCG scaffolds in
the xz, yz or Oz planes: (a) lx, (b) 2x, (c) 3x, and (d) 4x. Mean intercept length
ellipses, average pore size, D, and anisotropy ratio, R, for the top and bottom layers
of each thin section are shown to the right of each image [152].
Optical images of embedded specimens in the xz, yz, or Oz planes, through the thickness
of the scaffold sheet, are shown in Figure 3.6. Figure 3.6 also shows mean intercept
ellipses with the anisotropy ratio, R, and the pore diameter, D (to the right of the optical
images) at the top and bottom layers of the scaffolds. The scaffolds exhibited a gradation
in pore size with smaller pores at the top, closer to the air side during freeze-drying, and
increasing pore diameter through the thickness, closer to the cooling plate on the base.
Figure 3.6 indicates that pores at the top of the scaffolds were roughly equiaxed for all
densities, while the pores towards the bottom of the scaffold were more elliptical at
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higher densities. The 4x scaffold had a layered structure in the plane of the scaffold sheet
and a bimodal pore structure with significant large elliptical pores between these layers
and smaller spherical pores along the surfaces of these large pores (Figure 3.6). The 4x
scaffold also had a variation in thickness from the periphery to the center of the scaffold
indicating inhomogeneity in the vacuum filtration process.
SEM micrographs of scaffolds showing the plane through the thickness (images taken
along the planes containing the z-axis) are shown in Figure 3.7a-d. All the scaffolds
exhibited walls as well as thin struts. The 4x scaffold had layered structure as described
above with very large elliptical pores between these layers. An SEM micrograph of a
resin-embedded 5 [pm thick section of a Ix density scaffold strut is shown in Figure 3.7e.
The mineral particles are homogeneously distributed through the thickness of the walls.
EDAX analysis showed that the white flecks through the thickness of these walls are
calcium- and phosphorous- rich particles. In our previous paper [103], we confirmed
these to be either brushite or monetite. The mineral distribution was similar for the other
scaffolds (2x, 3x, and 4x). Both optical (Figure 3.6) and SEM (Figure 3.7) micrographs
show presence of defects such as disconnected walls and struts.
The average pore diameter, D, and the average wall thickness, t, for different relative
densities, p*/ps, are also listed in Table 3.2; note that porosity is 1 - p*/ps. The average
pore diameter and wall thicknesses were calculated by averaging all the measured values
(on different planes). Average pore diameter decreases with increasing relative density of
the scaffold. Average wall thickness remained same (statistically non-significant) for the
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1x, 2x, and 3x scaffolds whereas it increased for the 4x scaffolds due to inhomogeneous
microstructure with occasional thicker layers in the scaffold.
C b
Figure 3.7. SEM micrographs of the MCG scaffolds: (a) lx, (b) 2x, (c) 3x, and
(d) 4x. (e) Mineral distribution through the thickness of the scaffold walls and
struts for the lx scaffold (mineral particles are white). Mineral distributions for
2x, 3x, and 4x scaffold were similar [152].
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The relative density is plotted against t/D in Figure 3.8. The best fit curve (R2 = 0.9832)
through the data (that also passes through the origin) is:
= 2.14( (3.9)
The above equation is somewhat different from Eq (3.8), probably due to the presence of
walls as well as edges in the scaffold. We note that for a closed-cell foam, (p*/p,) a (t/l)
while for an open cell foam (p*/ps) a (t/1) 2; Eq (3.9) is intermediate to these two results.
The data for the 4x scaffold is not included in the plot, as, unlike the other 3 densities, it
had an inhomogeneous layered structure.
0.20
P 2.14 t
0.15 p,
0.10 2 = 0.9832
0.05
0.00
0.00 0.05 0.10 0.15 0.20
t/D
Figure 3.8. The relative density, p*/ps, plotted against the ratio of the wall
thickness to the pore diameter, t/D, for the MCG scaffolds [152].
More detailed data for the pore diameter, D, and the anisotropy ratio, R, on different
planes are listed in Table 3.3. All the scaffolds had roughly equiaxed pores in the planes
of the scaffold sheet (planes xy for 1 x, rO for 2x, 3x, and 4x). However, as noted above,
in the through thickness direction (planes xz or yz for lx, and plane Oz for 2x, 3x, and
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4x), as the density increased, the pores towards the bottom of the scaffold were larger and
more elliptical, decreasing the overall R.
yz 339 112*
x xz 303 85
S29 5 40.......................................S xv 295 + 40
0.945 ± 0.045
0.923 ± 0.060
0.940 ± 0.049
Oz 178 31 0.905 ± 0.057
2x
rO 208 ± 24* 0.929 + 0.047
Oz 152 + 31 0.852 0.087*
3x
rO 164 ± 28 0.928 + 0.049
Oz 155 30* 0.831 0.088*
ro 123 ± 20 0.948 ± 0.042
Table 3.3. Pore sizes (D) and anisotropy ratios (R) measured on different planes
of the MCG scaffolds. Note: lx scaffold was fabricated as rectangular sheet (and
hence Cartesian co-ordinate system) and 2x, 3x, and 4x scaffolds were fabricated
as circular sheets (and hence cylindrical co-ordinate system) [152].
Mechanical characterization
Compressive stress-strain plots for loading dry and hydrated scaffolds in the z-direction
are shown in Figure 3.9. Distinct linear elastic, collapse plateau and densification regimes
were observed for all the scaffolds indicating behavior similar to that of foams [95].
Elastic modulus (E*), crushing strength and strain (a* and e* respectively) and collapse
modulus (a/lAe) are measured from the stress-strain curves [95, 103]. Briefly, E* is the
slope of the linear elastic regime, Aa/Ac is the slope of the collapse regime, a* and e* are
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the point of transition from linear to the collapse regime (determined from the
intersection of the E* and Au/Ae regression lines).
The values of E*, a*, e* and Au/Ae for the scaffolds in the dry and hydrated states are
listed in Table 3.4. E*, a*, Ao/Ac increase with increase in relative density of the scaffold
from 1 x to 3x in both dry and hydrated states. However, the properties of the 4x scaffold
are lower compared to those of the 3 x scaffold in both the states (except u* in the dry
state). e* remains constant (not statistically different) for different relative densities in
both the dry and hydrated states (e* - 5%). The mechanical properties, E*, a*, Au/Ae of
the dry scaffolds are two orders of magnitude higher than those of the hydrated scaffolds.
For both the dry and the hydrated scaffolds, Au/Ae is in the same order as that of the E*.
The values of E*, a, E* and Au/Ac in the z-direction for the 3x scaffolds with different
crosslinking treatments are also listed in Table 3.4. The specific crosslinking treatments
had no statistically significant effect on any of the properties (p > 0.05) for both scaffolds
in the dry state, with the exception of the higher strength in the EDAC treatment. In the
hydrated state, DHT and EDAC crosslinking increased the E*, u*, and Au/Ae over that of
the non-crosslinked scaffold by 1.5 and 3 times, respectively. There was no statistically
significant effect on the crushing strain, e*.
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Figure 3.9. Compressive stress-strain plots for the MCG scaffolds: (a) dry (b)
hydrated. Distinct linear elastic, collapse plateau and densification regimes were
observed for the scaffolds. The linear elastic part is magnified in the insets to
show the change in slope between the linear elastic and collapse plateau regimes
[152].
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Young's modulus of the solid, Es, was measured on struts removed from the 1x scaffold
using the AFM bending test. A typical plot of L vs. (A/F)1 3 is shown in Figure 3.10. The
fact that the plot is linear indicates that the beam follows Eq (2.2) and the above method
is appropriate for measuring the solid Young's modulus. The Young's modulus, Es, for
the dry solid strut from the lx scaffold was measured to be 7.34 + 3.73 GPa (Eq (2.2)).
Since the higher density scaffolds have the same composition as the 1 x, we assume that
their solid properties are the same. The measured Young's modulus is not statistically
different from the value obtained in our previous work (9.15 ± 0.983 GPa) [103]
suggesting that the two different collagen sources used for making the scaffolds in the
current paper and in our previous paper [103] have similar mechanical properties. These
values are close to that of trabecular bone (e.g. E, of dry trabecular bone is - 18 GPa)
[156-160]. The rupture strength, aj, is assumed to be 201 + 52 MPa as measured in our
previous work [103].
The data for the relative modulus, E*/Es, and the relative crushing strength, ao*/fs, for the
dry scaffolds are plotted against relative density, p*/ps in Figure 3.11. The data for the 4x
scaffold is not included as, unlike the other 3 densities, it had an inhomogeneous layered
structure.
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Scaffold p'/p, E' (kPa) o' (kPa) e' (%)
lx 0.045 ± 0.002 780 95 39 ± 10 5.00 ± 1.00
2x 0.098± 0.004 3156 760* 132 ± 14* 4.00 ± 1.41
3x 0.137 ± 0.002 6500 ± 1270" 242 ± 32" 4.00 ± 1.00
4x 0.187 ±0.027 3660±820* 275 ±50" 4.38 ±1.15
Scaffold
1 x
2x
3x
4x
0.045 ± 0.002
0.098 ± 0.004
0.137 ± 0.002
0.187 ± 0.027
Scaffold Treatment
Non-crosslinked
3x DHT (105C, 24h)
EDAC (5:2:1)
Scaffold Treatment
Non-crosslinked
3x DHT (105oC, 24h)
EDAC (5:2:1)
E' (kPa)
6.44 ± 1.91
17.84 + 3.61*
34.83 -7.39**
38.77 - 31.2
E' (kPa)
6500 -1270
6147 ± 1459
6889 ± 1116
E' (kPa)
34.83 ± 7.39
55.95 ± 10.19*
91.67 ± 10.88"*
'r" (kPa)
0.55 - 0.07
0.83 + 0.18*
2.12 - 0.66"*
1.79 ±1.89
o' (kPa)
242 ± 32
264 ± 78
358 ± 84*
a* (kPa)
2.12 ± 0.66
3.26 ± 1.19"
4.15 ± 0.95"*
e'(/,)
6.80 - 2.20*
4.86 - 1.37
5.63 - 1.48*
4.18 ±1.26
Se(%)
4.00 ± 1.00
5.20 ± 2.50
6.10 ± 1.50
5.63 ± 1.48
5.55 ± 0.84
4.66 ± 0.88
Aa/A (kPa)
3.18 ± 1.49
11.99 + 2.29*
26.78 - 6.21"
15.95 -15.07
Ar/AC (kPa)
2680 ± 610
2262 ± 492
2544 ± 571
Aar/A (kPa)
26.78 ± 6.21
43.00 ± 4.06*
79.17 ± 9.66*
Table 3.4. Mechanical properties of the MCG scaffolds in the dry as well as the
hydrated state determined from the compression tests [152].
3.4 Discussion
We were able to increase substantially the Young's modulus and the crushing strength of
the mineralized scaffold in both the dry and hydrated state by increasing the relative
density by a factor of 3. The denser scaffolds, 2x and 3x, in the dry state sustained hard
thumb pressure that is critical for scaffold implantation at the defect site. Cross-linking
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Aar/A (kPa)
480 - 35
1300 ± 200*
2680 ± 610"
1875 ± 525***
1.III
the scaffolds with EDAC further increased the properties of the hydrated, but not the dry
scaffolds. We were able to achieve an increase in Young's modulus of the hydrated
scaffold from 6.44 kPa, for the non-cross-linked 1 x scaffold, to 34.9 kPa for the non-
cross-linked 3x scaffold. Note that the 3x hydrated scaffold has the stiffness in the right
range (25-40 kPa as described in chapter 1) for the stem cells to differentiate into
osteoblast-like cells. EDAC crosslinking increased the Young's modulus further for the
3x hydrated scaffold to 91.7 kPa. Similarly, we were able to achieve an increase in the
crushing strength of the hydrated scaffold from 0.55 kPa, for the non-cross-linked x
scaffold, to 4.15 kPa for the EDAC cross-linked 3 x scaffold.
400
300 L = 822.41 (A - 84.57
2F
S200 R= 0.9941
100
0 I
0.0 0.2 0.4 0.6
Figure 3.10. Plot of L vs. (A/F)1/3 for the lx MCG scaffold is shown. The slope of
this line fit is equal to (3EsI) 1/ 3. A linear variation indicates the strut behaves like a
cantilevered beam with constant moment of inertia. Knowing the dimensions of
the beam Es can be calculated [152].
The compressive stress-strain curves for the scaffolds were typical of cellular solids,
showing the three regimes of linear elasticity, the collapse plateau and densification. The
dependence of the relative Young's modulus and relative crushing strength on relative
density were well described by the power exponents derived from cellular solids models
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(Eq (2.4) and (2.5)). The curves plotted on Figure 3.11 correspond to the theory (Eq (2.4)
and (2.5)) with different constants that reflect the effect of the defects, such as
disconnected walls and struts, in the cellular structure. We note that the constants in Eq
(2.4) and (2.5) are empirical, based on data in the literature, for intact foams without such
defects. A previous finite element study of the effect of missing cell walls on the
modulus and strength of two-dimensional honeycombs found that the defects reduced the
constants but not the value of the exponent in the cellular solids models [101, 136, 138,
139, 161].
The Young's modulus and crushing strength of the lx mineralized scaffolds in this study
were similar to those of our previous study [103], although we used two different
collagen sources in the two studies. Our previous study used a medical grade collagen
(Integra Life Sciences, Plainsboro NJ); since then, this source became unavailable to us
so that in this study we used a non-medical collagen source (Sigma-Aldrich Chemical
Co., St. Louis MO). The slope of the stress-strain curve beyond the crushing strength
was steeper in this study than in the previous one, suggesting that there was a larger
difference between the weakest and the strongest cells in the structure in this study as
compared with our previous one.
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Figure 3.11. (a)E*/Es and (b) /crf, plotted against relative density, p*/ps, for the
dry MCG scaffolds [152].
The maximum dry scaffold relative density that we were able to achieve while
maintaining a more or less homogenous microstructure was 0.137 (or 3x). The 4x
scaffold had a layered structure with numerous large elliptical cells with the major axis
normal to the loading direction; the mechanical properties of the scaffold were adversely
affected by this. A practical upper limit on the relative density is that which limits the
degree of interconnection between the pores so that cells can migrate through the
scaffold; for this reason, the maximum practical relative densities is probably less than
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0.25. The cellular models suggest that an increase in the relative density from our base
p/ps = 0.045 (or 1 x) to 0.25 should increase the Young's modulus by a factor of 30 and
the crushing strength by a factor of 15. Further study is needed to develop methods of
increasing the relative density up to this limit while maintaining a homogeneous
microstructure.
The scaffolds had an interconnected pore structure with walls as well as struts. All the
scaffolds had average pore sizes in the range of 130-350 jim with porosities greater than
80% (Table 3.2). Note that porosity is 1 - p*/ps. Bone cells are 10 - 20 jtm in size [94,
162], substantially smaller than the smallest average pore size in our scaffolds. Previous
studies have shown that polymer scaffolds with pore sizes between 100 and 1000 jim are
suitable for bone growth [2-4, 62]. In addition, our group has previously demonstrated
that MC3T3-El mouse osteogenic cells attach and migrate into CG scaffolds with
average pore sizes between 96 - 150 jim [66]. MCG scaffolds have shown bone
regeneration in a goat model [19]. While we have not definitively demonstrated by cell
adhesion, migration, proliferation or differentiation studies that bone will grow in the
denser scaffolds, they do have a composition, pore size and porosity consistent with those
previously demonstrated to be suitable for bone growth. The mineral distribution was
homogeneous through the thickness of the walls. The dry densities of the scaffolds were
higher than the slurry densities due to the bound water content of the collagen [56, 154,
155]. All the scaffolds except the 4x had almost equiaxed pores but with increasing pore
size through the depth of the scaffold, with the largest pores at the bottom of the scaffold
for all the relative densities. During freeze drying the solidification front starts at the
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bottom (near to the cooling plate on the base) and moves slowly towards the top due to
the low thermal conductivity of polysulfone. Hence the coarsening time for the ice
crystallites in the top layer was less than that for those at the bottom, near the cooling
shelf, giving smaller pores at the top than at the bottom. The 4x scaffold had large
elliptical pores through the thickness of the scaffold sheet giving a layered structure in
that plane. This is due to the alignment of the collagen fibers in the plane of the scaffold
as the densification increased during vacuum filtration, ultimately blocking the solvent
filtration at - 4.5x (Figure 3.2).
3.5 Conclusions
50 wt.% MCG scaffolds with four different relative densities (0.045, 0.098, 0.137, and
0.187) were fabricated via a three step process: (1) titrant-free triple co-precipitation of
the slurry, (2) vacuum filtering the slurry to the desired density, and (3) freeze drying the
slurry to obtain the dry scaffold. The MCG scaffolds had an open cell pore structure with
both walls and struts and interconnected pores. While we have not definitively
demonstrated by cell adhesion, migration, proliferation or differentiation studies that
bone will grow in the denser scaffolds, they do have a composition, pore size and
porosity consistent with those previously demonstrated to be suitable for bone growth. As
the relative density of the scaffolds increased, the average pore size decreased and wall
thickness remained same. Pores varied from equiaxed to elliptical (in the planes
perpendicular to the plane of the scaffold sheet) as the relative density of the scaffold
increased. The densest scaffold (4x) had a layered structure (in the plane of the scaffold
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sheet) with occasional struts across the layers making it mechanically weaker for loading
in the z direction.
Compressive stress-strain plots of the scaffolds indicated distinct linear elastic, collapse
plateau and densification regimes. Mechanical properties of the scaffold increased with
increasing relative density. The Young's modulus and crushing strength of the scaffolds
in the dry state ranged from 780 to 6500 kPa and from 39 to 275 kPa, respectively. In the
hydrated state, the Young's modulus and crushing strength of the scaffolds ranged from
6.44 to 34.8 kPa and from 0.55 to 2.12 kPa, respectively. The density dependence of the
Young's modulus and crushing strength were well described by cellular solids models.
Specific cross-linking treatments increased the mechanical properties of the scaffolds in
the hydrated state by several fold. Future research is directed towards increasing the
mechanical properties of the unmineralized collagen-GAG scaffolds by increasing the
relative densities of the scaffolds through vacuum filtering. These scaffolds have
potential for regeneration of tissues such as cartilage, ligament, and tendon.
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CHAPTER 4. Microstructure, Mechanical, and Cell
Adhesion Properties of Collagen-Glycosaminoglycan
Scaffolds with Increased Relative Density
4.1 Introduction
Scaffolds for tissue engineering serve as analogs of extracellular matrices that physically
support cells and affect biological processes such as cell migration, differentiation, and
proliferation. Scaffolds have been extensively used in-vitro to study cell-scaffold
interactions and in-vivo for tissue and organ repair and regeneration. The cellular
response and the success in regenerating the host tissue are affected by the scaffold
microstructure [4, 5, 24, 64, 66], composition [163, 164], and mechanical properties
(especially Young's modulus) [4, 17, 26, 64, 165-168]. Relevant microstructural
properties include the pore size, the pore interconnectivity, and the relative density (the
density of the cellular solid, p*, divided by that of the solid from which it is made, ps).
Note that relative density is 1-porosity. Recently, Engler et al. [26] showed that human
mesenchymal stem cells (MSC) differentiate into specific lineage and commit to
phenotypes (neurogenic, myogenic, and osteogenic) depending on the matrix elasticity.
Scaffold mechanical properties are also critical from an implementation point of view as
the scaffold has to maintain its shape and size during surgical procedures [100]. Scaffolds
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are usually made of either synthetic polymers (such as polylactic acid, polyglycolic acid)
or natural polymers (such as collagen, proteoglycans). We use a collagen-
glycosaminoglycan (CG) scaffold that has been studied for use in a variety of tissue
engineering applications including skin [5, 22, 61], peripheral nerve [24, 31, 67, 143],
muscle [169], cartilage, and bone [69, 74-76, 110]. Collagen is a significant constituent of
natural extracellular matrices (ECM), possesses low antigenicity, and promotes cell
attachment and proliferation [24]. Additionally, CG scaffolds are biocompatible, with
non-toxic degradation products. They have a high porosity (> 90%), and interconnected
pore network [68]. These characteristics make CG-based scaffolds attractive for use in
tissue engineering applications. Unmineralzied CG scaffolds for skin, nerve, and cartilage
regeneration are fabricated by freeze drying a CG suspension [22, 61] while mineralized
CG scaffolds for the regeneration of bone are fabricated by freeze drying a triple co-
precipitate of collagen, glycosaminoglycan, and calcium phosphate [69, 74-76, 103, 152].
There is interest in using collagen-based scaffolds to regenerate tendon and ligament
[170-176]. The main function of ligaments and tendons is to transmit tensile loads [177].
Currently, if the damage is limited, the damaged tissue is surgically removed and the
remaining tissue is reattached by suturing. If the damage is more extensive, treatment
methods include: tissue grafts (such as bone-patellar tendon-bone, quadruple-strand
semitendinosus and gracilis tendons, Achilles tendon, Flexor digitorum longus tendon,
and fascia lata [177-179]) and synthetic grafts (such as carbon fiber graft, bundled
polytetrafluoroethylene fibers, Dacron, polypropylene [180-182]). Grafts are fixed to the
defect site through screws (metal or absorbable polymers) [182], suture anchors (such as
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Nitinol, coated braided polyester, monofilament nylon, monofilament polypropylene,
biodegradable poly-L-lactide) [183], staples [182], or cross-pins and titanium buttons
[177]. The aim of the fixation of grafts is to provide sufficient initial stiffness and
strength of the graft-bone interface at the attachment site such that appropriate stability
can be achieved. Although initial pull-out strength of the fixation may be adequate, it has
been shown that partial pull-out can occur during submaximal cyclic loading [184].
Therefore, in tendon and ligament repair, mechanical properties of the scaffold need to be
closer to that of the host tissue, as early rehabilitation and physiotherapy are required to
prevent joint stiffness after orthopedic surgery [178, 180].
The mechanical properties of current CG scaffolds are low. Typical CG scaffolds (p*/ps =
0.006) have compressive Young's modulus, E*, of-30 kPa (dry) and -208 Pa (hydrated),
and compressive strengths, a*et, of -5 kPa (dry) and -21 Pa (hydrated) [17]. They have a
uniform microstructure with roughly equiaxed pores (pore size 96 - 151 pm) [68]. The
moduli and compressive strength of the scaffolds, which can be modeled as foams, are
expected to increase with the square of the relative density [95]. Previous attempts to
increase the mechanical properties have focused on mixing higher volume fractions of
collagen and glycosaminoglycan into slurry prior to freeze drying, to increase the relative
density of the scaffold. The increased viscosity of the slurry makes it more difficult to
mix, however, giving an inhomogeneous CG scaffold. For P*/Ps = 0.018 the maximum
compressive Young's modulus and compressive strength in the dry state were -80 kPa
and -15 kPa respectively [17]. Note that tripling the relative density tripled E* and oet,
rather than an increase of a factor of 9 as expected from the micromechanical models of
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cellular materials [95]. The mechanical properties of the CG scaffolds are much lower
than those of tissues such as tendon and ligament (Table 1.5) [185, 186]. Even if some of
the load is carried by a surgical suture used in conjunction with the scaffolds, the
mechanical properties of the CG scaffolds need to be greatly improved to meet the
mechanical requirements.
We have previously characterized the microstructure and mechanical properties of
mineralized CG scaffolds with varying mineral content and relative density [103, 152]. It
was found, somewhat unexpectedly, that higher mineral content introduced defects such
as cracked and disconnected pore walls into the scaffold, which resulted in a net decrease
in the scaffold mechanical properties. We found we could produce a higher density
mineralized scaffold by starting out with the low-density slurry and suctioning off solvent
using vacuum. The resulting scaffolds were up to 3 times as dense as the initial ones, with
mechanical properties about 9 times that of the original scaffold, a square relationship as
expected from models for cellular solids.
In this paper we applied the same modified vacuum filtration process described above to
unmineralized CG scaffolds to increase their relative density. The measured mechanical
properties of the unmineralized CG scaffolds are compared with models for cellular
solids. Models for cellular solids also suggest that the surface area per unit volume (and
hence the number of binding sites per unit volume) increase with square root of the
relative density and with the inverse of the pore size [66]. Therefore we completed our
study by measuring the cell attachment on CG scaffolds of increasing relative density.
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4.2 Materials and methods
Fabrication of CG suspension
A collagen-glycosaminoglycan suspension was fabricated using microfibrillar, type I
collagen isolated from bovine dermis (Devro Pty Ltd, Bathurst, NSW, Australia),
chondroitin-6-sulfate (GAG) isolated from shark cartilage (Sigma-Aldrich Chemical Co.,
St. Louis, MO), and 0.05 M glacial acetic acid (pH 3.2) (Mallinckrodt Chemical Co.,
Paris, KY). The suspension was prepared by combining collagen (0.019 wt.%) and GAG
(0.002 wt.%), in a solution of 0.05 M acetic acid (pH 3.2) through a method described
elsewhere [22, 61, 66, 68]. Briefly, the collagen, chondroitin-6-sulfate, and acetic acid
were mixed at 15,000 rpm in an overhead blender (IKA Works Inc., Wilmington, NC);
the temperature of the suspension was maintained at 40C throughout mixing by a cooling
system (Brinkman, Westbury, CT) to prevent denaturation of the collagen fibers as a
result of the heat generated by mixing. The CG co-precipitate within the slurry had a
density of 0.0054 grams per ml of slurry (denoted 0.0054 g ml-1).
Densification of the CG slurry
The above slurry (denoted as 1x, where 1 x = 0.0054 g ml') was densified using a similar
set-up as was used for the mineralized CG scaffolds in our previous work [152].
However, a vibrating base plate was used in the current set-up (Figure 4.1) in an attempt
to avoid layering of the scaffold as was seen in the mineralized scaffold [152]. A
cylindrical polysulfone mold (McMaster Carr Supplies, Dayton NJ), with a diameter of
5.7 cm, was perforated at the base with holes of 1 mm diameter for filtering the solvent to
the aluminum base. Two filter papers with 5 [tm pore diameter (VWR, West Chester,
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PA) were placed at the base of the mold in order to filter out desired amount of the
solvent.
Final hi
density hi-A
Polysulfone
mold
r- Vacuum
Aluminum
base
Vibrates
in z-axis
Figure 4.1. Schematic of the vacuum filtering process. The initial low density
slurry is densified via vacuum suctioning the solvent to the bottom container. The
final density of the slurry is controlled by the time the slurry is subjected to
vacuum. Note that we have used a vibrating plate at the base in order to prevent
layering of the scaffold (as was noticed in our previous work on mineralized
scaffolds).
The l x slurry was poured into the mold and subjected to vacuum as shown in the
schematic (Figure 4.1). The extracted solvent was collected in the bottom container; the
slurry remaining in the top compartment became denser as the time the suspension was
subjected to vacuum increased. The density of the remaining slurry in the top
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compartment was calculated by dividing the initial solid weight by the remaining volume
of the slurry (or in other words x = h/(h-A) where h and (h-A) were the initial thickness of
the 1 x slurry and the final thickness of the densified slurry, respectively). The slurry
density was plotted against the time it was subjected to vacuum, as shown in Figure 4.2.
For a desired final slurry density the initial slurry can be filtered under vacuum for a
specific time according to this plot. For this study the CG slurry was densified to three
nominal higher densities of the co-precipitate within the slurry: 2x (0.0108 g ml'), 3x
(0.0162 g ml-1), and 4x (0.0216 g ml').
5.00
4.00 -
3.00 -
X 3X
2.00
1.00 2 1xlun = 0.0054 g ml
SXDry scaffold = 0.0075 g cni3
0.00 I
0 100 200 300 400 500 600
Time (min)
Figure 4.2. Densification vs. time for an input of 50 ml CG slurry is shown. The
starting density was 0.0054 g of CG co-precipitate per 1 ml of slurry which
corresponds to a dry scaffold density of 0.0076 ± 0.001 g cm -3
Fabrication of CG scaffolds using freeze-drying
Scaffolds with four nominal densities (lx, 2x, 3x, and 4x) were fabricated through
freeze-drying. All the suspensions, lx, 2x, 3x, and 4x, were freeze-dried in the
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cylindrical polysulfone molds (r- and z-axis are the radial and through-thickness
directions, respectively) in which they were subjected to vacuum because it was difficult
to transfer the densified slurry to another mold without disturbing the homogeneity of the
slurry (Figs. 1 and 3). The molds were placed in a freeze-drier at room temperature, and
then freeze-dried as described elsewhere [17, 66, 68, 74, 111]. Briefly, the CG
suspension was cooled to -100C at a cooling rate of 0.1 0C min1 and kept at that
temperature for 6 hours for the suspension to completely freeze. Heat transfer was
primarily in the through-thickness or z-direction. The frozen suspension was then
sublimated at 25C under vacuum for 48 hours to obtain the dry scaffold.
Cross-linking of the CG scaffolds
Dehydrothermal treatment (DHT) was used to cross-link the scaffolds. The parameters
for the DHT treatment were guided by previous work on CG scaffolds [17, 22, 69, 76,
110]. Briefly, the freeze-dried scaffold was placed under vacuum (30 mTorr) at a
temperature of 105C for 24 hr.
Microstructural characterization of the CG scaffolds
Relative density of the CG scaffolds, p*/ps, was calculated from the measured dry density
of the CG scaffold (p*) and the known dry density of solid collagen (ps = 1.3 g cm-3) [22,
116]. The contribution of GAG was not considered, as the amount of GAG was much
less than that of the collagen. The mean pore diameter of the scaffold, D, on different rO
and Oz planes (Figure 4.3) was measured using the mean intercept method. D for a
particular plane is the average of the major and minor axes of the best-fit ellipse on that
plane [66, 103]. The ratio of the minor to the major axes of the best-fit ellipse gives the
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pore anisotropy ratio, R, on that plane [66, 103]. The average wall thickness, t, was
calculated using Euclidean distance mapping from the 2D images of the scaffolds on
different planes [153]. Briefly, six rectangular specimens with dimensions 5 x 5 x 5 mm
were cut from different locations (for each plane: Oz, rO; and for each of the 4 densities)
and were embedded in glycolmythacrylate (Polysciences Inc., Warrington, PA). The
embedded specimens were cut into 5 gm-thick sections (5 sections from each rectangular
specimen) at various depths along the plane of analysis using a Leica RM2165
microtome (Mannheim, Germany). The sectioned films were stained with Aniline-Blue
(Polysciences Inc., Warrington, PA) and observed under an inverted optical microscope
(Nikon Optiphot, Japan) at 40x magnification. Images were obtained using a CCD color
video camera (Optronics Engineering, Inc., Goleta, GA), and image analysis was
conducted using Scion Image analysis software (Scion Corporation, Frederick, MD).
Scanning electron microscopy (Leo VP438 SEM Leo Electron Microscopy Inc.,
Thornwood, NY) was used to study the pore structure of the scaffolds. Specimens were
mounted on an aluminum holder; the specimens were not gold coated. The backscattered
electron detector was used under variable pressure mode to obtain the images.
Mechanical characterization of the CG scaffolds
Compressive stress-strain curves for the dry scaffolds were measured for loading in the z-
direction using a Zwick/Roell Z2.5 static materials tester (Zwick GmbH & Co., Ulm,
Germany). For each density of scaffold, six cylindrical specimens, 5 mm in diameter and
5 mm thick, were cut using biopsy punches (Miltex Inc., York, PA) at different locations
in the scaffold along the through-thickness direction (z-axis). All of the specimens were
compressed at a uniform strain rate of 0.002 sec-1 up to a maximum strain of 0.80.
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Tensile stress-strain curves for the dry scaffolds were measured for loading along the
plane of the scaffold sheet (plane rO in Figure 4.3) using the Zwick/Roell Z2.5 static
materials tester. For each density of scaffold, six rectangular (width: 5 mm, thickness: -3
mm, and gauge length: - 5 mm) specimens were cut from the plane of the sheet of the
scaffold. All the specimens were stretched at a uniform strain rate of 0.002 sec-1 up to
failure. The Young's modulus of the dry CG solid making up the scaffold, Es, was
previously measured via bending of individual scaffold struts using an atomic force
microscope as described by Harley et a.l [17, 103, 121, 122, 152]: Es = 762 MPa.
Figure 4.3. Scaffold geometries for the lx, 2x, 3x, and 4x scaffolds. Rectangular
specimens were cut out of these scaffolds from different planes (as shown above)
for pore size analysis. Plane of the scaffold sheet is normal to the z-axis.
Cell attachment on the CG scaffolds
Six cylindrical samples with diameter of 6 mm and thickness of 5 mm were cut from each
of the four CG scaffold variants (1x, 2x, 3x, and 4x) using biopsy punches. MC3T3-E1
mouse clonal osteogenic cells (ATCC, Manassas, VA) were maintained in MEM-a
medium supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Chicago, IL).
MC3T3 cells were chosen for this study for comparison with the results of O'Brien et al.
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[66], who also used MC3T3 cells. Cells were removed from the cultured flasks (VWR,
Edison, NJ) to seed the scaffolds using a trypsin-EDTA solution (ATCC, Manassas, VA).
Viable cell number was determined prior to seeding by live-cell staining using 0.4%
Trypan Blue (Invitrogen, Chicago, IL) and counting viable cells with a standard
hemocytometer (Bright-Line, Hausser Scientific, Horsham, PA) [18]. Prior to seeding,
the scaffolds were placed into wells of a 6-well tissue culture ultra low attachment
agarose coated plate (Coming Inc., Coming, NY). The CG scaffolds were hydrated with
10% phosphate buffered saline, PBS, (VWR, Edison, NJ) for 12 hr under vacuum
followed by hydrating with the MEM-a medium supplemented with 10% FBS for
another 12 hr under vacuum. CG scaffolds were removed from the medium and partially
dried using a filter paper. The CG scaffolds were seeded on both sides with 2.5 x 105
cells in a manner that has previously been described [18, 167]. 10 [l of the MC3T3-E1
cell suspension (1.25 x 104 cells/ t) was pipetted onto one surface of the dry scaffold.
The scaffolds were then placed inside an incubator for 30 min to allow for initial cell
attachment through that surface. The seeded scaffolds were then turned over and an
additional 10 p1 of the cell suspension was pipetted onto the reverse surface of the
scaffold. The scaffolds were then returned to the incubator for additional 30 min to allow
for initial cell attachment through the reverse surface. The wells were then filled with 3ml
of the MEM-a medium (supplemented with 10% FBS) and placed into a cell culture
incubator and maintained at 370C with 5% CO2 for 24 hr. The relatively high cell density
was chosen to provide a high density of integrins (cells) to allow a test of the hypothesis
that the density of available ligands increases with increased relative density and
decreased pore size as described below (Eq (4.4)). The attachment time of 24 hr was
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selected based on a previous study by O'Brien et al. [66] who found that there was no
significant difference in the percentage of cells attaching to the CG scaffold after 24 hr
and 48 hr post seeding (using MC3T3-El mouse clonal osteogenic cells). Following each
adhesion experiment, the seeded scaffold was removed from the tissue culture plate. Each
sample was rinsed with 10% PBS at 370C to remove unattached cells and was then placed
in a 2.0 U/ml solution of dispase (Invitrogen, Chicago, IL) for 15 min to digest the
scaffold [18, 167]. The number of attached, viable cells was then counted using a
hemocytometer.
Cellular Solids Model of the CG scaffolds
The relative density of the scaffold can be related to the ratio of edge thickness, t, to the
average pore diameter, D, using a polyhedral unit cell model [95, 152]. In the literature a
tetrakaidecahedral unit cell (Figure 3.5) (a fourteen-sided polyhedron that packs to fill
space) has been used to model the geometry of CG scaffolds [66]. Here we have used the
same unit cell to model the CG scaffolds. The relative density of a low density open cell
foam modeled with the tetrakaidecahedral unit cell is given as [152]:
* 8.19 (4.1)
From eqn (1) it is evident that the increase in relative density, p*/ps, of a scaffold results
in either increase in the strut thickness, t, or decrease in the pore diameter, D, or both.
For an open-cell tetrakaidecahedral unit cell with edges of circular cross-section, the
surface area per unit volume (SA/V), or specific surface area can be described by the
relation [66, 95]:
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SA 3.65 (0)/ (4.2)SA= -___(4.2)
V I P,
where 1 is the edge length of the tetrakaidecahedral unit cell. Edge length, 1, can be
related to the average pore diameter, D, by [66, 95]:
D = 2.781 (4.3)
Therefore the specific surface area of the unit cell is calculated using Eq(4.2) and (4.3)
as:
SA 10.15 P (4.4)
V D p,
Specific surface area of the CG scaffold can be calculated by measuring the relative
density (p */ps) and the average pore diameter (D).
The mechanical properties of foams (Young's modulus, E*, and elastic compressive
strength, o*el) depend on their relative density (p*/ps), the properties of the solid of which
the cellular solid is made (such as Young's modulus, E,) and the cell geometry (e.g.,
open- or closed-cells) [17, 95, 103]. Simple relationships between overall foam
mechanical properties (Young's modulus, E*, and elastic compressive strength, *,et), and
the relative density and solid cell wall properties can be derived using dimensional
analysis [95]. Key relationships for the Young's modulus, E*, and elastic buckling
compressive strength, aet, for open-cell foams that are relevant for mechanical
characterization of the CG scaffolds are given below:
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E* (* (4.5)
E, P, )
d = C2 (4.6)
where C1 and C2 are empirical constants derived by comparing data for a variety of open
cell foams. Both E*, and *,el, vary with the square of the relative density so that the strain
at which cells collapse by bucking, e*el, remains constant and equal to C2 C1. C1 and C2
are empirically determined to be 1 and 0.05 respectively, for open-cell engineering
foams.
Statistical analysis
One-way analysis of variance (ANOVA) and Fisher's protected least significant
difference (Fisher's PLSD) methods were used to determine statistical significance
between different sets of data and pair wise data sets, respectively. A probability value of
95% (p < 0.05) was used to determine the significance. All the measurements are
reported as mean ± standard deviation. The symbols , , and indicates statistically
significantly different results.
4.3 Results
Microstructural characterization
The measured overall scaffold dry densities (po*) for the CG scaffolds are listed in Table
4.1. The starting densities of the co-precipitate in the slurry were less than the dry
scaffold densities (for example: for the 1 x scaffold, 0.0054 g ml-1 and 0.0076 g cm -3 are
the slurry and dry densities respectively) partly because some of the solvent was soaked
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into the collagen reducing the solidified solvent volume (and hence increasing the dry
density) [56, 154, 155]. This was also observed in previous work on umineralized CG
scaffolds [17] and mineralized CG scaffolds [103, 152]. The relative densities are
calculated as described above and are also listed in Table 4.1. As expected, the relative
densities of the 2x, 3x, and 4x scaffolds were roughly two, three, and four times that of
the lx scaffold, respectively.
: -:- -: _:: :: _:_-:-:: -.;i...:;:;:: ::::;::::; ::::::::: :i,: ... . ; .- :.,,;,; -*:--;
0.0076 ± 0.0010
0.0153 ± 0.0020
0.0257 ± 0.0018
0.0311 ± 0.0040
0.0062 ± 0.0008
0.0120 ± 0.0016
0.0198 ± 0.0014
0.0239 ± 0.0021
343 ± 61
279 ± 70 *
258 ± 54 **
257 ± 57 *"
11.9 ± 0.57
13.1 ± 1.66*
14.1 ± 2.27 **
15.6 ± 2.88 ***
Table 4.1. Dry densities (p*), relative densities (p / ps), average pore diameters(D), and average wall thicknesses (t) for the 1 x, 2x, 3x, and 4x CG scaffolds.
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Figure 4.4. Optical micrographs of thin sections of the embedded CG scaffolds in
the Oz planes: (a) lx, (b) 2x, (c) 3x, and (d) 4x.
Optical images of embedded specimens in the Oz planes, through the thickness of the
scaffold sheet, are shown in Figure 4.4. Figure 4.4 indicates that pores in the bulk of the
scaffolds were roughly equiaxed for all densities, while the pores towards the bottom of
the scaffolds were more elliptical at higher densities. This was expected as vacuum was
applied at the bottom of the slurry which formed a boundary layer that prohibited further
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densification. The strut thickness appeared thicker with increasing relative density. SEM
micrographs of scaffolds showing the plane through the thickness (images taken along
the planes containing the z-axis) are shown in Figure 4.5a, b, c, d. All the scaffolds
exhibited low density open cell structure with mostly struts and some thin walls; the
occurrence of walls increased with increasing relative density. This is expected as with
increasing density more material is available to form walls as well as struts.
The average pore diameter, D, and the average wall thickness, t, for different relative
densities are also listed in Table 4.1. The average pore diameter and wall thicknesses
were calculated by averaging all the measured values (on planes rO and Oz). Average pore
diameter decreased (except 4x which was statistically equivalent to 3 x) and average wall
thickness roughly remained constant with increasing relative density of the scaffold. The
relative density is plotted against t/D in Figure 4.6. The curve plotted on Figure 4.6
corresponds to the theory (Eq (4.1)) indicating that the scaffold behaves very much like
an open cell foam with slightly different constants that reflect that the geometry of the
scaffold is more complex than an array of identical tetrakaidecahedral cells [95, 138,
139]. More detailed data for the pore diameter, D, and the anisotropy ratio, R, on different
planes are listed in Table 4.2. All the scaffolds had roughly equiaxed pores with higher
anisotropy ratio, R, on the Oz plane (through the thickness of the scaffold). The pore sizes
were slightly different in the two planes, rO and Oz. However, as noted above, in the
through thickness direction (plane Oz), as the density increased, the pores towards the
bottom of the scaffold were more elliptical, decreasing the overall R.
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Figure 4.5. SEM micrographs of the CG scaffolds: (a) lx, (b) 2x, (c) 3x, and (d)
4x.
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Oz 365 + 58 0.750 + 0.089
1X
rO 306 + 48* 0.856 ± 0.058*
Oz 246 + 52 0.738 ±0.109
2X
rO 308 + 71* 0.835 + 0.075*
Oz 219 ± 46 0.761 + 0.118
3X
r9 285 + 42* 0.804 + 0.086
Oz 268 + 62 0.676 + 0.124
4X
rO 244 ± 48* 0.803 ± 0.114*
Table 4.2. Pore sizes (D) and anisotropy ratios (R) measured on different planes
of the MCG scaffolds.
Mechanical characterization
Compressive stress-strain plots for loading dry, DHT cross-linked scaffolds in the z-
direction are shown in Figure 4.7. Distinct linear elastic, collapse plateau and
densification regimes were observed for all the scaffolds indicating behavior similar to
that of foams [95]. Elastic modulus (E*), elastic compressive strength (ret), elastic
compressive strain (e*el), and collapse modulus (Au/Ae) are measured from the stress-
strain curves [95, 103]. Briefly, E* is the slope of the linear elastic regime, Au/Ae is the
slope of the collapse regime, aet and e*eI are the point of transition from linear to the
collapse regime (determined from the intersection of the E* and Au/Ae regression lines).
The values of E*, a el, E*et and Au/As for the scaffolds in the DHT cross-linked dry state
are listed in Table 4.3. E*, u*, Aa/Ae increase with increase in relative density of the
scaffold from lx to 4x. *ei roughly remains constant for different relative densities (*el -
C2 1 C 17%) as predicted by Eq (2.4) and (4.6). Therefore we have used C, and C2 to be
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1 and 0.15 respectively in our analysis. Au/Ae is in the same order as that of the E*. The
data for the relative modulus (E*/Es) and the relative elastic compressive strength (*, e/E,)
for the scaffolds are plotted against relative density (p*/ps) in Figure 4.8. The best-fit
curves through the data for the relative modulus (R2 = 0.996) and for the relative strength
(R2 = 0.958) are:
E* = 0.006 P 0.98(4.7)
a Es P(4.8)el = 0.0009 
(4.8)
0.05 1
P - t5.5 
0.04 - P,
0.03 -
0.01 -
0.00 I
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t/D
Figure 4.6. The relative density, p*/ps, plotted against the ratio of the wall
thickness to the pore diameter, t/D, for the CG scaffolds.
E*/Es and o*,e/Es vary roughly linearly with p*/ps while cellular solids model predicts a
square relationship (Eq (2.4) and (4.6)). Data from Harley et al. [17] for relative modulus
and the relative elastic compressive strength are also plotted against respective relative
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densities in Figure 4.8. Their data also varied linearly with relative density and is similar
to the data of this study.
Scaffold p *p E* (kPa) a (kPa) ) /de (kPa) Er,, (kPa)
1x 0.0062 + 0.0008 32.4 ± 6.25 5.02 + 1.09 15.8 + 3.52 10.6 + 1.03 295 + 123
2x 0.0120 0.0016 60.6 + 4.96* 11.8 +2.36* 18.9 ±2.46* 43.6 +2.51* 810 + 221*
3x 0.0198 0.0014 97.3 16.7** 15.6 3.13** 15.9 +1.19 54.8 9.25"* 971 ± 202**
4x 0.0239 + 0.0021 127 - 23.1** 19 + 3.93* 14.6 ± 3.45 43.3 1 5.62** 3087 ± 488***
Table 4.3. Mechanical properties of the CG scaffolds in the DHT cross-linked dry
state determined from the uniaxial compression and tension tests.
Tensile stress strain curves for loading dry, DHT cross-linked scaffolds along the plane of
the scaffold sheet are shown in Figure 4.9a. The curves are typical of the tensile response
of foams, with increasing stiffness with increasing strain, as the cell walls align with the
direction of loading [95]. The tangent stiffness at any given strain increased with relative
density. Failure occurred at the grips, and so is not characteristic of the tensile strength of
the scaffold, due to the non-uniform stress state at the grips. The Young's modulus was
calculated from the initial linear slope of the stress-strain curve (Table 4.3). The tensile
modulus is greater than the compressive modulus. The data for the relative moduli are
plotted against relative density in Figure 4.9b, along with the best-fit curve through the
data (R2 = 0.852):
/- , )1.43
E= 0.56 [P*1 (4.9)
The relative modulus-relative density relationship is closer to the squared dependence as
predicted by the cellular solids model (Eq (2.4)).
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Figure 4.7. Compressive stress-strain plots for the CG scaffolds in the DHT
crosslinked dry state. Distinct linear elastic, collapse plateau and densification
regimes were observed for the scaffolds.
Cell attachment
The specific surface area for the scaffolds, SA/V, was calculated according to Eq (4.4).
The percentage of viable MC3T3-El cells attached to the scaffolds 24 hr after seeding, N,
is plotted against the measured specific surface area for the scaffolds in Figure 4.10. The
best-fit curve through the data (R2 = 0.972) is:
N=8.88 -- 0.595 (4.10)
V
There is a strong linear relationship between the percent cells attached and the specific
surface area of the scaffolds. There was no statistical difference between the percent of
cells attached to the 3x and 4x scaffolds. As described above, cells were seeded from
both top and bottom surfaces. We believe that the thicker elliptical pore walls (Figure
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4.4) at the bottom of the 4x scaffold acted as barrier to cell migration through that surface
inhibiting cell attachment relative to that for the 3x scaffold. Data from O'Brien et al.
[66] for percentage of viable MC3T3-El cells attached to the their CG scaffolds 24 hr
post seeding is also plotted against the respective specific surface area for their scaffolds
in Figure 4.10. The best-fit curve through their data (R2 = 0.954) is:
SAN = 7.16 SA 12.6 (4.11)
V
Their data also varied linearly, but, follows a different regression line that does not pass
through the origin; the reason for this is not clear.
4.4 Discussion
In our previous work on mineralized CG scaffolds [152], we were able to achieve an
increase in Young's modulus from 780 kPa, for the 1 x dry scaffold, to 6500 kPa for the
3x dry scaffold. Similarly, we were able to achieve an increase in the crushing strength
from 39 kPa, for the 1 x dry scaffold, to 242 kPa for the 3x dry scaffold. The densification
was achieved by vacuum filtering the 1 x slurry as described above. The dependence of
the relative Young's modulus and relative crushing strength on relative density were well
described by the power exponents derived from cellular solids models [95]. In this work
we expected a similar increase in the mechanical properties of the unmineralized CG
scaffolds by increasing the relative density of the 1 x CG slurry through the vacuum
filtration method.
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Figure 4.8. (a) Compressive E /Es and (b) compressive o*/ Es plotted against
relative density, p*/ps, for the dry CG scaffolds. Data obtained from Harley et al.
[17] is also plotted for comparison.
In this work on unmineralized CG scaffolds, the compressive stress-strain curves for the
scaffolds were typical of foams, showing the three regimes of linear elasticity, the
collapse plateau and densification. The relative density, p*/ps, varied with (t/D)2,
suggesting an open cell microstructure of the CG scaffolds (Figure 4.6) [95]. We were
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able to achieve an increase in Young's modulus from -32 kPa, for the lx dry scaffold, to
-127 kPa for the 4x dry scaffold. Similarly, we were able to achieve an increase in the
elastic compressive strength from -5 kPa, for the lx dry scaffold, to -19 kPa for the 3x
dry scaffold. However, the dependence of the relative Young's modulus, E*/Es, and
relative elastic compressive strength, a*e/Es, on relative density were linear (Figure 4.8)
in contrast to Eq (2.4) and (4.6) which predicts a squared dependence. The model predicts
E*/Es and oa/E well for the standard l x scaffold (p*/ps = 0.0062), but overestimates the
experimental results for the higher p*/ps (Figure 4.8).
Previous work on unmineralized CG scaffolds by Harley et al. [17] also predicted a linear
relationship for E*/Es and a*el/Es. In his work, the higher density scaffolds were fabricated
by blending high volume fraction slurries that resulted in microstructural heterogeneities
in the scaffolds with holes as well as local regions of higher densities. These
heterogeneities contributed to properties lower than that predicted by the model. One of
the objectives in our current fabrications technique was to avoid these local
microstructural heterogeneities by using the vacuum filtration method. While we
succeeded in avoiding local heterogeneities with the current method, we revealed that as
we increased the relative density of the scaffolds, the pores at the bottom became
increasingly elliptical with the major axis perpendicular to the loading directions (Figure
4.4). These elliptical pores adversely affected the compressive behavior of the higher
density scaffolds. Clearly, vacuum filtration of the CG slurry can achieve higher densities
than that obtained by blending high volume fraction slurries as was done by Harley et al.
(Figure 4.8).
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Figure 4.9. (a) Tensile stress-strain plots for the CG scaffolds in the DHT cross-
linked dry state. ETens* was calculated from the initial linear slope of the stress-
strain plot for each scaffold. (b) Relative tensile modulus, ETe,,s */E,, plotted
against relative density, p*/ps, for the DHT cross-linked dry CG scaffolds.
The tensile stress-strain behavior is consistent with those for foams: increased stiffness at
higher strain as the pore struts and walls align with the direction of loading [18, 167, 187-
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189]. The CG scaffolds were significantly stiffer under tension (Table 4.3), similar to
previous investigations [17, 18, 187]. A mechanistic explanation of this phenomenon
based upon the observation of a thin layer of higher density scaffold at the top surface of
the scaffold sheets has been given by Harley et al. [17]. We also observed a similar thin
denser layer at top of our scaffold sheets which partly explains the stiffer behavior under
tension. In addition, with increasing relative density the scaffolds formed thicker pore
walls and struts towards the bottom of the scaffold sheet (Figure 4.4). These thicker
layers significantly increased the stiffness under tension in the plane of the scaffold sheet.
The relative modulus under tension is somewhat closer to the squared dependence
predicted by the cellular solids model (Figure 4.9b) as a result of the thicker pore walls in
the higher density scaffolds. Even though the tensile Young's modulus (Table 4.3) is
lower than those for tendon and ligament (Table 1.5), we have achieved a significant
increase (- 11 x) in the properties by increasing the relative density of the scaffold.
Mechanical properties of the scaffolds in the hydrated state are critical as the scaffolds
are hydrated by the body fluid soon after placed in the defective tissue site. We did not
measure the hydrated properties of the CG scaffolds in this work as the effect of
hydration on CG scaffolds has been well documented by Harley et al. [17]. Hydration
decreases E* and a*ei of the CG scaffolds by 150 and 250 times respectively. Therefore,
E* and *,el of the hydrated CG scaffolds (lx, 2x, 3x, and 4x) can be predicted using the
above factors. The Young's modulus and elastic compressive strength in the hydrated
state will increase with increasing relative density from 213 Pa to 844 Pa and 20 Pa to 75
Pa, respectively. Effect of different cross-linking on the mechanical properties can also be
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predicted in a similar fashion based on the results documented by Harley et al. on CG
scaffolds [17]. The maximum Young's modulus and elastic compressive strength in the
hydrated state that can be achieved through EDAC (5:2:1) cross-linking for the 4x
scaffold is - 6 kPa and 540 Pa respectively. Note that these values are an order of
magnitude higher than that of the 1 x CG scaffold in hydrated state.
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Figure 4.10. Compressive stress-strain plots for the CG scaffolds in the DHT
crosslinked dry state. Distinct linear elastic, collapse plateau and densification
regimes were observed for the scaffolds.
A practical upper limit on the relative density is that which limits the degree of
interconnection between the pores so that cells can migrate through the scaffold; for this
reason, the maximum practical relative densities is probably less than 0.25 [101, 152].
Our experimental results suggest that an increase in the relative density from our base
p/ps = 0.0062 (or l x) to 0.25 should increase the Young's modulus and elastic collapse
strength almost by a factor of 40. Further study is needed to develop methods of
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increasing the relative density up to this limit while maintaining a homogeneous
microstructure.
The scaffolds had an interconnected pore structure with mostly struts and occasional
walls. All the scaffolds had average pore sizes in the range of 250-350 gm with
porosities greater than 97% (Table 4.2). The dry densities of the scaffolds were higher
than the slurry densities due to the bound water content of the collagen [56, 154, 155].
All the scaffolds had similar pore sizes throughout except at the bottom of the scaffold
where the pores become increasingly elliptical with increase in density. This is due to the
alignment of the collagen fibers in the plane of the scaffold as the densification increased
during vacuum filtration.
In a previous study by O'Brien et al. [66], the MC3T3-E1 cell attachment was found to
be inversely proportional to the average pore size of the CG scaffolds (with a constant
relative density) for a pore size range of 96-151 gm. However, the relationship between
cell attachment and relative density of the scaffold has not been studied before. In this
study we used our CG scaffolds with four different relative densities to investigate the
cell attachment behavior. The specific surface area of the scaffolds, SA/V, was estimated
using a tetrakaidecahedral unit cell (Figure 3.5, Eq (4.4)). The density of ligands
available for binding on each scaffold is assumed to be proportional to the scaffold
specific surface area; the specific surface area is proportional to the square root of the
relative density and inversely proportional to the mean pore diameter (Eq (4.4)). The
estimated specific surface area of the scaffolds is remarkably consistent with the results
from the cell attachment study, showing a linear relationship between the percentage of
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cell attached and specific surface area (Figure 4.10, Eq (4.10)). The attached cell number
increases linearly with specific surface area similar to the results by O'Brien et al., [66],
although with a slightly difference slope and intercept. We believe that there are three
reasons for this: (1) we hydrated our scaffolds with the MEM-a medium prior to cell
seeding while they used dry scaffolds, (2) we used smaller cylindrical specimens rather
than the rectangular specimens used by O'Brien et al., and (3) our scaffolds are made
from a different collagen source compared to O'Brien et al. (their source was Integra
LifeSciences, Plainsboro, NJ).
4.5 Conclusions
Collagen-GAG scaffolds with four different relative densities (0.0062, 0.0120, 0.0198,
and 0.0239) were fabricated via a three step process: (1) coprecipitation of the CG slurry,
(2) vacuum filtering the slurry to the desired density, and (3) freeze drying the slurry to
obtain the dry scaffold. The CG scaffolds had an open cell pore structure with mostly
struts and interconnected pores. As the relative density of the scaffolds increased, the
average pore size decreased and wall thickness remained roughly constant. Pores varied
from equiaxed to elliptical at the bottom (with the major axis perpendicular to the through
thickness direction) as the relative density of the scaffold increased. Compressive stress-
strain plots of the scaffolds indicated distinct linear elastic, collapse plateau and
densification regimes. Compressive properties of the scaffold increased roughly linearly
with increasing relative density in contrast to the square dependence described by cellular
solids models. Young's modulus under tension was an order of magnitude higher than the
compressive Young's modulus due to presence of a dense thin layer at the top of the
-160-
scaffold sheet as well as thicker walls at the bottom of the scaffold sheet with increasing
relative density. The tensile relative Young's modulus increased with relative density
raised to the power 1.43, somewhat less than the squared dependence predicted by the
cellular solids model. A linear relationship was found between cell attachment and
specific surface area, indicating that over the range of pore sizes (257-353 Pm) and
relative densities (0.0062-0.0239) studied short-term MC3T3 cell viability is governed by
the specific surface area available for binding. Future research is directed towards
increasing the mechanical properties of the unmineralized collagen-GAG scaffolds by
increasing the relative densities of the scaffolds by applying external load instead of
vacuum.
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CHAPTER 5. Conclusions and Recommendations for
Future Research
5.1 Thesis conclusions
Mechanical properties (Young's modulus and strength) of scaffolds used for tissue
regeneration are critical from an implantation perspective (the scaffold should have
sufficient stiffness and strength to maintain its shape and size during surgical procedures)
[100, 151] as well as tissue regeneration perspective (human mesenchymal stem cells
(MSC) differentiate into specific lineages and commit to phenotypes (neurogenic,
myogenic, and osteogenic) depending on the substrate elasticity)[21, 25, 26, 28].
Currently collagen-based scaffolds have been approved by the United States Food and
Drug Administration (FDA) for regenerating skin and nerves [24]. However, the
mechanical properties of the current collagen-based scaffolds are low for use in
regeneration of relatively stiffer tissues such as bone, tendon, and ligament. Therefore the
goal of this thesis was to improve the mechanical properties of the collagen-based
scaffolds by manipulating the current techniques for fabricating these scaffolds. The
microstructure and mechanical properties of these newly developed scaffolds have been
characterized.
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Collagen-glycosaminoglycan (CG) scaffolds have been fabricated through freeze-drying
a CG suspension. Recently, mineralized CG (MCG) scaffolds have been developed by
Lynn et al. [69] through a titrant-free triple co-precipitation method followed by freeze-
drying for bone regeneration. Bi-layer scaffolds with CG and MCG layers have been
developed for cartilage-bone joint regeneration. The two types of scaffolds, CG and
MCG, have been the subject of this thesis. We describe the mechanical properties of
MCG scaffolds for bone regeneration in chapter 2 and 3, and CG scaffolds for tendon and
ligament regeneration in chapter 4.
MCG scaffolds made by previous techniques (p*/ps = 0.15, and 50 wt.% mineral content)
have a compressive Young's modulus, E*, of -762 kPa (dry), and a compressive strength,
S*, of -85 kPa (dry) [69]. The compressive strength is so low that the scaffold can be
compressed between the thumb and fingers. From an implementation perspective the dry
scaffolds should at least withstand hard thumb pressure. The hydrated properties of these
scaffolds had not been characterized by Lynn et al. [69]. For the MCG scaffold, we set
our target mechanical properties (especially Young's modulus) to be the modulus at
which MSC stem cells differentiate into osteoblast-like cells: 25-40 kPa [26]. The
Young's modulus of the scaffolds in the hydrated state should optimally be in this range
for bone regeneration. Typical CG scaffolds (p*/ps = 0.006) have a compressive Young's
modulus, E*, of -30 kPa (dry) and -208 Pa (hydrated), and compressive strengths, &eI, of
-5 kPa (dry) and -21 Pa (hydrated) [17], much lower than those of tendon and ligament
(E* -500 MPa and a*e, of-50 MPa). In tendon and ligament repair, it is anticipated that
the scaffolds would be used in conjunction with sutures that would carry load, at least
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temporarily, while the tissue is regenerated. For the CG scaffolds our target was to
increase the mechanical properties as much as possible.
Models for cellular solids suggest that the overall mechanical properties (E* and ur) of a
foam can be increased by either increasing the mechanical properties of the solid (Es, as)
from which the foam is made or by increasing the relative density, p*/ps, of the foam (Eqs
2.4, 2.5, 4.6). Previous studies have shown that CG scaffolds, with porous microstructure,
can be mechanically modeled as foams [17, 66]. Therefore, we first attempted to increase
the mechanical properties of the MCG scaffold by increasing the mechanical properties
of the solid (chapter 2). Next, we attempted to increase the mechanical properties of the
MCG scaffolds by increasing the relative density of the scaffold (chapter 3). Finally we
attempted to increase the mechanical properties of the CG scaffolds by increasing the
relative density of the scaffold (chapter 4).
MCG solid is made from the CG copolymer and a calcium phosphate mineral phase. The
mechanical properties (Young's modulus and strength) of the calcium phosphate ceramic
phase are much higher than that of the CG copolymer. A simple composites model
suggests that the overall mechanical properties of the MCG solid can be improved by
increasing the mineral content of the solid. One of the advantages of the triple co-
precipitation method is that we can control the mineral phase and content by the pH of
the solvent and molar ratios of the reactants (calcium hydroxide and calcium nitrate). We
fabricated MCG scaffolds with two different mineral contents (chapter 2): 50 wt.% (as a
control) and 75 wt.%. We were able to fabricate scaffolds with pore sizes between 200-
350 pm, which is optimal for bone growth [20, 37, 128, 129]. The mechanical properties
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of the 50 wt% MCG scaffold (control scaffold) had similar properties as that fabricated
by Lynn et al. (E* - 780 kPa and &* - 91 kPa). Unfortunately, the 75 wt.% MCG scaffold
mechanical properties (E* - 367 kPa and o* - 35 kPa) were lower than the 50 wt.% MCG
scaffold mechanical properties. The pore microstructure revealed that there are higher
fraction of disconnected pore walls and struts in the 75 wt.% scaffold compared to the 50
wt.% scaffold. It has been shown that the overall mechanical properties (Young's
modulus and strength) of the foam decreases significantly with slight increase in the
fraction of disconnected pore walls and struts (for example: a 10% disconnected pore
walls and struts corresponds to roughly - 40% decrease in the Young's modulus and
strength)[136]. In addition, measurement of the mechanical properties of the MCG solid
for both the scaffolds also showed that the 75 wt.% solid had slightly lower Young's
modulus than the 50 wt.% scaffold. Microstructural characterization showed that there
are more defects in the pore walls such as voids and cracks, in the higher mineral content
scaffold reducing the solid mechanical properties which in turn reduce the overall
scaffold mechanical properties. X-ray analysis showed that the higher mineral content
scaffold also had an undesirable mineral phase, monetite (30% of the mineral content was
monetite in the 75 wt.% scaffolds compared to 100% brushite in the 50 wt.% scaffold)
that reduced the mechanical properties of the solid (and in turn that of the scaffold). Apart
from reduction in properties for the higher mineral content scaffold, the 50 wt.% scaffold
mechanical properties did not match up to the mechanical properties predicted by cellular
solids models; partly because the scaffold microstructure was not exactly like an ideal
open cell foam microstructure. In addition, even though there were not as many defects as
-166-
were in the higher mineral content scaffold, there were some and the overall combined
effect of these defects reduced the mechanical properties.
Next, we attempted to increase the properties of the 50 wt.% scaffold by increasing the
relative density of the scaffold. An attempt to increase the relative density by increasing
the solid volume fraction of the slurry did not work satisfactorily as the high viscosity
slurry was difficult to mix homogeneously using an overhead blender. Then, we
developed a new technique of vacuum filtering low-viscosity slurry. We fabricated 50
wt.% MCG scaffolds with four different relative densities (chapter 3) between 0.045-
0.187 and pore sizes between 100-350 gm (appropriate for bone regeneration). The pore
sizes decreased and wall thickness remained roughly constant with increasing relative
density. The mechanical properties-relative density relationship of the MCG scaffolds
followed closely to the predictions of the cellular solids model: a squared dependence of
the Young's modulus and to the power 3/2 dependence of the collapse strength on
relative density [95]. We were able to increase the Young's modulus and collapse
strength from 780 kPa to 6.5 MPa (-9 times) and 39 kPa to 242 kPa, respectively (- 6
times) with three times increase in the relative density. More importantly, the hydrated
Young's modulus of the scaffolds increased from - 6 kPa to -35 kPa. This is critical
from bone regeneration point of view, because as described above, MSC stem cells
differentiate into osteblast-like cells on a substrate with stiffness ranging from 25-40 kPa.
The 50 wt.% MCG scaffold with a relative density of 0.137 has the Young's modulus
(-35 kPa) in the optimal range for bone regeneration. In addition, the denser scaffolds
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could withstand hard thumb pressure without deforming which is critical from
implementation perspective as described above.
Inspired by the success of the vacuum filtration technique to improve the mechanical
properties of the 50 wt.% MCG scaffold, we attempted to improve the mechanical
properties of the CG scaffold using the same techcnique. There is interest in using
collagen-based scaffolds to regenerate tendon and ligament [170-176]. We fabricated CG
scaffolds with four different relative densities (chapter 4) between 0.045-0.187 and pore
sizes between 250-350 ptm. Similar to the trend noticed in the MCG scaffolds with
different relative densities, pore sizes decreased and wall thickness remained roughly
constant with increasing relative density. The mechanical properties-relative density
relationship of the CG scaffolds followed a linear relationship in contrast to the
predictions of the cellular solids model: a squared dependence [95]. We were able to
increase the dry compressive Young's modulus and compressive elastic strength from 32
kPa to 127 kPa (-4 times) and 5 kPa to 19 kPa, respectively (- 4 times) with four times
increase in the relative density. Dry tensile Young's modulus increased from 295 kPa to
3.1 MPa (closely following the squared dependence as expected by the cellular solids
model). Cell adhesion experiments showed a linear relationship between the fraction of
cells attached to the scaffold and the measured scaffold specific surface area (calculated
from the relative density and mean pore diameter) confirming the fact that fraction of
viable cells attached to the scaffolds is primarily influenced by the scaffold specific
surface area.
The key results of this thesis are:
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o Higher mineral content decreased the overall mechanical properties of the MCG
scaffolds due to defects such as disconnected pore walls, cracks and holes on the
pore walls, and an undesirable mineral phase.
o Higher relative density MCG scaffolds fabricated using the vacuum filtration
technique had significantly higher mechanical properties that closely followed the
models for cellular solids. The pore sizes were in the right range for bone
regeneration.
o Further control over mechanical properties can be achieved by cross-linking the
scaffolds chemically (EDAC) or physically (DHT).
o 50 wt.% MCG scaffold with relative density of 0.137 in the hydrated state has
Young's modulus of -35 kPa that is in the optimal range of stiffness required for
MSC stem cells to differentiate into osteoblast-like cells.
o Denser MCG scaffolds could withstand hard thumb pressure making them suitable
from an implementation point of view where the scaffolds are often subjected to
different stresses in this range during surgery.
o MCG scaffolds closely followed characteristics of cellular solids. Therefore, the
mechanical properties can be further improved by increasing the relative density
further beyond what we have achieved.
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o Denser CG scaffolds fabricated using the above vacuum filtration technique had
improved mechanical properties; however they did not follow the squared
dependence as expected by the cellular solids model.
o Cell attachment increased linearly with increasing specific surface area (which
increases with the square root of the relative density and inversely with the mean
pore size) of the CG scaffolds. Therefore the increasing relative density not only
increases the mechanical properties of the scaffold, but also improves the cell
attachment characteristic of the scaffold.
5.2 Future work
Consolidation of CG and MCG slurry by application of external load
One of the disadvantages of the above vacuum filtration technique is that for denser
scaffolds, the pores become increasingly elliptical (Fig. 3.6 and Fig. 4.4) and layering
(Fig. 3.7) of the scaffold takes place on the side which is subjected to vacuum. As a
result, denser scaffolds had a gradual pore size and shape change from the top of the
scaffold to the bottom of the scaffold (vacuum was applied from the bottom). In order to
fabricate a more homogeneous scaffold with uniform pore microstructure, pressure has to
be applied from both the surfaces, top and bottom. We believe that by applying external
load in a manner that has been applied to densify soil [190], CG slurries can be densified
more homogeneously. The set-up for the load application technique is demonstrated in
Figure 5.la.
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The top piston as well as the base of the mold is perforated to allow solvent filtration
from both the surfaces. The whole set-up is submerged in distilled water to counter the
gravitational effect which might drive solvent filtration through the bottom surface more
than the top surface. For a specific load, W (corresponding to a stress of r), the piston
gradually moves down with time (t) from the initial thickness, h, ultimately saturating at a
specific strain, (A/h), (Figure 5.1b). The saturation densification (A/h)c for different
stresses can be measured and plotted versus the stress (Figure 5.1c). Using the
densification-stress plot (Figure 5. lc) the amount of load can be exactly predicted for a
known densification. The time of densification can also be predicted from the (A/h)-t plot
at that stress (Figure 5.1b).
Preliminary studies on densification of CG slurries using the above technique have been
performed in our lab. A typical (A/h)-t plot for a CG slurry (0.0054 g m'-1) at a stress of
-75 Pa is shown in Figure 5.2a. The variation of (A/h) with t is very similar to that
obtained in densification of soil (Figure 5.1b). (A/h)c-G plot for the CG scaffold is shown
in Figure 5.2b. Clearly, (A/h)c varies linearly with ( as expected from densification of the
soil (Figure 5.1c). Further research needs to be performed to fabricate and characterize
scaffolds of various densities to understand structure-property relationship of the denser
scaffolds.
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Figure 5.1. (a) Set-up for the consolidation of the CG slurry using external loads
[190]. An external load, W (corresponding to a stress ac), is applied to the top
piston that moves down from the initial slurry thickness of h. (b) The variation of
the distance moved down by the top piston (A) versus time (t) for a specific stress
(a) is plotted. The piston saturats after a critical time (t). (c) The above steps can
be carried out for various stresses and the saturation densification (A/h)c can be
plotted versus the applied stress (a).
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Fabrication of denser and higher mineral content MCG scaffolds
We observed higher fraction of defects such as disconnected pore walls, cracks and holes
on pore walls for the higher mineral content MCG scaffolds (such as 75 wt.% mineral
content). We believe that in the higher mineral content MCG scaffold, the fraction of CG
copolymer was lower which may have contributed to the pore wall defects. Densification
(using the vacuum filtration technique or the external load technique) may avoid these
defects and improve the mechanical properties.
Cell adhesion, traction and contraction on MCG scaffolds
We fabricated 50 wt.% MCG scaffolds with higher relative densitites using the vacuum
filtration technique. However, the cell adhesion properties of these scaffolds were not
measured. For final application of this higher density MCG scaffolds at the osteochondral
defect sites, cell (osteogenic cells such as MC3T3 cells) adhesion, traction, and
contraction in the scaffolds are critical. Therefore, MC3T3 osteogenic cells can be seeded
to these scaffolds with different pore sizes, densitites, and mineral contents, and cell-
matrix interaction can be studied subsequently.
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Figure 5.2. (a) A typical A-t plot for the CG slurry with a starting density of
0.0054 g ml' at a stress of -75 Pa. (b) A typical (A/h)c,- plot for the CG slurry.
These plots are similar to the schematic plots shown in Figure 5. lb and c.
Bi-layer CG-MCG scaffolds for cartilage repair
Bi-layer osteochondral scaffolds have been developed by Lynn et al. for repair of
articular cartilage defects [69]. Their scaffolds were made by freeze-drying a slurry
consisting of two layers: MCG layer on the top (0.042 g ml') and CG layer on the bottom
(0.0054 g ml-'). The slurries were kept in touch in the liquid phase for the slurries to
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inter-diffuse and create a diffused boundary layer that mimics the cartilage-bone
interface. However, we believe that the gradation of the diffused boundary can be
improved by application of pressure through the external loads (as described above) from
both the surfaces. Therefore, scaffolds with a gradual change in mineral content can be
fabricated with coherent mechanical properties through the boundary.
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APPENDIX A Collagen-Based Scaffold Fabrication and
Characterization Protocols
A.1 Collagen-Glycosaminoglycan (CG) Suspension Protocol
References: [5, 66, 68, 145]
Supplies
o 3.6 gm type I microfibrillar collagen isolated from bovine ((1) Integra
LifeSciences, Inc., Plainsboro, NJ, (2) Sigma-Aldrich Chemical Co, St. Louis,
MO, (3) Devro Pty Ltd, Bathurst, NSW, Australia); store at 40C.
o 2991.3 ml distilled, deionized water
o 8.7 ml Glacial Acetic Acid (Mallinckrodt Chemical Co., Paris, KY)
o 0.32 gm Chondroitin 6-sulfate from shark cartilage (Cat. No. C-4384, Sigma-
Aldrich Chemical Co., St. Louis, MO); store at 40C.
Procedure
1. Turn on the cooling system (Brinkman model RC-2T) for the blender (Ultra
Turrax T 18 Overhead blender, IKA Works) and allow the mixing chamber to cool
to 40C (-30 minutes).
2. Prepare a 0.05 M acetic acid (HOAc) (pH 3.2) solution: add 8.7 ml HOAc
(Glacial Acetic Acid, Mallinckrodt Chemical Co) to 2991.3 ml of distilled,
deionized water in the chemical fume hood. This solution has a shelf life of
approximately 1 week.
3. Blend 3.6 gm of microfibrillar bovine tendon collagen with 600 ml of 0.05 M
acetic acid at 15,000 rpm (Blender Setting: 3.25) for 90 minutes at 40 C.
4. Prepare the chondroitin 6-sulfate solution: dissolve 0.32 gm chondroitin 6-sulfate
(from shark cartilage: Cat. No. C-4384, Sigma-Aldrich) in 120 ml of 0.05 M
acetic acid.
5. Calibrate the peristaltic pump (Manostat Cassette Pump, Cat. No. 75-500-000) to
120 ml per 1. 5 minutes.
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6. Add the 120 ml chondroitin 6-sulfate solution dropwise to the blending collagen
dispersion over 15 minutes using the peristaltic pump, while maintaining the
blender at 15,000 rpm (Blender Setting: 3.25) and 40C.
7. Blend the collagen-GAG suspension an additional 90 minutes at 15,000 rpm
(Blender Setting: 3.25) at 40 C.
8. Degas the collagen-GAG suspension in a vacuum flask for 60+ minutes until
bubbles are no longer present in the solution.
9. Store the suspension in a capped bottle at 40C; it will keep for up to four months.
10. If collagen-GAG suspension has been stored for more than one week, re-blend it
for fifteen minutes at 10,000rpm (Blender Setting: 2) at 40 C and degas again.
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A.2 Mineralized Collagen-Glycosaminoglycan (MCG) Suspension Protocol
References: [69, 70, 72, 74-76]
Supplies
o Type I microfibrillar bovine tendon collagen ((1) Integra LifeSciences, Inc.,
Plainsboro, NJ, (2) Sigma-Aldrich Chemical Co, St. Louis, MO, (3) Devro Pty
Ltd, Bathurst, NSW, Australia); store at 40C.
o Distilled, deionized water
o Phosphoric acid (H3PO 4) (EMD Chemicals Inc., Gibbstown, NJ)
o Chondroitin 6-sulfate from shark cartilage (Cat. No. C-4384, Sigma-Aldrich
Chemical Co., St. Louis, MO); store at 40C.
o calcium nitrate (Ca(N03)2.4H 20) and calcium hydroxide (Ca(OH)2) (Sigma-
Aldrich Chemical Co., St. Louis, MO).
Table A. 1 lists the amount of different supplies and the molarity of the solvent (H3PO 4)
for the 50 wt.% and 75 wt.% mineralized CG slurries.
Procedure
1. Turn on the cooling system (Brinkman model RC-2T) for the blender (Ultra Turrax
T18 Overhead blender, IKA Works) and allow the mixing chamber to cool to 40C
(-30 minutes).
2. Prepare 0.138M and 0.225M phosphoric acid solutions (pH 1.47 and 1.35
respectively) in the chemical fume hood for the 50 wt.% and 75 wt.% MCG slurries
respectively. These solutions have a shelf life of approximately 1 week.
3. Weigh out the required amount of collagen on weighing papers (don't use the plastic
boats as they create too much static electricity). Add the collagen to a 250mL beaker,
then add 171.4mL of the appropriate H3PO4 solution (Table A. 1). Before placing the
collagen on to blend, weigh out the appropriate amount of chondroitin-6-sulphate into
a 25mL vacuum flask, and add 14.3mL of the same phosphoric acid solution, then
cover with parafilm. Be sure that the entire GAG is immersed in the solution, and that
none is left dry on the walls of the flask above the liquid surface. Allow the GAG to
dissolve over the 90 minutes that the collagen is blending, swishing the solution
around in the flask periodically (i.e. once every 20 minutes or so).
4. Place beaker containing the collagen and acid in the cooling vessel, place the plastic
lid over the top of the vessel, and then blend at 15,000rpm for 90 minutes. The stator
should be cleaned with detergent, rinsed thoroughly with warm tap water, and finally
rinsed with demonized water before it is placed in the solution.
5. After 90 minutes of stirring, confirm that all the chondroitin-6-sulphate has dissolved
(when the solution is swished, there should be no translucent streaks), then add the
GAG solution to the mixing collagen suspension using the peristaltic pump. Note that
the pump should be set to reverse. The end of the hose nearest the mixing can be
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secured in place using tape, to ensure that the GAG solution actually ends up in the
collagen solution and not on the side of the cooling vessel. Be extremely careful that
(i) the 25mL vacuum doesn't tip over (i.e. hold or secure it until all the solution goes
through), (ii) that all of the solution enters the pump (tip the flask on its side and stick
the tubing in the bottom comer and (iii) that all of the solution travels all the way
through the tubing to and out the other end (this may require some lifting of various
parts of the hose to coax the last drops through to the end). Allow the slurry to mix
for 60 minutes.
6. Measure out the required quantity of calcium nitrate (Ca(N0 3)2.4H20) on to a sheet
of weighing paper; set aside. Measure out the required quantity of calcium hydroxide
(Ca(OH) 2) onto another sheet of weighing paper. Slide the calcium nitrate onto the
sheet holding the calcium hydroxide (don't try doing it the other way as calcium
hydroxide is a little harder to transfer), then mix the two substances together with a
spatula, until they are well dispersed.
7. After the collagen-GAG slurry has mixed for 60 minutes, remove the beaker from the
cooling vessel, and place it on the bench top. Reinsert the stator and continue to
blend, making sure that there is at least a portion of the suspension surface that is not
covered by foam. Add the mixed calcium powders a little bit at a time; full addition
of the powders should take about 15 minutes. Once a given spatula-full of powder
enters the slurry and sinks to the bottom, move the beaker around so as to disperse
any clumps of the powder. Make sure that all the powder from the paper and spatula
gets into the slurry, that no powder is caught in the foam, and that all large clumps are
broken up by moving the beaker up, down and around with your hand.
8. Add an additional 14.3mL of the same H3PO 4 solution used to disperse the collagen
and the GAG. This should be added using a pipette, and should be used to rinse any
calcium powders stuck to the stator or the side of the beaker into the solution. Allow
the slurry to mix for an additional 30 minutes.
9. Turn off the blender, and remove the stator. Insert a cleaned and sterilized stir bar
(medium length), cover tightly with parafilm and place on a stir plate to mix for 24
hours at room temperature at setting 10 (on the blue and white plates). Be sure that
the stir bar is spinning in a stable manner, and not jumping all over the beaker
randomly. If the latter occurs, turn the stir plate setting to zero, and slowly increase it
back to 10.
10. After 24 hours stirring, transfer both the solution and the stir bar to a labeled, cleaned
and sterilized 250mL bottle and store in the fridge.
11. Before use, blend at 15,000 rpm at room temperature for 5 minutes, making sure to
move the container around to break-up any clumps that have formed. The blended
solution should then be allowed to stir on a stir plate for 1 hour at setting 10. Before
pipetting into moulds, remove the solution from the stir plate and allow it to settle for
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about 1 minute before pipetting (this will ensure that there aren't too many air
bubbles in it).
Table A. 1 Concentration of reactants for a 200 ml MCG slurry.
50 0.138 3.25 347 3.86 0.336 1.81 0.780
75 0.225 5.00 360 1.93 0.168 3.03 0.966
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A.3 Scaffold Fabrication: Constant Cooling Lyophilization Protocol
References: [66, 68]
Supplies
o CG/MCG slurry
o Cylindrical polysulfone mold
Equipment
o Genesis freeze dryer (VirTis)
Procedure
1. Turn on the freeze dryer (VirTis Genesis):
* Check that the vacuum oil level is at least 2/3, the oil appears clean, and that
the vacuum pump is properly vented (either outside or into a chemical fume
hood)
* Plug the condenser drain valve and close the condenser and main chamber
door
* T urn the main Power switch on
* T urn the Condenser switch on
* Set the SV gauge to 200 C and turn on the Freeze and Heat switches
You need to allow approximately 60 minutes for the freeze dryer temperature to stabilize
and for the condenser to reach a cold enough temperature to continue.
2. Degas the CG suspension in a vacuum flask (Pressure: -50 mTorr). Degas
approximately twice the required volume to allow appropriate removal of all air
bubbles. The length of time needed to degas the suspension varies from 30-90 min.
depending on the total volume being degassed and the length of time the entire
volume of suspension was degassed immediately following mixing.
3. Clean the stainless steel pan (VirTis) with ethanol and wipe the inside with Kim-
Wipes to remove all dust and any remaining CG content from the previous run. When
cleaning and handling the pan, do not touch the inside of the pan with your bare
hands. Use gloves. Allow the pan to air dry.
4. Put enough CG/MCG suspension into the polysulfone mold such that the height of
the slurry is - 5 mm. Remove any air bubbles introduced into the suspension during
the pipetting step using a 200 pl pipette tip. Drag the bubbles to the edge of the pan,
allowing them to stick to the edge. Place the pan into the freeze dryer.
5. Freeze the CG suspension using a ramping protocol to produce uniform CG scaffolds.
Check the appropriate program is selected using the Wizard controller. Press the
button under Program X (X = 1 - 12) (Button #1) on the digital display. Select the
appropriate program number using the Up and Down keys and then press the Edit
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key. Check the program variables (Temperature, Time, Ramp/Hold). If the
progression is incorrect, correct the values. Use the outer two buttons to scroll left or
right through the program and the inner two keys to change the value of the selected
criteria to match the desired program. In this thesis we have used different freezing
temperature and freezing rates as described below.
* Maintain freeze dryer chamber temperature at 20'C for 5 minutes
* Ramp the chamber temperature from 200 C to the final freezing temperature
(Tf= -10, -20, -30, -400C) at a specific rate (0.9, 0.33, 0. 10C/min).
* Maintain the chamber temperature at the final freezing temperature for 12 hr
to allow solidification to complete.
* After confirming the program, press the two middle keys on the Wizard
together to end the editing step. Select the Save option from the menu
displayed after ending the editing step. The Wizard screen should return to the
original screen seen at start-up.
6. Turn off the Freeze and Heat buttons, turn the Auto button on, and press the Start
key. The program should start running. Leave the program to run for the specified
length of time.
7. At the end of the 12 hr annealing period, cancel the program. Press the inner two
buttons on the wizard controller together, and then when prompted press the outer
two keys. Turn off the Auto switch, then turn on the Freeze and Heat switches and
set the SVto the appropriate freezing temperature (-10, -20, -30, or -400C).
8. Turn on the Vacuum switch. Make sure the seal on the condenser and main chamber
doors is tight and put pressure on the door to the main chamber until a vacuum
pressure registers on the Wizard control screen (typically -1900 mTorr).
9. When the vacuum pressure reaches below 300 mTorr, raise the temperature in the SV
display to 00 C. Allow the freeze dryer to run for 17 hours at OoC and a pressure <300
mTorr.
10. After 17 hours, raise the value of the SV control to 20 0C. Wait for the chamber
temperature to equilibrate to 200C (temperature displayed in the PV display). Turn off
the Vacuum switch and turn on the Chamber Release switch. Wait for the pressure to
equilibrate to atmospheric pressure. Remove the pan from the main chamber.
11. Turn off the freeze dryer:
* Turn off the Chamber Release switch
* Turn off the Freeze and Heat switches
* Turn off the Condenser Switch
* Turn off the Power Switch
* Open the condenser door, unplug the condenser drain line allow condense to
drain
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12. Remove the CG/MCG scaffold from the pan with gloved hands. Place the scaffold
into an aluminum foil packet and store it in a desiccator.
13. Wash the stainless steel pan with ethanol or 0.05 M acetic acid and wipe down with
kim-wipes to remove any portion of the scaffold that may have torn during removal.
Return the pan to storage.
14. Make a notation on the run sheet attached to the front of the freeze dryer in order to
keep track of the total number of runs between oil changes. When a row is completely
checked off (8 freeze dryer runs), change the oil.
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A.4 Dehydrothermal Crosslinking Protocol
References: [5, 116, 143]
Equipment
o Isotemp vacuum oven (Model 201, Fisher Scientific, Hanover Park, IL)
Procedure
1. Place the collagen-GAG scaffold into an aluminum foil packet. Leave the packet
open at the top.
2. Select the appropriate processing conditions. The following processing conditions are
those that are typically utilized:
Table A. 2 Typical dehydrothermal cross-linking conditions used on CG/MCG
scaffolds.
DHT90/24 900C 24 hr
DHT 105/24 (lab standard) 1050C 24 hr
DHT120/24 1200C 24 hr
DHT120/48 1200C 48 hr
DHTI05/24 is the accepted laboratory standard crosslinking technique and is the
default crosslinking applied to collagen-GAG scaffolds unless otherwise noted.
3. Place the packet into vacuum oven (Isotemp Model 201, Fisher Scientific) maintained
at the desired temperature. Open the "Vacuum" knob (turn the knob
counterclockwise) and close the "Purge" knob (turn the knob clockwise).
4. Turn on the vacuum pump. Wait until the vacuum has been obtained (nearly full scale
on the vacuum oven dial).
5. At the end of the processing period, turn off the vacuum and vent the chamber by
closing the "Vacuum" knob (clockwise) and opening the "Purge" knob
(counterclockwise). Once the vacuum has completely vented, open the vacuum oven
door and immediately seal the aluminum foil bag(s). The scaffold is now cross-linked
and considered sterile; to maintain sterility, handle the scaffold from this point on
using aseptic techniques.
6. Store the scaffold in a desiccator. Cross-linked scaffolds can remain indefinitely in a
desiccator prior to use.
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A.5 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide (EDAC) Cross-linking
Protocol
References: [191-193]
Supplies
o 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC, Cat. No. E-7750,
Sigma- Aldrich Chemical Co., St. Louis, MO); store in a dessicator at -200C.
o N-hydroxysuccinimide (NHS, Cat. No. H-7377, Sigma-Aldrich); store in a
dessicator at room temperature.
o Polystyrene cell culture 6-well plate (BD Falcon Multiwell Flat-Bottom Plates,
Cat. No. 62406-161, VWR Scientific, Inc., Bridgeport, NJ)
o Sterile Phosphate Buffered Saline (PBS, Cat. No. 20012-043, Invitrogen, Inc.,
Carlsbad, CA)
Equipment
o Analytical balance (Model No. CP124S, Sartorius AG, Goettingen, Germany)
o 5, 6, or 8 mm dermal biopsy punch (Miltex, Cat. No. 52441, 52442, 52443,
Moore Medical LLC, New Britain, CT)
Procedure
1. Cut the scaffold samples to be cross-linked using a 5, 6, or 8 mm dermal biopsy
punch (Miltex) or using a razor blade.
2. Weigh the scaffold samples to determine the average mass of each scaffold
sample to be cross-linked (Mscaffold)T. o maintain the sterility of the scaffold
samples to be used, weigh a series of additional samples that you can remove
from the sterile environment for weighing and then discard.
3. For cross-linking scaffold disks, 1 ml of cross-linking solution volume will be
required for each disk.
4. Determine the concentrations of EDAC and NHS to be used in the cross-linking
solution. This protocol was designed to determine the molar ratio of
EDAC:NHS:Carboxylic Acid (where the carboxylic acid groups are on the CG
scaffold) based off of the mass of the scaffold samples, the assumption that the
scaffolds are entirely composed of collagen, and the observed 1.2 mmol of
carboxylic acid (COOH) groups per gram of collagen (Olde Damink, Dijkstra, et
al.., 1996). Typical EDAC:NHS:COOH concentrations used to crosslink CG
scaffolds are 1:1:5, 5:2:5, and 5:2:1 (primary crosslinking density). The mass of
EDAC (MEDAC) and NHS (MNHS) required for a 5:2:1 EDAC:NHS:COOH solution
are calculated here (Eq.(Al.1), Eq. (A1.2)) as an example:
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MEDAC = (# Samples) .MScaffol. 0.0012 mOlCH moEDAC 1 7 gm (A
gm ICollag molCOOH IMOEDAC
M = (#Samples).MSaffold. 0.0012 molCOOH 2 molNHS 116.0gmNHS )gmco01 agen lmolCHO lmol (A1.2)
5. Mix the EDAC and NHS in a half volume (0.5 ml/disk) of sterile PBS
(Invitrogen), making a 2X EDAC/NHS solution.
6. Hydrate the scaffolds in a 6 well tissue culture plate (VWR) in the sterile tissue
culture hood. Place 5 to 6 scaffold disks in each well and hydrate in a half volume
(0.5 ml/disk) of sterile PBS (Invitrogen). Allow the scaffolds to become initially
hydrated ('-15 minutes)
7. Pipette the half volume of the EDAC/NHS solution (the 2x EDAC/NHS solution
in PBS made in step 5) into each well and mix thoroughly.
8. Allow crosslinking to take place for 30 minutes.
9. Remove the EDAC/NHS solution with a pipette and rinse twice with sterile PBS
for an additional thirty minutes. Transfer the crosslinked scaffolds to a sealed,
sterile container containing sterile PBS for storage.
10. Do not allow the scaffolds to dehydrate once they have been hydrated as this will
lead to complete pore collapse.
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A.6 CG Scaffold Glycolmethacrylate Embedding Protocol
References: [66, 68, 167]
Supplies
o Plastic embedding mold (Cat. No. 16643A, Polysciences, Inc., Warrington, PA)
o JB-4 plastic block holders (Cat. No. 15899-50, Polysciences)
o 10% Neutral buffered formalin (Cat. No. 08379-3.75, Polysciences):
* 900 ml dH20
* 100 ml 38% formaldehyde
* 4 g monobasic sodium phosphate NaH2PO4
* 8.95 g dibasic sodium phosphate Na2HPO4
o JB-4 A embedding solution:
* 100 ml JB-4 A monomer solution (Cat. No. 0226A-800, Polysciences)
* 0.9 g JB-4 A catalyst, (Benzoyl Peroxide, plasticized, Cat. No. 02618-12,
Polysciences)
o JB-4 B embedding solution (Cat. No. 0226B-30, Polysciences)
Equipment
o Chemical Fume Hood
Procedure
1. Cut samples from the scaffold for analysis. For analysis of CG scaffold sheets,
remove samples from five locations equidistantly spaced through the sheet; for
analysis of the longitudinal plane through the scaffold cut 10 x 10 mm square
sections, and for analysis of the transverse plane cut 10 x 5 mm rectangular
sections.
2. Fix the samples in 10% neutral buffered formalin for 24-48 hrs at room
temperature
3. Dehydrate the samples in increasing concentrations of ethanol in water as follows
(5 min. in each bath): 0% (dH20 ), 50%, 70%, 80%, 95%, 95%, 100%, 100%,
100%.
4. Infiltrate the samples with catalyzed JB-4 A solution (Polysciences) at 40C for 24
h in the chemical fume hood in a sealed vacuum flask. Replace with fresh JB-4 A
and place under vacuum for several hours. Hold at 40C for an additional 24 h in a
sealed vacuum flask. If air bubbles are present, repeat vacuum treatment. All
infiltration steps should be performed in the fume hood.
5. Mix 25ml of the JB-4 A solution with Iml of the JB-4 B solution (Polysciences)
and pipet -4 ml into each well of the plastic embedding mold (Polysciences).
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6. Place each sample into a well. The JB-4 mixture will polymerize quickly (< 25
min.) so make sure the samples are placed in the proper orientation. The mixture
will become progressively browner in color as polymerization proceeds.
7. After the JB-4 mixture becomes viscous enough that the samples do not float,
place one plastic stub (Sample block holder, Polysciences) onto each well and
place the plastic mold tray in a refrigerator (40 C). Wait overnight for the
polymerization to complete.
8. Remove the embedded samples from the mold and store at 40C until use.
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A.7 Sectioning the Embedded CG Scaffold Samples Protocol; Aniline Blue
Staining Protocol
References: [66, 68]
Supplies
o Aniline Blue
* 2.5 gm aniline blue (Cat. No. AC40118-0250, Fisher Scientific, Hanover Park,
IL)
* 2 ml glacial acetic acid (Mallinckrodt Chemical Co., Paris, KY)
* 100 ml distilled water
* Filter before use
o 1% Acetic Acid
* 1 ml glacial acetic acid (Mallinckrodt Chemical Co.)
* 99 ml distilled water
o 95%, 100% ethanol
o Cytoseal 60 (Cat. No. NC9472256, Fisher Scientific)
Equipment
o Leica RM2165 microtome (Mannheim, Germany)
Procedure
1. Serially section the embedded CG scaffold samples on a Leica RM2165 microtome
2. (Mannheim, Germany) at a 5m thickness. Mount each section on a glass microscope
slide.
3. Dip the slides in the Aniline Blue solution for 2 - 4 minutes.
4. Place the slides into a 1% acetic acid solution for 1 minute.
5. Dip each slide 5-10 times in 95% alcohol until most of background staining goes
away.
6. Dip each slide 5-10 times 100% alcohol to complete the rinsing process.
7. Mount each sample with 4 drops of Cytoseal 60 (Fisher Scientific) and coverslip. Try
to not introduce air bubbles when placing the coverslip onto the sample.
8. Dry the coverslipped samples laying flat in a chemical fume hood for 1 hour
(arbitrary time). Continue to dry the coverslipped samples while laying flat for an
additional 2 days on the bench top or in the chemical fume hood.
-190-
A.8 CG Scaffold Pore Size Analysis Protocol: Image Acquisition and Linear
Intercept Analysis using Scion Image Software
References: [66, 68, 103, 167]
Equipment
o Inverted optical microscope (Nikon Optiphot, Japan)
o CCD color video camera (Optronics Engineering, Inc., Goleta, GA)
o Scion Image analysis software (Scion Corporation, www.scioncorp.com,
Frederick, MD)
Procedure
Image Acquisition
1. Visualize the embedded, sectioned, and stained scaffold samples using an optical
microscope (Nikon Optiphot).
2. Acquire digital images from the longitudinal section and the transverse section using
a CCD color video camera (Optronics Engineering).
Image Editing
1. Open Scion Image. Open each scaffold image and prepare it for pore size analysis.
2. Under the 'Options" menu, select "Threshold." Change the threshold values until an
optimal image of struts is visible. Clean up any remaining spots with the erase tool.
The pore analysis macro will not count any artifact under 5 pixels across, so it is not
necessary to remove every stray spot.
3. Under "Process" menu, select "Make Binary" under the "Binary" sub-menu. This
will transform the thresholded image into a permanent binary image. Save the image
as an edited *.TIF file.
Pore Analysis
1. Under the Special menu in Scion Image, select "Load macros", and open the "pore
characterization macros" file.
2. Set the scale for the analysis using the "Set Scale" option in the "Analyze" menu.
Under the "Analyze" menu, choose "Options" and select the number of significant
digits to be displayed after the decimal point to be 5. The microscope scale was
calibrated for the microscope-camera assembly in the Mechanical Behavior of
Materials laboratory (Prof. Lorna Gibson), rm. 8-102:
Table A. 3 Calibration scales for Scion image for the camera-microscope
assembly in 8-102.
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4x 1 mm
10x 1 mm 838.31
40x 1 p.m 2.5279
100x 1 pm 8.3842
3. Select an area of the image to be analyzed using the oval drawing tool. Try to get as
much of the viable image enclosed within the curve.
4. Under the "Special" menu, run Linear Intercept. The distance between the pore walls
along lines at various angles emanating from the center of the selected region will be
calculated. Next, run the Plot Intercepts macro. This macro will transform the
average distance between struts along each line into a best-fit ellipse and will
calculate linear intercept coefficients CO, C1, and C2 for that ellipse.
5. Transfer Co, C1, and C2 data to an Excel spreadsheet for each scaffold sample.
Calculate the minor (a) and major (b) axes of the best-fit ellipse describing the
average CG scaffold pore as well as the aspect ratio using the following equations:
1
a = (Al.3)
co + C 2 + C2 2
b + 2  (A 1.4)
Co C + C22 C22 - 2
aAspectRatio = a- (Al.5)b
6. Calculate the mean pore diameter (d) from the major and minor axes of the best-fit
ellipse (Eq (Al.6)). To account for the effects of pores that were not sectioned
through their maximal cross-section but rather at an arbitrary angle, the ellipse major
and minor axes were corrected by multiplying by 1.5 [95]. The mean pore size was
calculated from the average radius by multiplying by a factor of 2.
d = 1.5 x 2 (A1.6)
2
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325.43
Linear Intercept Macro Code:
macro 'Linear Draw'
{This macro is used for testing different line drawing routines
for use
with the macro 'Linear Intercept'}
var
left,top,width,height,MinDim,nx,ny,i,j,k:integer;
ThetaStep,NSteps,PI,xl,x2,yl,y2,dy,dx:real;
Theta,valx,valy,plength,scale,AspectRatio:real;
IntLength,LineSum:real;
Intercepts:integer;
switch,indicator:boolean;
unit: string;
begin
GetRoi(left,top,width,height);
if width=0 then begin
PutMessage('Selection required.');
exit;
end;
if width<height then MinDim:=width
else MinDim:=height;
PI:=3.141592654;
GetScale(scale,unit,AspectRatio);
NSteps:=GetNumber('Enter theta steps between 0 and 90
deg.',3,0);
ThetaStep:=PI/(2*NSteps);
for j:=0 to 2*NSteps-1 do begin
xl:=left;
yl:=top;
Theta:=j*ThetaStep;
nx:=5*sin(Theta)*width/height;
ny:=5*abs(cos(Theta));
for i:=0 to nx do begin
if Theta=0 then begin
xl:=left;
x2:=xl+width;
end else begin
xl:=left+(width*i/(nx+l))+width/(2*(nx+l));
x2:=xl+(height*cos(Theta)/sin(Theta));
end;
y2:=top+height;
if x2>=left+width then begin
x2:=left+width;
y2:=yl+(x2-xl)*sin(Theta)/cos(Theta);
end else if x2<left then begin
x2:=left;
if Theta>PI/2 then y2:=yl+(x2-
xl)*sin(Theta)/cos(Theta);
end;
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{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch:=true;
if plength>=MinDim then begin
for k:=O to plength do
PutPixel(xl+k*dx,yl+k*dy,255);
end;
end;
for i:=l to ny do begin
if Theta<=PI/2 then begin
xl:=left;
x2:=left+width
end else begin
xl:=left+width;
x2:=left;
end;
yl:=top+height*i/(ny+l);
y2:=yl+(width*sin(Theta)/abs(cos(Theta)));
if y2>top+height then begin
y2:=top+height;
x2:=xl+((y2-yl)*cos(Theta)/sin(Theta));
end;
{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch: =true;
if plength>=MinDim then begin
for k:=O to plength do
PutPixel(xl+k*dx,yl+k*dy,255);
end; {if}
end; {i}
end; {j}
end;
macro 'Linear Intercept'
{This macro measures the linear intercept distance over a giver
ROI
at intervals of angle}
var
left, top, width, height,MinDim,nx,ny, i,j,k:integer;
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ThetaStep,NSteps,PI,xl,x2,yl,y2,dy,dx:real;
Theta,valx,valy,plength,scale,AspectRatio:real;
IntLength,LineSum,dummy:real;
Intercepts: integer;
switch, indicator :boolean;
unit: string;
begin
SetOptions('Userl;User2');
GetRoi(left,top,width,height);
if width=0 then begin
PutMessage('Selection required.');
exit;
end;
if width<height then MinDim:=width
else MinDim:=height;
PI:=3.141592654;
GetScale(scale,unit,AspectRatio);
NSteps:=18;{GetNumber('Enter # steps between 0 and 90
deg. ',3,0) ;
ThetaStep:=PI/(2*NSteps);
{block out next line when doing cumulative measurements}
SetCounter(2*NSteps);
SetUserlLabel('Theta(rad)');
SetUser2Label('Lxl0^3 ') ;
for j:=0 to 2*NSteps-1 do begin
LineSum:=0;
Intercepts :=0;
xl:=left;
yl:=top;
Theta:=j*ThetaStep;
nx:=10*sin(Theta)*width/height;
ny:=10*abs(cos(Theta));
for i:=0 to nx do begin
if Theta=0 then begin
xl:=left;
x2:=xl+width;
end else begin
xl:=left+(width*i/(nx+l) ) +width/(2*(nx+l));
x2:=xl+(height*cos(Theta)/sin(Theta));
end;
y2:=top+height;
if x2>=left+width then begin
x2:=left+width;
y2:=yl+(x2-xl)*sin(Theta)/cos(Theta);
end else if x2<left then begin
x2:=left;
if Theta>PI/2 then y2:=yl+(x2-
xl)*sin(Theta)/cos(Theta);
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end;
{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch:=true;
if plength>=MinDim then begin
LineSum:=LineSum+(plength/scale);
for k:=0 to plength do begin
if GetPixel(xl+k*dx,yl+k*dy)>0
then indicator:=true
else indicator:=false;
if (switch=true) and (indicator=true) then begin
Intercepts :=Intercepts+l;
switch:=false;
end;
if (indicator=false) then switch:=true;
end;
end;
end;
for i:=1 to ny do begin
if Theta<=PI/2 then begin
xl:=left;
x2:=left+width
end else begin
xl:=left+width;
x2:=left;
end;
yl:=top+height*i/(ny+l);
y2:=yl+(width*sin(Theta)/abs(cos(Theta)));
if y2>top+height then begin
y2:=top+height;
x2:=xl+((y2-yl)*cos(Theta)/sin(Theta));
end;
{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch :=true;
if plength>=MinDim then begin
LineSum:=LineSum+(plength/scale);
for k:=0 to plength do begin
if GetPixel(xl+k*dx,yl+k*dy)>0
then indicator:=true
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else indicator:=false;
if (switch=true) and (indicator=true) then begin
Intercepts :=Intercepts+1;
switch:=false;
end;
if (indicator=false) then switch:=true;
end;
end;
end; {i}
IntLength:=LineSum/Intercepts;
dummy:=rUser2 [j+l];
rUserl[j+l]:=180*Theta/PI;
{to do cumulative measurements, type in 'dummy+ before Intlength
in the next line}
rUser2[j+l]:=IntLength*1000;
end; {j}
ShowResults;
end;
macro 'Linear Intercept +'
{This macro measures the linear intercept distance over a giver
ROI
at intervals of angle}
var
left, top, width, height,MinDim,nx,ny,i,j,k:integer;
ThetaStep,NSteps,PI,xl,x2,yl,y2,dy,dx:real;
Theta,valx,valy,plength,scale,AspectRatio:real;
IntLength,LineSum, dummy:real;
Intercepts :integer;
switch, indicator:boolean;
unit: string;
begin
SetOptions('Userl;User2');
GetRoi(left,top,width,height);
if width=0 then begin
PutMessage('Selection required.');
exit;
end;
if width<height then MinDim:=width
else MinDim:=height;
PI:=3.141592654;
GetScale(scale,unit,AspectRatio);
NSteps:=18;{GetNumber('Enter # steps between 0 and 90
deg. ',3,0);
ThetaStep:=PI/(2*NSteps);
{block out next line when doing cumulative measurements}
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{SetCounter(2*NSteps);}
SetUserlLabel('Theta(rad)');
SetUser2Label('Lxl0^3');
for j:=0 to 2*NSteps-1 do begin
LineSum:=0;
Intercepts :=0;
xl:=left;
yl:=top;
Theta:=j*ThetaStep;
nx:=10*sin(Theta)*width/height;
ny:=10*abs(cos(Theta));
for i:=0 to nx do begin
if Theta=0 then begin
xl:=left;
x2:=xl+width;
end else begin
xl:=left+(width*i/(nx+l))+width/(2*(nx+l));
x2:=xl+(height*cos(Theta)/sin(Theta));
end;
y2:=top+height;
if x2>=left+width then begin
x2:=left+width;
y2:=yl+(x2-xl)*sin(Theta)/cos(Theta);
end else if x2<left then begin
x2:=left;
if Theta>PI/2 then y2:=yl+(x2-
xl)*sin(Theta)/cos(Theta);
end;
{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch: =true;
if plength>=MinDim then begin
LineSum:=LineSum+(plength/scale);
for k:=0 to plength do begin
if GetPixel(xl+k*dx,yl+k*dy)>0
then indicator:=true
else indicator:=false;
if (switch=true) and (indicator=true) then begin
Intercepts :=Intercepts+l;
switch: =false;
end;
if (indicator=false) then switch:=true;
end;
end;
end;
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for i:=1 to ny do begin
if Theta<=PI/2 then begin
xl:=left;
x2:=left+width
end else begin
xl:=left+width;
x2:=left;
end;
yl:=top+height*i/(ny+1);
y2:=yl+(width*sin(Theta)/abs(cos(Theta)));
if y2>top+height then begin
y2:=top+height;
x2:=xl+((y2-yl)*cos(Theta)/sin(Theta));
end;
{plength is the length of the line to be drawn in
pixels}
plength:=sqrt(sqr(x2-xl)+sqr((y2-yl)/AspectRatio));
valx:=xl;
valy:=yl;
dx:=(x2-xl)/plength;
dy:=(y2-yl)/plength;
switch:=true;
if plength>=MinDim then begin
LineSum:=LineSum+(plength/scale);
for k:=0 to plength do begin
if GetPixel(xl+k*dx,yl+k*dy)>0
then indicator:=true
else indicator:=false;
if (switch=true) and (indicator=true) then begin
Intercepts :=Intercepts+l;
switch:=false;
end;
if (indicator=false) then switch:=true;
end;
end;
end; {i}
IntLength:=LineSum/Intercepts;
dummy:=rUser2[j+l];
rUserl[j+l]:=180*Theta/PI;
{to do cumulative measurements, type in 'dummy+ before Intlength
in the next line}
rUser2[j+l]:=dummy+IntLength*1000;
end; {j}
ShowResults;
end;
Macro 'Plot Intercepts'
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{This macro plots the linear intercept distance as a function of
angle
in cylindrical coordinates
It then finds the best-fit ellipse to a set of linear intercept
distance vs. angle data
using multiple linear regression of the equation Y=C0+C1*X+C2*Z,
where
Y=1/L^2 , where L is one half the linear intercept distance at
Theta
X=cosine(2*Theta), Z=sine(2*Theta)
CO=(Mii+Mjj)/2 , Cl=(Mii-Mjj)/2 , C2=Mij.
The objective is to solve for Mll, Mjj, and Mij
The best-fit ellipse it then plotted on top of the linear
intercept measurements}
var
left,top,width,height,X0,YO,Xl,Yl,i,n:integer;
pscale,aspectRatio,dxl,dx2,dyl,dy2,maxdim:real;
unit:string;
sumX,sumY,sumZ,sumXZ,sumXY,sumYZ,sumZsqr,sumXsqr:real;
CO,Cl,C2,Mii,Mjj,Mij,Y,X,Z,PI,Thetal,Theta2, L, L2 : real;
begin
PI:=3.141592654;
SaveState;
SetForegroundColor(255);
SetBackgroundColor(0);
width:=400;
height:=400;
maxdim:=0;
for i:=l to rCount do begin
if rUser2[i]>maxdim then maxdim:=rUser2[i];
end;
pscale:=.8*(width+height)/(2*maxdim);
SetNewSize(width,height);
MakeNewWindow('Linear Intercepts vs. Theta');
SetLineWidth(l);
XO:=(width/2);
YO:=(height/2);
MakeLineROI(0,YO,width,YO);
Fill;
MakeLineROI(XO,0,XO,height);
Fill;
for i:=1l to rCount do begin
dxl:=pscale*0.5*rUser2[i]*cos(rUserl[i]*PI/180);
dyl:=pscale*0.5*rUser2[i]*sin(rUserl[i]*PI/180);
if i<rCount then begin
dx2:=pscale*0.5*rUser2[i+l]*cos(rUserl[i+1]*PI/180);
dy2:=pscale*0.5*rUser2[i+l]*sin(rUserl[i+l]*PI/180);
end else begin
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dx2:=-pscale*0.5*rUser2[1]*cos(rUserl[l] *PI/180);
dy2:=-pscale*0.5*rUser2[1]*sin(rUserl[1]*PI/180) ;
end;
MoveTo(XO+dxl,YO+dyl);
LineTo(XO+dx2,YO+dy2);
MoveTo(XO-dxl,Y0O-dyl);
LineTo(XO-dx2,YO-dy2);
end;
n:=rCount;
sumX:=0;
sumY:=0;
sumZ:=0;
sumXY:=0;
sumYZ:=0;
sumXZ:=0;
sumZsqr:=0;
sumXsqr:=0;
for i:=l to n do begin
Y:= / (sqr(rUser2[i]/2)) ;
X:=cos(2*PI*rUserl[i]/180);
Z:=sin(2*PI*rUserl[i]/180);
sumX:=sumX+X;
sumY:=sumY+Y;
sumZ:=sumZ+Z;
sumXY:=sumXY+(X*Y);
sumYZ:=sumYZ+(Y*Z);
sumXZ:=sumXZ+(X*Z);
sumZsqr:=sumZsqr+sqr(Z);
sumXsqr:=sumXsqr+sqr(X);
end;
Cl:=((sumXY*sumZsqr)-(sumXZ*sumYZ))/((sumXsqr*sumZsqr)-
sqr(sumXZ));
C2:=((sumYZ*sumXsqr)-(sumXY*sumXZ))/((sumXsqr*sumZsqr)-
sqr(sumXZ));
CO:=(sumY/n)-C1*(sumX/n)-C2*(sumZ/n);
for i:=l to rCount do begin
Thetal:=rUserl[i]*PI/180;
if i<rCount then Theta2:=rUserl[i+l]*PI/180
else Theta2:=rUserl[l]*PI/180;
L1:=1/sqrt(CO+C1*cos(2*Thetal)+C2*sin(2*Thetal));
L2:=1/sqrt(CO+C1*cos(2*Theta2)+C2*sin(2*Theta2));
dxl:=pscale*Ll*cos(Thetal);
dyl:=pscale*L1l*sin(Thetal);
if i<rCount then begin
dx2:=pscale*L2*cos(Theta2);
dy2:=pscale*L2*sin(Theta2);
end else begin
dx2:=-pscale*L2*cos(Theta2);
dy2:=-pscale*L2*sin(Theta2);
end;
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MoveTo(XO+dxl,YO+dyl);
LineTo(XO+dx2,YO+dy2);
MoveTo(XO-dxl,YO-dyl);
LineTo(XO-dx2,YO-dy2);
end;
NewTextWindow('Results');
write('C0 = ',CO:8:8);
write('C1 = ',Cl:8:8);
write('C2 = ',C2:8:8);
end;
macro 'Count Black and White Pixels [B]';
{Counts the number of black and white pixels in the current
selection and stores the counts in the Userl and User2 columns.}
begin
RequiresVersion(l.44);
SetUserlLabel('Black');
SetUser2Label('White');
Measure;
rUserl[rCount]:=histogram[255];
rUser2[rCount]:=histogram[O];
UpdateResults;
end;
macro 'Compute Percent Black and White';
{Computes the percentage of back and white pixels in the
current selection. This macro only works with binary images.}
var
nPixels,mean,mode,min,max:real;
begin
RequiresVersion(1.44);
SetUserlLabel('Black');
SetUser2Label('White');
Measure;
GetResults(nPixels,mean,mode,min,max);
rUserl[rCount]:=histogram[255]/nPixels;
rUser2[rCount]:=histogram[O]/nPixels;
UpdateResults;
if (histogram[O]+histogram[255])<>nPixels
then PutMessage('This macro requires a binary image.');
end;
macro 'Compute Area Percentage [P]';
{Computes the percentage of foreground
pixels in the current selection.}
var
mean,mode,min,max:real;
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i,lower,upper,fPixels,nPixels,count:integer;
begin
RequiresVersion (. 50);
SetUserlLabel('%');
Measure;
GetResults(nPixels,mean,mode,min,max);
GetThresholds(lower,upper);
if (lower=0) and (upper=0) and
((histogram[O]+histogram[255])<>nPixels)
then begin
PutMessage('This macro requires a binary or thresholded
image. ');
exit;
end;
if nPixels=0 then begin
end;
if (lower=0) and (upper=0) then begin
if nPixels=0
then rUserl[rCount]:=0
else rUserl[rCount]:=(histogram[255]/nPixels)*100;
UpdateResults;
exit;
end;
fPixels:=0;
nPixels:=0;
for i:=0 to 255 do begin
count:=histogram[i];
nPixels:=nPixels+count;
if (i>=lower) and (i<=upper)
then fPixels:=fPixels+count;
end;
rUserl[rCount]:=(fPixels/nPixels)*100;
UpdateResults;
end;
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A.9 CG Scaffold Pore Size and pore wall thickness Analysis Protocol: Image
Acquisition and Analysis using Matlab Software
References: [104, 152]
Equipment
o Inverted optical microscope (Nikon Optiphot, Japan)
o CCD color video camera (Optronics Engineering, Inc., Goleta, GA)
o Matlab software (https://nic-too.mit.edu/cgi-bin/matlab)
Procedure
Image Acquisition
1. Visualize the embedded, sectioned, and stained scaffold samples using an optical
microscope (Nikon Optiphot).
2. Acquire digital images from the longitudinal section and the transverse section using
a CCD color video camera (Optronics Engineering). Save the images in the BMP
format with two digit numbers, such as 01.BMP, 02.BMP, etc. Also acquire a
background image of the "glass slide + glycomethacrylate" (without any scaffold
cross-section) with the same microscope set up (magnification and brightness) and
name it as bkg.BMP.
3. For each of the planes: xy, yz, and xz (in case of the rectangular scaffolds) and rO, and
Oz (in case of the circular scaffolds), put all the images of that plane and the
background image (bkg.BMP) in a specific folder.
Pore Diameter and Thickness Analysis
1. Seven different programs are written in Matlab to do the pore microstructure
calculations. The programs are:
* eliminateComponents.m
* ellipsefit.m
* getThickness.m
* mainl.m
* main2.m
* poreDia.m
* poreThickness.m
The files are written out below. Put all these files in one folder and name it as "code".
Open matlab and direct the "current directory" (in the top of the window) to the folder
"code".
2. In the command window type "edit mainl", adjust the "thresh" value to the desired
threshold value to get the optimum black and white image from the actual images.
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Also adjust the "threshSize" to the optimum value so that you do not include stray
spots. Under "Directories", for "codepath" write the path to the folder "code", and
for "Path to the images", write the path name to the specific image folder you want to
run the analysis on.
3. Run the file "mainl". It creates a folder called "thresh#" (# is the threshold value you
put in the main] program in the previous step). Look at the thresholded images in this
folder and see if the images are thresholded well enough to calculate the pore
diameter and thickness. Otherwise delete the folder and go back to previous step and
put a different "thresh" value and "threshSize". Keep trying step 2 and 3 until you
have a set of images that is good enough to run the analysis.
4. In the command window type "edit main2", adjust the "scale" to the scale of the
image in "pim/pixel". It can be calculated from Table A1.3. Adjust "minSize" and
"maxSize" to the minimum and maximum possible pore wall thickness in pm. Under
"Directories", for "codepath" write the path to the folder "code", and for
"threshpath", write the path name to the folder "thresh#" (from step 3).
5. Run the file "main2". It creates a text file called "output.txt" within the folder
"thresh#" (from step 3). The folder "output.txt" has the outputs in the order of: a, b,
R, d, and t2D (a: major axis, b: minor axis, R: anisotropic ratio, d: pore diameter, and
t2D: pore thickness measured in 2D). The pore wall thickness in 3D can be calculated
from t2D by Eq (3.5).
MatLab Codes
eliminateComponents
function L = eliminateComponents(Im,sc) [L,num] = bwlabel(Im);
for i = 1:num
s = sum(sum(L==i));
if s<sc
L = L.*(L~=i);
end
end
L=L>O;
ellipsefit
function [varargout]=ellipsefit(x,y)
%ELLIPSEFIT Stable Direct Least Squares Ellipse Fit to Data.
% [Xc,Yc,A,B,Phi,P]=ELLIPSEFIT(X,Y) finds the least squares
ellipse that
% best fits the data in X and Y. X and Y must have at least 5
data points.
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% Xc and Yc are the x- and y-axis center of the ellipse
respectively.
% A and B are the major and minor axis of the ellipse
respectively.
% Phi is the radian angle of the major axis with respect to the
x-axis.
% P is a vector containing the general conic parameters of the
ellipse.
% The conic representation of the ellipse is given by:
% P(1)*x^2 + P(2)*x*y + P(3)*y^2 + P(4)*x + P(5)*y + P(6) = 0
% S=ELLIPSEFIT(X,Y) returns the output data in a structure with
field names
% equal to the variable names given above, e.g., S.Xc, S.Yc, S.A,
S.B,
% S.Phi and S.P
% Reference: R. Halif and J. Flusser, "Numerically Stable Direct
Least
% Squares FItting of Ellipses," Department of Software
Engineering, Charles
% University, Czech Republic, 2000.
% Conversion from conic to conventional ellipse equation inspired
by
% fit ellipse.m on MATLAB Central
% D.C. Hanselman, University of Maine, Orono, ME 04469
% Mastering MATLAB 7
% 2005-02-28
% Rotation angle fixed 2005-08-09
%----------------------------------------------------------------
x=x(:); % convert data to column vectors
y=y(:);
if numel(x)-=numel(y) I numel(x)<5
error('X and Y Must be the Same Length and Contain at Least 5
Values.')
end
Dl=[x.*x x.*y y.*y]; % quadratic terms
D2=[x y ones(size(x))]; % linear terms
S1=D1'*D1;
S2=Dl'*D2;
[Q2,R2]=qr(D2,0);
if condest(R2)>1.0e10
warning('ellipsefit',...
-206-
'Data is Poorly Conditioned and May Not Represent an
Ellipse.')
end
T=-R2\(R2'\S2'); % -inv(S3) * S2'
M=S1+S2*T;
CinvM=[M(3,:)/2; -
[V,na]=eig(CinvM);
c=4*V(1, :) .*V(3,:)
A1=V(:,c>O);
P=[Al; T*A1];
M(2,:) ; M(1, :)/2];
- V(2,:).^2;
% correct signs if needed
P=sign (P (1)) *P;
Phi=atan (P (2) / (P (3)
c=cos(Phi);
s=sin(Phi);
-P(1) ) ) /2;
% rotate the ellipse parallel to x-axis
Pr=zeros (6,1);
Pr(l)=P(1)*c*c - P(2)*c*s + P(3)*s*s;
Pr(2)=2*(P(1)-P(3))*c*s + (c^2-s^2)*P(2);
Pr(3)=P(1)*s*s + P(2)*s*c + P(3)*c*c;
Pr(4)=P(4)*c - P(5)*s;
Pr(5)=P(4)*s + P(5)*c;
Pr(6)=P(6);
% extract other data
XcYc=[c s;-s c]*[-Pr(4)/(2*Pr(1));-Pr(5)/(2*Pr(3))1;
Xc=XcYc(1);
Yc=XcYc(2);
F=-Pr(6) + Pr(4)^2/(4*Pr(l)) + Pr(5)^2/(4*Pr(3));
AB=sqrt(F./Pr(1:2:3));
A=AB(1);
B=AB(2);
Phi=-Phi;
if A<B % x-axis not major axis, so rotate it pi/2
Phi=Phi-sign(Phi)*pi/2;
A=AB(2);
B=AB (1);
end
S.Xc=Xc;
S.Yc=Yc;
S.A=A;
S.B=B;
S.Phi=Phi;
S.P=P;
if nargout==l
varargout { 1 }=S;
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else
outcell=struct2cell(S);
varargout=outcell(1 :nargout);
end
getThickness
function avg = getThickness(line)
len = length(line);
grad = line(2:len) - line(l:len-l);
n = sum(line(l:len));
t = sum(grad>0);
if (n==len)
avg = n;
return;
end
if (t-=0)
avg = (n/t);
else
avg = 0;
end
mainI
clear all;clc;close all
% Parameters for calculation of pore diameter
thresh = 25; % intensity for cleaning images
threshSize = 30; % maximum component size that gets deleted
% Directories
codepath = 'C:\Documents and Settings\Biraja
Kanungo\Desktop\code';
path(path,'C:\Documents and Settings\Biraja
Kanungo\Desktop\Code'); % Path to code
% Path to images
pathname = 'C:\Documents and Settings\Biraja Kanungo\Desktop\PORE
ANALYSIS\lX';
% Cleaned images are written here
threshpath = ['C:\Documents and Settings\Biraja
Kanungo\Desktop\PORE ANALYSIS\lX\thresh' num2str(thresh)];
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
mkdir (threshpath);
cd (pathname)
files = dir;
for ind = l:length(files)
name = files(ind).name
if ( (upper(name(end)) == 'P') && (upper(name(end-4))~='G' ) )
% Note the file extension of the background
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bgname = ['bkg.BMP'];
cd (pathname)
If = imread(name);
Ib = imread(bgname);
if size(If,3)>1
If = rgb2gray(If);
end
if size(Ib,3)>1
Ib = rgb2gray(Ib);
end
If = double(If);
Ib = double(Ib);
Im = Ib - If < thresh;
Im = eliminateComponents(Im, threshSize);
Im = ~eliminateComponents(~Im, threshSize);
cd(threshpath)
imwrite(uint8(255*(Im)),[name(l:end-4) '.bmp'])
end
end
cd(codepath);
main2
clear all;clc;close all
stepSize = 5; % angle discretization in [0, 180]
lineSpacing = 10; %
scale = 1000/746; % Scaling
minSize = 5; % Minimum wall thickness possible
maxSize = 120; % Maximum wall thickness possible
% Directories
codepath = 'C:\Documents and Settings\Biraja
Kanungo\Desktop\Code';
path(path,'C:\Documents and Settings\Biraja
Kanungo\Desktop\Code'); % Path to code
% Cleaned images are written here
threshpath = 'C:\Documents and Settings\Biraja
Kanungo\Desktop\PORE ANALYSIS\1X\thresh25';
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
cd (threshpath)
files = dir;
fid = fopen('output.txt', 'w');
for ind = l:length(files)
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name = files(ind).name
if ( (upper(name(end)) == 'P')
Im = imread(name);
[X Y b a phi aspect ratio D Dscale] =
poreDia(Im,stepSize,lineSpacing,scale);
thickness = poreThickness(Im,scale,minSize,maxSize);
%Dscale and thickness in microns
out = [b a aspect ratio Dscale thickness];
fprintf(fid,'%s %6.2f %6.3f %6.2f %6.2f
%6.2f\n',name,out);
% % Graphical plotting of results
% figure,
% subplot(2,2,1),imagesc(If),colormap gray,axis
equal,axis tight
% title('Original Image')
% subplot(2,2,2),imagesc(Im),colormap gray,axis
equal,axis tight
% title('Thresholded Image')
% subplot(2,2,3),plotellipse(gca, [Xc Yc],a,b,phi,'k-
'),hold;
% subplot(2,2,3),plot([X X(1)],[Y Y(l)],'rx-'), axis
equal,axis tight
% title('Least square ellipse fit in polar coordinates');
% xlabel('X\rightarrow'); ylabel('Y\rightarrow');
end
end
fclose(fid); %Closes the file opened for writing results
cd(codepath);
poreDia
function [X Y b a phi aspect ratio D Dscale] =
poreDia(Im, step size,line spacing,scale)
[row,col] = size(Im);
angles = [O:step size:180-stepsize];
N = length(angles);
for i = 1:N
Jr = (imrotate(Im,angles(i),'crop')>0.5);
n=O;s=O;
for j = l:line spacing:row
t = getThickness(Jr(j,:));
s = s + t;
n = n + (t~=O);
end
if (n == 0)
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intercepts(i) = 0;
else
end
intercepts(i) = s/n;
end
% Figure quantities
X = cos(pi*angles/180).*intercepts/2;
Y = sin(pi*angles/180).*intercepts/2;
X = [X -X]; Y = [Y -Y];
% Final parameters
[Xc,Yc,a,b,phi,p] = ellipsefit(X,Y);
aspect ratio = b/a;
D = 2 * sqrt( (a^2 + b^2)/2 );
Dscale = 1.5*D*scale;
% [b a phi aspect ratio D Dscale]
poreThickness
function dia = poreThickness(Im,scale, minSize, maxSize)
If = ~Im;
Ib = Im;
L = bwdist(Ib);
T = imdilate(L,ones(5,5));
S = (T==L).*(If). *(L>minSize).*(L<maxSize);
% Diameter
D = (L.*S);
radius = sum(sum(D))/sum(sum(S));
dia = 2*radius*scale;
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A.10 CG Scaffold Mechanical Characterization Protocol using Zwick Mechanical
Tester: Compression
References: [17, 103, 104, 152]
Supplies
o 5 mm dermal biopsy punch (Miltex, Cat. No. 52442 or 52443, Moore Medical
LLC, New Britain, CT)
o Phosphate Buffered Saline (PBS, Cat. No. 20012-043, Invitrogen, Inc., Carlsbad,
CA)
Equipment
o Zwick/Roell Mechanical Tester (Model No. Z2.5/TN1S, Zwick GmbH & Co.,
Ulm, Germany)
o 20 N load cell (Part No. BTC-LC0020N.P01, Zwick)
o Video Extensometer software (Correlated Solutions, Inc., West Columbia, SC)
o High-speed, digital CCD Camera (Retiga 1300, QImaging Corp., Canada)
o 200 mm lens (Nikon, Japan)
Procedure
1. Attach the 20 N load cell (Zwick Part No. BTC-LC0020N.P01) to the mechanical
tester (Zwick Model No. Z2.5/TN1S). Confirm the connection between the load cell
and the testXpert (Zwick) test environment and data acquisition software package.
2. Using the integrated testXpert software package, define the mechanical
characterization environment. Save the test environment as a *.ZPV file.
* Test type: Unconfined compression
* Sample geometry: Cylindrical disk, 5 mm diameter
* Strain range: 0 - 9 5 % strain
* Loading rate: 0. 1-2% strain/sec, strain controlled
* Sampling frequency: 2 Hz
* Hold time at max strain: 30 seconds
3. For mechanical characterization of dry or hydrated CG scaffolds, cut cylindrical disks
from the scaffold sheet using a 6 or 8 mm diameter dermal biopsy punch (Miltex).
Hydrate the scaffold samples, if necessary, for 12 hours in Phosphate Buffered Saline
(PBS, Invitrogen).
4. Measure the dimensions of each scaffold sample being tested in order to calculate
stress and strain from the load-displacement data.
5. In order to measure the lateral strains of the scaffold sample under unconfined
compression and calculate the Poisson's ratio of the scaffold, set up the high-speed,
digital CCD Camera (Retiga 1300, QImaging Corp.) with a 200 mm lens (Nikon)
linked to a laptop running the video extensometer software (Correlated Solutions);
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link the data acquisition laptop to the Zwick mechanical tester so that a lateral strain
data point is acquired every time an unconfined compression data point is taken.
6. Using the testXpert control software, perform sequential mechanical tests on a series
of CG scaffold samples. Save the data file for each series of tested scaffolds as a
*.ZSE file.
7. Export the acquired Standard Force (N), Standard Strain (%), and Test Time (s) data
from the testXpert software package to an Excel spreadsheet. Export the lateral strain
data from the video extensometer package to the same spreadsheet.
8. Calculate stress from the acquired force data and the measured scaffold dimensions.
9. Determine E* and Ac/Ae from the linear regions of the linear elastic and collapse
plateau regimes. Calculate u* and e* from the intersection of the linear regressions of
E* and Aa/Ae.
10. Determine the Poisson's ratio, v, from the measured vertical and lateral strains in the
linear elastic and collapse plateau regimes.
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A.11 CG Scaffold Mechanical Characterization Protocol using Zwick Mechanical
Tester: Tension
References: [17, 103, 104, 152]
Supplies
o Rectangular specimen cut on the plane of the scaffold sheet (length: - 15 mm,
width: - 10 mm, and thickness: - 5 mm). After clamping the specimen on the top
and bottom, the effective length of the sample becomes - 5 mm.
o Phosphate Buffered Saline (PBS, Cat. No. 20012-043, Invitrogen, Inc., Carlsbad,
CA)
o Special fixtures to hold the samples under tensile loading
Equipment
o Zwick/Roell Mechanical Tester (Model No. Z2.5/TN1S, Zwick GmbH & Co.,
Ulm, Germany)
o 20 N load cell (Part No. BTC-LC0020N.P01, Zwick)
o Video Extensometer software (Correlated Solutions, Inc., West Columbia, SC)
o High-speed, digital CCD Camera (Retiga 1300, QImaging Corp., Canada)
o 200 mm lens (Nikon, Japan)
Procedure
1. Attach the 20 N load cell (Zwick Part No. BTC-LC0020N.P01) to the mechanical
tester (Zwick Model No. Z2.5/TN1S). Confirm the connection between the load cell
and the testXpert (Zwick) test environment and data acquisition software package.
2. Clamp the samples at the top and bottom by the special fixtures for tension tests.
After clamping - 5mm of the scaffold specimen on both ends, the effective testing
length becomes - 5mm.
3. Using the integrated testXpert software package, define the mechanical
characterization environment. Save the test environment as a *.ZPV file.
* Test type: Uniaxial Tension
* Sample geometry: Rectangular, 5 x 10x 5 mm 3
* Strain range: 0 - 95% strain
* Loading rate: 0.1-2% strain/sec, strain controlled
* Sampling frequency: 2 Hz
* Hold time at max strain: 30 seconds
4. For mechanical characterization of dry or hydrated CG scaffolds, cut rectangular
samples from the scaffold sheet Hydrate the scaffold samples, if necessary, for 12
hours in Phosphate Buffered Saline (PBS, Invitrogen).
5. Measure the dimensions of each scaffold sample being tested in order to calculate
stress and strain from the load-displacement data.
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6. In order to measure the lateral strains of the scaffold sample under uniaxial tension
and calculate the Poisson's ratio of the scaffold, set up the high-speed, digital CCD
Camera (Retiga 1300, QImaging Corp.) with a 200 mm lens (Nikon) linked to a
laptop running the video extensometer software (Correlated Solutions); link the data
acquisition laptop to the Zwick mechanical tester so that a lateral strain data point is
acquired every time an unconfined compression data point is taken.
7. Using the testXpert control software, perform sequential mechanical tests on a series
of CG scaffold samples. Save the data file for each series of tested scaffolds as a
*.ZSE file.
8. Export the acquired Standard Force (N), Standard Strain (%), and Test Time (s) data
from the testXpert software package to an Excel spreadsheet. Export the lateral strain
data from the video extensometer package to the same spreadsheet.
9. Calculate stress from the acquired force data and the measured scaffold dimensions.
10. Determine E* from the initial linear region of the stress-strain plot (at - 0% strain).
11. Determine the Poisson's ratio, v, from the measured vertical and lateral strains in the
linear elastic and collapse plateau regimes.
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A.12 MC3T3-E1 mouse clonal osteogenic cell passaging
Supplies
o MC3T3-E1 mouse clonal osteogenic cells (ATCC, Manassas, VA)
o Pre-warmed complete MEM-a media supplemented with 10% FBS (Invitrogen,
Chicago, IL)
o Pre-warmed Dulbecco's Phosphate Buffered Saline Solution (PBS, Invitrogen)
o Pre-warmed trypsin-EDTA (Catlog# 25300062, Invitrogen)
o Trypan blue (15250-01, Gibco, Grand Island, NY)
Equipment
o Hemacytometer, cleaned and washed (Bright-Line, Hausser Scientific, Horsham,
PA)
o Inverted microscope
o 10, 25, and 50 ml Pipettes
o 10, 25, and 50 ml pipette tips
o 10, 200, 1000 FL pipettes and pipette tips
o 75 cm2 tissue culture flasks (BD Falcon T-75, 353136)
o Centrifuge (Labofuge 400, Heraeus)
o 50 ml Falcon tubes
o 1 ml Eppendorf tubes or PCR tubes
Procedure
1. Turn on the water bath.
2. Prepare the hemocytometer.
* Clean the hemocytometer and cover slip with water and ethanol (EtOH).
* Check under the microscope for debris that can be mistaken for cells. If debris
is present, clean the hemocytometer again. Otherwise position the cover slip.
3. Thaw and/or warm up media, PBS, and trypsin-EDTA in the 37 C water bath (about
30 min before passaging).
4. Remove the cells from the incubator and place them in the hood.
5. Remove the media from each culture flask.
6. Wash the cells in each flask with 5 ml PBS.
* Add the PBS to the cells.
* Gently rock the flask back and forth to spread the PBS over the entire surface
area.
* Leave the PBS on the cells for about 20 seconds; then pipette it out of the
flasks.
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7. Pipette 4 ml trypsin in each flask and put cells in incubator 8 min. Make sure that the
trypsin solution covers the cells.
8. After 8 min, take the cells out of the incubator. Shake the flasks gently and check for
cells floating in the trypsin (visible without microscope). Double check for
9. non-adherent cells under the microscope. If the cells are still adherent, incubate them
in trypsin a little longer. Otherwise put cells in hood and continue.
10. Deactivate the trypsin by adding 6 ml of media to each flask.
11. Put the cells+media+trypsin in a 50 ml falcon tube.
12. Remove 100 uL of cells and transfer them to an eppendorf tube. Centrifuge the
remainder of the cells at 2700 rpm for 5 min to pellet the cells.
13. While the cells are centrifuging, determine the cell the total cell number.
* Add 100 uL trypan blue to the 100 uL of cells in the eppendorf tube; i.e.,
dilution factor of 2.
* Mix well.
* Remove 10 uL and pipette it onto the hemocytometer.
* Count the number of cells, N, in a given number of squares, n (at least 5)
using the counter.
* Calculate the total cell number, TN, from the following formula:
N x dilution fa cot r x 10000 x (# ml the 100 pl of cells were taken from) (Al.7)TN =(A1.7)
n
* Dispose of the trypan blue cells in a special waste container.
* Wash off hemocytometer with water and ethanol.
14. After centrifuging, decant the media, being careful not to disturb the cell pellet.
15. Resuspend the cells in fresh media to the desired concentration.
16. Pipette the desired number of cells into culture flasks, and add media so that the final
volume concentration is about 17 ml.
17. Put cells in incubator, changing media every 3-4 days if cells are not passaged.
Passage the cells again when they subconfluent.
18. Clean everything, making sure to bleach any items that came in contact with cells.
Note: When using flasks that don't have vented caps, be sure that the cap is untwisted
about a quarter or half turn while the cells are in the incubator.
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A.13 MC3T3-E1 mouse clonal osteogenic cell seeding onto the scaffolds and
counting the cells after 24 hour.
Supplies
o MC3T3-E1 mouse clonal osteogenic cells (ATCC, Manassas, VA)
o Pre-warmed complete MEM-a media supplemented with 10% FBS (Invitrogen,
Chicago, IL)
o Pre-warmed Dulbecco's Phosphate Buffered Saline Solution (PBS, Invitrogen)
o Pre-warmed trypsin-EDTA (Catlog# 25300062, Invitrogen)
o 6 mm diameter and 5 mm thick CG scaffolds
o 6-well tissue culture ultra low attachment agarose coated plate (Coming Inc.,
Coming, NY).
o Dispase (Invitrogen, Chicago, IL)
Procedure
1. Place the CG scaffold samples into wells of a 6-well tissue culture ultra low
attachment agarose coated plate (Coming Inc., Coming, NY). Hydrate the CG
scaffolds with 10% PBS for 12 hr under vacuum followed by hydrating with the
MEM-a medium supplemented with 10% FBS for another 12 hr under vacuum.
2. Remove the CG scaffolds from the medium and partially dry using a filter paper.
3. Pipette 10 [tl of the MC3T3-E1 cell suspension (1.25 x 104 cells/gl) onto one surface
of the partially dry scaffold.
4. Place the scaffolds inside an incubator for 30 min to allow for initial cell attachment
through that surface.
5. Turn over the seeded scaffolds and pipette an additional 10 pl of the cell suspension
onto the reverse surface of the scaffold.
6. Place the scaffolds in the incubator for additional 30 min to allow for initial cell
attachment through the reverse surface.
7. Fill the with 3ml of the MEM-a medium (supplemented with 10% FBS) and place
into a cell culture incubator and maintained at 37C with 5% CO 2 for 24 hr.
8. Remove the seeded scaffold samples from the tissue culture plate. Rinse each sample
with 10% PBS at 370C to remove unattached cells and place it in a 2.0 U/ml solution
of dispase for 15 min to digest the scaffolds.
9. Count the number of viable cells attached using a hemocytometer as mentioned in
previous protocol (Eq (Al.7)).
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